Adrenergic control of hepatic carbohydrate metabolism in the perinatal rat. by Evans, Carole A.
ADRENERGIC CONTROL OF 
HEPATIC CARBOHYDRATE METABOLISM 
IN  THE PERINATAL RAT
A thesis subm itted to the 
U n ivers ity  o f Surrey
by
(c )  CAROLE A . EVANS, B.A., M.Sc.
in fu lf ilm e n t o f the requirements fo r 
the award o f the degree o f
DOCTOR OF PHILOSOPHY
Departm ent o f B iochem istry 
U nivers ity  o f Surrey 
Guildford 
Surrey, U.K. August, 1986
ProQuest Number: 10798434
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10798434
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
ABSTRACT
Carbohydrate metabolism in the liv e r  o f the laboratory ra t im m ediate ly 
before and a fte r b irth  has been shown to  be regulated by the hepatic adrenergic 
system.
125[ I ]  -iodopindolol was used to characterise the B-adrenoceptor population of 
live r membranes prepared from  fe ta l and neonatal rats. The receptors were 
predom inantly o f the f^-sub type . The dissociation constant o f th is radioligand 
(about 75pM) was not s ign ifican tly  d iffe re n t when membranes from  animals o f 
d iffe re n t ages were used, indicating th a t the type and subtype o f receptors being 
labelled did not change w ith  age. However, the size o f the B-adrenoceptor 
population did vary w ith  age and reached a maximum in membranes isolated from  
term  fe ta l rats.
Hepatocytes were isolated from  ra ts during the perinata l period and 
incubated w ith  various adrenergic agents. Both glucose production and glycogen 
breakdown in freshly isolated hepatocytes were shown to  be stim ula ted by 
adrenergic agonists. The use o f adrenoceptor type- and subtype-specific agents 
confirm ed tha t adrenergic modulation o f carbohydrate metabolism in these cells 
was B2~mediated. When hepatocytes were isolated from  term  fetuses o f 
gestationally diabetic dams, glucose production and glycogen breakdown in these 
cells was shown to be resistant to adrenergic action.
Adrenaline administered ]n  vivo to  new ly-delivered rats was shown to 
increase plasma glucose and lacta te  concentrations and to decrease liv e r glycogen 
content at two hours a fte r delivery. A t  appropriate doses, adrenaline prevented the 
hypoglycaemia norm ally seen in the hours im m ediate ly fo llow ing b irth  in the ra t. 
Adrenergic antagonists, when administered in traperitonea lly  im m edia te ly a fte r  
delivery, prevented the natural increase in plasma glucose concentration a t three
hours post partum . The B-adrenergic antagonist propranolol was more e ffe c tive  
than the a-adrenergic antagonist phentolamine. These findings support ac tiva tion  
o f the adrenergic system as an essential fa c to r in the mechanism fo r recovery from  
postnatal hypoglycaemia in the laboratory ra t.
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CHAPTER 1 
GENERAL INTRODUCTION
1.1 METABOLISM IN  THE PERINATAL RAT
A number o f books and reviews on the top ic o f metabolism in the neonate are 
available (Ballard, 1971a; B a ttag lia  & Meschia, 1978; Bohme et al., 1983; DeMeyer, 
1981; Hommes & Van Den Berg, 1975; Jones, 1982; Snell & Walker, 1973a).
1.1.1 OVERVIEW
M ajor changes occur in metabolism during the transition  from  fetus to adult; 
such changes are a consequence of the very d iffe re n t n u trition a l environm ent a t 
various stages o f development. A t  b irth , and fo llow ing weaning, the com position o f 
nutrients available changes sharply; the trans ition  from  fetus to  neonate, and the 
mechanism o f adaption o f glucose metabolism to this transition , is the top ic o f 
investigation o f th is pro ject.
For the ra t fetus jn  u tero , i t  has been estim ated tha t 50-80% o f the ca lo ric  
requirement is satisfied by glucose supplied transplacentally from  the m other 
(B attag lia  & Meschia, 1978). A lthough fe ta l plasma glucose levels are generally 
found to be lower than m aternal values (G irard e t al., 1973a; D iMarco e t al., 1976), 
when the gravid ra t is fasted, fe ta l glucose levels are maintained p re fe re n tia lly  
(Bossi & Greenberg, 1972; Goodner et aj., 1969). Follow ing pa rtu rition , m ilk  is the 
sole nu trition a l source and hence the m a jo rity  o f calories taken by the neonate are 
in fa t or prote in (Luckey et al., 1954). I t  has been estim ated tha t the ca lo rie  
content o f m ilk due to  carbohydrate is only 8% (Dymsza et al., 1964; Hahn e t al., 
1961), which is insu ffic ien t to balance the glucose u tilisa tion  o f the suckling anim al 
(Snell & Walker, 1973a).
F a tty  acids and ketone bodies are the m ajor substrates o f ox ida tive  energy 
metabolism in the suckling ra t (Bailey & Lockwood, 1973; Vernon & W alker, 1968).
Free fa tty  acids do not cross the placenta free ly  (Koren & Shafrir, 1964) and are 
present at lower concentrations in fe ta l than m aternal blood (Blazquez e t al., 1975; 
G irard et al., 1973a). Increases in free fa tty  acids fo llow ing b irth  have been seen; 
s ligh tly  less than a tw o-fo ld  increase w ith in  three or four hours o f b irth , in the 
absence o f feeding (G irard e t al., 1973a; Snell & Walker, 1973b), or a more 
sign ifican t increase maintained fo r 24 hours when the neonates were allowed to 
suckle (Blazquez et al., 1974; D ierks-Ventling, 1971; Snell & Walker, 1973b) have 
been observed. The oxidation o f fa tty  acids in the neonate is v ita l fo r the supply o f 
ace ty l coenzyme-A required fo r gluconeogenesis (Ferre, 1978b; Snell, 1974). 
Ketone bodies, which are at about the same blood level in mother and fe tus (G irard 
e t al., 1973a), remain steady or decrease im m ediate ly postnata lly but show a 
marked increase a fte r suckling starts  (Ferre e t al., 1978a; G irard et al., 1973a; 
Haymond et al., 1972; Snell & Walker 1973b). G lycerol plasma levels are high in the 
neonate (Vernon & Walker, 1970) and have been reported to show no change in the 
f irs t  few hours fo llow ing delivery (Cuezva et al., 1980b) or to  show a marked but 
transient increase, returning to levels s im ila r to those im m ediate ly a fte r  b irth  by 6 
hours post partum  (G irard e t al., 1973a).
M ille r (1970) has shown tha t weight gain in the suckling ra t is proportiona l to 
prote in intake, although the calorie content o f the m ilk , o f which pro te in  accounts 
fo r only 23% (Dymsza et al., 1964), is also cruc ia l to achieve fu ll grow th. About 
70% o f the prote in content o f m ilk  is used in biosynthesis (Hahn & Koldovsky, 
1961), but some amino acids may also serve as gluconeogenic substrates (Snell, 
1982a). Alanine is probably quan tita tive ly  the most s ign ifican t amino acid used in 
glucose fo rm ation  in the neonatal ra t liv e r (Snell & Walker, 1973a), w ith  g lutam ate 
and aspartate also making im portant contributions (Yeung & O liver, 1967). A lso, an 
increased gluconeogenic capacity from  serine and threonine in the neonate has 
been reported (Vernon et al., 1968), and confirm ed in the case o f serine (Snell,
1975). A lanine plasma levels are high in the la te  fe ta l and newly born ra t, but show 
a marked decrease in the f ir s t  few postnatal hours (Cuezva e t al., 1980b; G irard e t 
al., 1973a; Haymond et al., 1972; Snell Sc Walker, 1973a). L i t t le  has been published 
concerning the plasma levels o f other amino acids in the perinata l period; G irard e t 
al. (1975) have reported tha t plasma concentrations o f 18 o f the 22 amino acids 
investigated showed decreases up to 16 hours post partum .
1.1.2 GLUCOSE METABOLISM
Follow ing b irth , and the loss o f the m aternal supply o f glucose, a period o f 
hypoglycemia is seen in the neonatal animal. The pattern  usually seen is a decrease 
to  a nadir at 1 to  2 hours post partum , fo llowed by recovery to  la te - fe ta l levels by 
approxim ately 3 hours post partum (Butcher Sc P otte r, 1972; Cake e t al., 1971; 
Cuezva e t al., 1982a; Dawkins, 1963a; Fernandez e t al., 1983; G irard e t al., 1972; 
G irard et al., 1973a; P h illipe  Sc K itz m ille r, 1981; Snell Sc Walker, 1973b; Sodoyez- 
Goffaux e t al., 1979a). Occasionally, low levels have been seen fo r up to  5 hours 
a fte r b irth  (Ballard, 1971a; Benito et al., 1980; M artin  et al., 1981).
The m a jo rity  o f studies perform ed to investigate this phenomenon have been 
carried out by caesarian section and rem oval o f the young close to  term , in order 
to  synchronise the tim e o f b irth  fo r the entire  l i t te r .  Follow ing delivery, pups are 
usually placed at constant hum id ity and tem perature and remain unfed u n til they 
are k illed  and the ir blood glucose level determ ined (e.g. G irard et al., 1973a; Snell 
Sc Walker, 1973b). Gain and Watts (1976) and Gain e t al. (1981) have cla im ed tha t 
th is does not give an accurate p ic ture  o f the natural s ituation. They allowed ra ts to 
l i t te r  spontaneously, and marked each pup at b irth  to allow tim e o f de live ry o f 
individual pups to be known. The neonates were allowed to remain w ith  the m other 
and suckle u n til they were k illed . No hypoglycaemia was seen in the six hours
fo llow ing b irth  in these studies, nor in th a t reported by Blazquez e t al. (1974), when 
natura l b irth  was allowed to occur in preference to surgical delivery. However, 
ether anaesthesia o f the neonates was used to obtained blood samples in the work 
by Gain and coworkers, and this is known to cause elevations in blood glucose levels 
(DiMarco et al., 1976). Also, postnatal hypoglycemia fo llow ing natura l b irth  has 
been noted by other workers (Cake et al., 1971; DiMarco et al., 1976; Sodoyez- 
Goffaux et al., 1979a). Discrepancies in findings may be due, at least in part, to 
differences in the temperature at which neonates are kept. Cuezva e t al. (1980a) 
noted only s ligh t postnatal hypoglycemia when neonates were kept a t 30°C, 
compared w ith  37°C, w h ils t Kervran et al. (1976) saw no reduction in plasma 
glucose levels when surgica lly-de livered neonates were kept a t 24°C, although 
there was marked hypoglycemia a t one hour post partum i f  the tem perature was 
maintained at 37°C. The tem perature o f the nest in which na tura lly-born neonates 
are kept by the dam is 35°C (Pegorier et al., 1978), and so the balance o f evidence 
would appear to support a period o f postnatal hypoglycemia as a physiological 
phenomenon.
P rio r to the commencement o f suckling, the blood level o f glucose is the net 
result o f its  u tilisa tion  and production by the neonatal tissues. Radioactive 
labelling studies have shown tha t glucose u tilisa tion  is approxim ate ly 14 
umol/m in/lOOg at b irth , and decreases during suckling, returning to  levels o f the 
same order as tha t seen im m ediate ly a fte r delivery fo llow ing weaning (W alker & 
Snell, 1973). The rate o f glucose u tilisa tion  was reported to be reduced by 2 to  3 
hours post partum , which the authors suggested was the resu lt o f the changing 
hormonal environment, and the onset o f fa tty  acid oxidation (Snell & W alker, 
1973b); in the same study, glucose production increased markedly in the f ir s t  two 
hours post partum , and then dropped again, probably as a result o f decreased 
ava ila b ility  o f gluconeogenic substrates. However, o ther work has shown increased
glucose turnover at 4 and 6 hours post partum (G irard & G u ille t, 1975). Recycling 
o f glucose via the Cori and alanine cycle has been reported to  be less than 10% o f 
tha t u tilised at any tim e from  b irth  to day 30 post partum (Vernon & Walker, 1972), 
however other work has suggested recycling o f glucose o f approxim ately 20% in the 
1 day old suckling ra t (Ferre et al., 1980, 1981b).
Glucose production may be from  two possible sources; breakdown o f stored 
glycogen or de novo synthesis from  gluconeogenic precursors may both contribu te  
to blood glucose levels. Studies investigating the prenatal accum ulation o f 
glycogen, or the postnatal production o f glucose, have determ ined both the levels 
o f the substrates and products o f pathways o f carbohydrate metabolism, and the 
a c tiv ity  o f the enzymes involved in these pathways. Before describing the findings 
o f such studies, i t  is appropriate to discuss the enzymes o f glucose metabolism  and 
th e ir regulation.
Enzymes o f glucose metabolism
In addition to synthesis and degradation o f enzyme molecules, enzyme 
ac tiv itie s  may be modulated by both stable, covalent, m odifica tions or rap id ly - 
reversible, non-covalent changes (Hems & W hitton, 1980); Van De Werve e t al. 
(1977a) proposed the te rm  'ac tiva tion1 fo r the fo rm er type o f m od ifica tion  and 
's tim u la tion ' fo r the la tte r.
Glycogen synthase catalyses the conversion o f UDP-glucose to glycogen. This 
enzyme exists in the D (or b) form  (in which i t  may be stim ulated by the a llos te ric  
m od ifie r glucose-6-phosphate) or in the I (or a) fo rm  (active  even in the absence of 
glucose-6-phosphate). Conversion o f the I to the D form  is by phosphorylation 
(Lehninger, 1975; W illiamson et al., 1981). Conversely, glycogen phosphorylase, 
which is involved in the breakdown o f glycogen to glucose 1-phosphate, is 
converted from  the less active (b) fo rm  to  the more active  (a) fo rm  by
phosphorylation (Hems & W hitton, 1980; W illiamson et al., 1981). The activa tion  
and inactiva tion  o f glycogen synthase and phosphorylase are contro lled by the
a c tiv itie s  o f kinase and phosphatase enzymes. Phosphorylase b kinase is its e lf
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activa ted by a cyc lic  AMP-dependent phosphorylation or by Ca + (Vandenheede et 
al., 1977; Cohen, 1982). An inverse relationship between the ac tiv itie s  o f glycogen 
synthase and phosphorylase has been noted, which appears to be the resu lt o f an 
inh ib ito ry  e ffe c t o f phosphorylase a on synthase phosphatase (Stalmans e t al., 
1974). Glucose is known to increase the a c tiv ity  o f phosphorylase phosphatase 
(Stalmans et al., 1974), and th is has been suggested to be the mechanism by which 
glucose activates glycogen synthase (Pines et al., 1976; Stalmans e t al., 1974; 
W illiamson et al., 1981). However, there is evidence o f a d irec t s tim u la tion  o f 
synthase a c tiv ity  by glucose in adult (W atts et al., 1982c) or day 17 post partum  
fe ta l live r (Pines et al., 1976).
Glucose form ation by the liv e r may involve not only glycogen breakdown but 
also gluconeogenesis. The existence o f enzymes unique to gluconeogenesis, ra the r 
than enzymes o f the g lyco ly tic  pathway acting in the reverse d irection , is an 
im portant feature o f regulation o f th is  pathway. Another im portan t fea tu re  stems 
from  the in trace llu la r com partm entation o f gluconeogenesis which necessitates the 
transfer o f pyruvate from  the cytosol in to  the m itochondria and the export o f 
carbon, in the form  o f malate or aspartate, from  the m itochondria to the cytosol. 
An increased m itochondria l uptake o f pyruvate is associated w ith  a s tim u la tion  o f 
gluconeogenesis (Denton & Halestrap, 1979), but there is a general concensus th a t 
the prim ary event is an in tram itochondria l response (Haynes, 1985). Pyruvate 
carboxylase, which catalyses the conversion o f pyruvate to oxaloacetate in the 
m itochondria, is an obvious point o f con tro l o f gluconeogenesis, being the f ir s t  
enzyme o f the gluconeogenic pathway. This enzyme is stim ulated a llo s te rica lly  by 
acety l coenzyme-A; fo rm ation  o f acety l coenzyme-A from  pyruvate is catalysed by
pyruvate dehydrogenase, which has been shown to be inactiva ted  by 
phosphorylation (Bailey et al., 1976). Pyruvate carboxylase is also regulated 
a llos te rica lly  by ATP (activates) and by glutam ate (inhibits). Pyruvate kinase, 
which catalyses the reaction converting phosphoenol pyruvate to pyruvate has been 
reported to be inactiva ted by phosphorylation (Soling at al., 1978; Claus & P ilk is , 
1981; W illiamson et al., 1981). No evidence o f phosphorylation-induced a c tiv ity  
changes in phosphoenolpyruvate carboxykinase (PEPCK), which together w ith  
pyruvate carfeo^iase reverses the conversion catalysed by pyruvate kinase, has been 
reported. The interconversion o f fructose 6-phosphate and fructose 1,6- 
bisphosphate is the next step in the gluconeogenic pathway contro lled by d iffe re n t 
enzymes dependent on the d irection o f conversion. The gluconeogenic enzyme 
fructose 1,6-bisphosphatase is activated by phosphorylation (Soling e t al., 1978; 
W illiamson et al., 1981), which has been reported to  have no e ffe c t on (W illiam son 
et al., 1981), or to decrease the a c tiv ity  o f (Soling e t al., 1978), the g lyco ly tic  
enzyme phosphofructokinase. Phosphofructokinase a c tiv ity  is also regulated by the 
concentrations o f its  substrate, fructose 6-phosphate, and its  product, fructose 1,6- 
bisphosphate (Van Schaftingen et al., 1980a) and is stim ulated by fructose 2,6- 
bisphosphate (Van Schaftingen et al., 1980b). Glucose 6-phosphatase is the fin a l 
enzyme in the glycogenolytic and gluconeogenic pathways, catalysing the 
form ation o f glucose from  glucose 6-phosphate. There is no evidence fo r con tro l o f 
the a c tiv ity  o f this enzyme, nor o f the opposing g lyco ly tic  enzyme, glucokinase, by 
a phosphorylation-dephosphorylation cycle. Regulation o f the in terconversion o f 
glucose and glucose 6-phosphate appears to be by synthesis/degradation o f the tw o 
enzymes involved and by k ine tic  activa tion  o f the enzymes through changes in 
substrate concentration (Newsholme & Leech, 1983).
P erinata l glycogen synthesis
In a ll species so fa r examined, glycogen deposition is seen in the fe ta l liv e r 
towards the end o f gestation (Shelley, 1961). Glycogen deposition in the la te  fe ta l 
ra t liv e r was f irs t  noted by Dawkins (1963a). In the term  ra t fetus, glycogen makes 
up 10% or more o f the net weight o f the live r. (Bashan et al., 1979; Gain e t al., 
1981; G irard et al., 1972; Greengard & Dewey, 1970; Pines e t al., 1975; W atts et 
al., 1982a). The hepatic glycogen content is low at day 17 post co itum  (Greengard 
& Dewey, 1970; Pines et al., 1975; Watts et al., 1982b), and increase slowly up to 
day 19 post co itum , a fte r which a marked increase is seen p rio r to te rm  (Bashan et 
al., 1979; Pines et al., 1975; Watts et al., 1982b). Acce lera tion o f glycogen storage 
appears to be a result o f an increase in the a c tiv ity  of the enzyme glycogen 
synthase due to both increased enzyme synthesis and conversion to the active  fo rm  
by dephosphorylation (Bashan et al., 1979; Devos & Hers, 1974; Pines e t al., 1975; 
Vanstapel e t al., 1980; Watts & Gain, 1976). Glycogen synthase is present la rge ly in 
the inactive  (b or D) form  in early fe ta l live r (Devos & Hers, 1974; Pines e t al., 
1975; Vanstapel et al., 1980); an increased conversion to the active  fo rm  results 
from  the increase in synthase phosphatase a c tiv ity , which appears on day 18 post 
coitum  (Devos & Hers, 1974), and increases u n til day 19 post co itum  (Bashan et al., 
1979) or u n til b irth  (Vanstapel et al., 1980). Burch (1965) reported glycogen 
synthase a c tiv ity  in la te  fe ta l live r to be 400-500% o f tha t norm ally found in adu lt 
liver.
The possib ility o f glycogen degradation during th is period o f net deposition is 
disputed. Devos and Hers (1974) reported glycogen synthase a a c tiv itie s  only ju s t 
high enough to account fo r the rate o f glycogen deposition; they suggested any 
phosphorylase present was in the b form , and thus showed low a c tiv ity . Le Provost 
e t al. (1980) also found no indication o f glycogen degradation from  day 19.5 post 
coitum  to term . However, fe ta l live r glycogen has been described as being in
'dynamic equ ilibrium ' w ith  blood glucose (Bossi & Greenberg, 1972). G ilb e rt & 
Bourbon (1978) concluded from  radioactive labelling studied tha t physiological 
turnover o f hepatic glycogen occurs in the la te  fe ta l period, despite net deposition. 
Watts & Gain (1976) proposed a cycle due to the simultaneous presence o f synthase 
a and phosphorylase a in the la te  fe ta l live r; they suggested tha t the glycogen level 
its e lf would contro l the ra tio  o f phosphorylase a to synthase a, and thus the 
presence o f net glycogen synthesis or breakdown.
P erinata l qlycoqenolysis
Follow ing delivery, the glycogen stored in la te  gestation is rap id ly  degraded; 
a 40-50% decrease in five  hours has been reported (Benito e t al., 1980; Cuezva et 
al., 1982a; M artin  et al., 1981), w ith  glycogen stores 'exhausted' a t 12 hours post 
partum  (G irard, 1981) or reduced to  1% or less o f term  level a t 24 hours post 
partum  (Ballard, 1971a). Most data suggest breakdown of less than 10% o f hepatic 
glycogen in the f ir s t  hour a fte r b irth  (Cuezva et al., 1982a; Fernandez e t al., 1983; 
Ferre e t al., 1978b; G irard et al., 1972, 1973a; Snell & Walker, 1973b) but i t  was 
reported tha t when rats were allowed to l i t te r  natura lly, the steepest decline in 
glycogen content occurred between b irth  and 30 minutes post partum  during which 
period 25% o f the glycogen stored in the term  fe ta l live r was lost (Gain & Watts,
1976). This s ign ifican t glycogen loss in the im m ediate ly postnatal period has been 
confirm ed fo r spontaneously delivered rats in another study by th is  group (Gain e t 
al., 1981). However, Ferre et al. (1978b) reported no s ign ifican t glycogenolysis up 
to two hours post partum  in na tura lly  born rats. I t  is in teresting to note th a t the 
in it ia l glycogen content, im m ediate ly a fte r delivery reported by Gain & colleagues 
(300 pm ol/g wet w t., or 60 mg/g wet w t.) is only 65% o f tha t reported in o ther 
studies (Benito et al., 1980; Butcher & P o tte r, 1972; Cuezva et al., 1980b, 1982a; 
Fernandez et al., 1983; G irard et al., 1972, 1973a; Snell & Walker, 1973b). I f  th is
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was the result o f glycogen loss during vaginal delivery, i t  is surprising tha t Ferre e t 
al. (1978b) noted s ta rting  glycogen levels (94 mg/g wet wt) s im ila r to  workers 
delivering animals surgica lly. The reasons fo r the findings o f Gain’s group are not 
clear, but the onset o f postnatal glycogenolysis only a fte r a delay o f one or two 
hours seems to be a common finding (Benito e t al., 1980; Butcher & P o tte r, 1972; 
Cuezva et al., 1982a; Ferandez et al., 1983; Ferre et al., 1978b; G irard e t al., 1972, 
1973a; Snell & Walker, 1973b).
I t  is generally accepted tha t an increase in the a c tiv ity  o f hepatic glycogen 
phosphorylase, coupled w ith  decreased glycogen synthase a c tiv ity , are responsible 
fo r postnatal glycogenolysis. Although glucose-6-phophatase a c t iv ity  also 
increases sharply a fte r b irth , m obiliza tion o f liv e r glycogen has been shown to be 
independent o f this increase (Dawkins, 1963a). There is some debate as to the 
exact tim ing  o f the increase in phosphorylase a c tiv ity , and whether increase o f 
to ta l phosphorylase present (i.e. enzyme synthesis) or conversion o f phosphorylase b 
to phosphorylase a (i.e. activa tion  by phosphorylation) is responsible. An increase 
in to ta l phosphorylase a c tiv ity  was seen from  day 16 post coitum  onwards in one 
study (Devos & Hers, 1974), and in the last two days o f gestation in another 
(Dawkins, 1963b). An 18-fo ld increase in to ta l phosphorylase between days 17 and 
22 post co itum , and appearance o f phosphorylase a from  day 20 post co itum  (Burch 
et al., 1963), or an increase o f phosphorylase a a c tiv ity  from  day 19 post co itum  
(Pines et al., 1975) have been reported. Another study indicated liv e r phosphorylase 
a c tiv ity  reached a peak two days before term  (Blazquez e t al., 1972). Cake & 
O live r (1969) observed 30% o f phosphorylase in la te  fe ta l live r in the a fo rm , 
increasing to 45% by four hours post partum , and then decreasing. G irard e t al. 
(1972) noted a postnatal increase in phosphorylase a a c tiv ity  at 1 hour post partum , 
w ith  high levels maintained at six hours post partum , and Bashan et al. (1979) 
reported a 50% increase in the a c tiv ity  o f phosphorylase a in the f ir s t  three 
postnatal hours.
Despite the emphasis on phosphorylase a c tiv ity  changes in neonatal glycogen 
breakdown, other enzymes are capable o f causing glycogenolysis; th is aspect o f 
postnatal glycogen metabolism w ill be discussed in Chapter 5 (section 5.1.3).
Perinata l qluconeoqenesis
Gluconeogenesis is very low or absent in fe ta l ra t liv e r (Ballard & O live r, 
1963, 1965; Bossi & Greenberg, 1972; Ph ilipp id is & Ballard, 1970) including te rm  
and 'post mature' fetuses (Le Provost et al., 1980; Pearce et al., 1974). However, 
gluconeogenic a c tiv ity  has been reported in fe ta l liv e r under conditions o f m aternal 
starvation (Bossi & Greenberg, 1972; G irard a t al., 1977; Goodner & Thompson, 
1967). H igher levels o f gluconeogenesis are seen in the suckling ra t than the adult 
(Ballard & O liver, 1965; Snell, 1981b, Vernon et al., 1968).
There is disagreement as to the tim ing  o f onset o f gluconeogenesis. G irard e t 
al. (1975) reported the capacity fo r  gluconeogenesis developing im m edia te ly a fte r  
b irth , and Snell & Walker (1973b) described in itia tio n  o f gluconeogenesis between 
30 minutes and one hour o f b irth . However, Medina et al. (1980) have found an 
ins ign ifican t rate o f glucose fo rm ation  from  lac ta te  in the f ir s t  two hours post 
partum , and Pearce et al. (1974) found only a s ligh t increase in th is process during 
the f ir s t  postnatal hour, although gluconeogenesis from  lac ta te  was marked by 
three hours post partum .
The widely-accepted cause o f postnatal gluconeogenesis is the large increase 
in cytosolic phosphoenolpyruvate carboxykinase (PEPCK) a c tiv ity  a fte r  b irth . More 
than 90% o f PEPCK a c tiv ity  in the adult ra t liv e r is cytosolic, w h ils t in the 17 day 
post coitum  fetus, more than 90% o f the very low to ta l a c tiv ity  is located in the 
m itochondria or nuclei (Ballard & Hanson, 1967). Ballard and Hanson (1967)
observed a 25-fo ld increase in cytosolic PEPCK a c tiv ity  from  neglig ible levels in 
the fe ta l live r over the f ir s t  two days post partum ; this paralle led the pa tte rn  fo r 
the onset o f hepatic gluconeogenesis. Increases in a c tiv ity  o f 2 -fo ld  a t 1 hour post 
partum , 16-fold a t 3 hours post partum  and 44-fo ld  at 6 hours post partum  have 
been observed (Le Provost et al., 1980). G irard (1981) reported tha t adu lt levels o f 
a c t iv ity  were obtained by 12-24 hours post partum , and substrate supply and/or 
other factors were then ra te -lim itin g  fo r gluconeogenesis. A lthough i t  does appear 
tha t the postnatal increase in PEPCK a c tiv ity  is essential fo r the in it ia t io n  o f 
gluconeogenesis, a number o f other factors are believed to also influence the onset 
o f de novo glucose synthesis.
I t  appears tha t the increase in PEPCK a c tiv ity  leads to gluconeogenic 
a c tiv ity  only a fte r an increase in the oxidation state o f the liv e r fo llow ing b irth  
(Ballard, 1971b; Pearce et al., 1974). I t  is known tha t hypoxia causes a high NADH 
to N A D + ra tio , and tha t NADH causes reduced concentrations o f oxaloacetate, and 
thus hypoxia could in h ib it gluconeogenesis i f  supply o f oxaloacetate is ra te - lim it in g  
(Ballard, 1971a). O ther po ten tia l sites o f regulation o f gluconeogenesis are at the 
levels o f pyruvate kinase (o f m ajor im portance in the adult) or pyruvate 
carboxylase, which acts in series w ith  PEPCK to reverse the g lyco ly tic  step 
catalysed by pyruvate kinase. An increase in pyruvate carboxylase a c t iv ity  in 
m itochondria l extracts from  day 18 post co itum , reaching adult levels by te rm , has 
been reported (dost &. Picon, 1970), suggesting th is enzyme is un like ly to  be 
involved in postnatal onset o f gluconeogenesis. However, Bailey e t al. (1976) 
reported an increase in pyruvate carboxylase a c tiv ity  a fte r b irth , and Snell (1974) 
described an increase in m itochondria l carboxylation in the suckling ra t, compared 
w ith  the adult, w ith  such an increase occurring w ith in  one hour o f b irth . There have 
been no reports o f perinata l changes in pyruvate kinase a c tiv ity .
14
1.2 HORMONES IN  THE PERINATAL RAT
1.2.1 INSULIN
F e ta l plasma insulin increased in the last th ird  o f gestation, and achieved 
levels in excess o f m aternal levels p rio r to b irth  (Blazquez e t al., 1970, 1972; Fe lix  
e t al., 1971; G irard et a l., 1973a; V in ico r & K iedrowski, 1982). Most data suggest an 
increase in plasma levels from  about day 18 post coitum  (Blazquez et al., 1974; 
Cohen & Turner, 1972; Felix et al., 1971; G irard et al., 1974; Kervran & G irard, 
1974), w ith  a decrease in the day before b irth  (Blazquez et al., 1974; D iMarco et 
al., 1978; G irard et al., 1974; Kervran & G irard, 1974). A sharp drop in the plasma 
insulin level in the im m ediate postnatal period appears to be a universal finding 
(Benito et al., 1980; Blazquez et al., 1974; Cohen & Turner, 1972; Cuezva e t al., 
1982a; D iMarco e t al., 1978; Gain e t al., 1981; Gain & Watts, 1976; G irard et al.,
1973a; M artin  et al., 1981; Sodoyez-Goffaux et al., 1979a). A  decrease to
approxim ately 30% o f fe ta l values in 30 minutes (Cuezva et al., 1982a; D iM arco e t 
al., 1978; Sodoyez-Goffaux et al., 1979a) or in the f irs t  postnatal hour (Benito et 
al., 1980; Blazquez et al., 1974; Portha et al., 1978b) have been seen. Low er insulin
levels have been reported to be maintained fo r a t least 1 day post partum
(Sodoyez-Goffaux et al., 1979a) or up to day 5 post partum , w ith  an increase from  
day 10 post partum and a sharp increase at weaning to the leve l in fed adults 
(Blazquez e ta l. ,  1970).
The hyperinsulinemia seen in the ra t fetus could be the resu lt o f an increase 
in maternal insulin reaching the fe ta l c ircu la tion , reduced clearance o f plasma 
insulin by the fetus, increased fe ta l pancreatic secretion o f insulin, or any 
combination o f these. Radiolabelling studies have shown tha t m aterna l insulin 
cannot cross the placenta (G irard et al., 1974) and studies o f clearance o f -
monoiodoinsulin from  prem ature ly delivered rats indicates tha t low clearance rates
are unlike ly to be the cause o f fe ta l hyperinsulinemia (Sodoyez-Goffaux e t al., 
1979a). Pancreatic content and secretion o f insulin in the perinata l period has been 
investigated in a number o f laboratories. 8 -ce lls have been iden tified  on day 16 
post coitum  (Cohen & Turner, 1972) and rapid increases in pancreatic insulin have 
been reported between days 16 and 22 post coitum  (Hegre et al., 1973), on day 20 
post coitum  (Blazquez e t al. 1972) or between day 20 post coitum  and day 2 post 
partum  (Sodoyez-Goffaux et al., 1971). One study using a very sensitive double 
antibody immunoassay showed insulin to be present in the pancreas a t its  in it ia l 
appearance (11 days o f gestation) and low but s ign ifican t pancreatic insulin levels 
a t day 12 post co itum , undergoing a 200-fold increase between days 14 and 19 post 
coitum  (C lark & R u tte r, 1972). Several groups have examined the secretory 
capacity o f isolated pancreatic islets m v itro . In one such study, insulin secretion 
rates increased from  three days p rio r to term  to a few hours a fte r  b irth ; despite 
the postnatal fa ll in plasma insulin no reduction in the secretory capacity o f the 
pancreatic 8 -ce lls was seen a fte r b irth  (Sodoyez-Goffaux e t al., 1979a). 
S ign ifican tly  higher insulin release from  the pancreas in v itro  has been seen fo r 
la te  fe ta l rats than adults (Blazquez et al., 1970). An increase in pancreatic insulin 
storage a fte r b irth , presumably re fle c ting  continuing synthesis w ith  reduced 
secretion, has also been reported (Cuezva e t al., 1982a; Sodoyez-Goffaux e t al., 
1979b); neonatal pancreatic insulin has been reported to reach levels three tim es 
higher than in the adult (Freie et al., 1975).
1.2.2 GLUCAGON
Plasma glucagon levels in the near-term  ra t fetus have been reported to be 
lower than m aternal levels (G irard e t al., 1973a) or in the same range as adu lt 
levels (Blazquez e t al., 1976). An increase in plasma glucagon occurs in la te  
gestation (D iM arco et al., 1978; G irard et al., 1974), but the exact pa tte rn  is
disputed; the presence o f cross-reacting substances in radioimmunoassays, resulting 
in the determ ination o f ’glucagon-like im m unoreactiv ity1 (GLI) as w e ll as 
im m unoreactive glucagon (IRG), in some studies (e.g. Blazquez e t al., 1974; G irard 
et al., 1972), may be one o f the reasons fo r lack o f agreement.
Most data support a glucagon 'surge' (Sodoyez-Goffaux e t al., 1981a) in the 
imm ediate postnatal period. An increase in plasma glucagon o f as much as fou r­
fold, w ith  a peak at 30 minutes (D iM arco et al., 1978; G irard et al., 1972, 1973a; 
Kervran et al., 1976; Portha et al., 1978b), one hour (Cuezva e t al., 1982a) or two 
hours (Benito et al., 1980; M artin  et al., 1981) post partum has been observed. 
Follow ing this in it ia l sharp rise, i t  appears tha t glucagon levels drop; basal levels 
have been reported a t three hours post partum  (Benito e t al., 1980; M artin  e t al.,
1981), and six hours post partum (Portha et al., 1978b). However, although a 
decrease was seen fo llow ing the postnatal increase in a ll studies, glucagon levels 
remained above b irth  levels fo r a ll four (Kervran e t al., 1976) or six (Cuezva e t al., 
1982a; G irard et al., 1972, 1973a) hours investigated in these studies.
Glucagon is unable to cross the placenta (Blazquez e t al., 1972; G irard e t al., 
1974; Greengard & Dewey, 1970). A lthough no reports o f studies on rates o f 
glucagon clearance in the perinata l period have appeared in the lite ra tu re , i t  is 
generally assumed tha t changes in glucagon concentration re fle c t pancreatic 
content and release. Pancreatic glucagon was shown to increase by about 50% from  
day 18.5 to day 21.5 post coitum  (G irard et al., 1973c) and in another report was 
described as reaching a maximum on day 5 post partum (Edwards e t al., 1972). 
Glucagon secretion has been reported to increase just before b irth  (Blazquez e t al.,
1972), but jn  v itro  the pancreas from  a 19 day post coitum  fetus secreted glucagon 
(Blazquez et al., 1974). An increase in pancreatic release o f glucagon on day 20.5 
post coitum  was suggested to be the reason fo r the increase in plasma glucagon
seen on this day- (G irard et al., 1973c). U ltra s tru c tu ra l studies show the presence 
o f pancreatic A cells on day 16 post co itum  (Perrier, 1970), or day 18 post co itum  
(Lam bert e t al., 1969c) and the ir complete m aturation on day 20.5 post coitum  
(Perrier, 1970).
1.2.3 INSULIN: GLUCAGON RATIO
A great deal o f emphasis has been placed in the lite ra tu re  on the changing 
ra tio  o f insulin: glucagon in the perinata l period, ra ther than the plasma levels o f 
e ithe r hormone per se. The molar ra tio  o f insulin to glucagon was reported as 22.3 
on day 21.5 post coitum  (Portha et al., 1978b), and as decreasing from  15.6 to  5.9 
from  day 21 to day 22 post coitum  (D iM arco et al., 1978). D e livery  by cesarian 
section on day 21 or 22 post coitum  caused a rapid drop o f th is ra tio , reaching a 
minimum in 30 minutes (D iM arco et al., 1978). In one study, the ra tio  fe ll from  10.5 
in the term  fetus to 1.0 in one hour a fte r  delivery, and then stayed low (G irard et 
al., 1973a); in another, i t  fe ll from  10 at b irth  to 2.2 at 6 hours post partum  (Portha 
e t al., 1978b).
1.2.4 ADRENQCQRTICQSTERQIDS
Corticosterone is the major c ircu la ting  adrenocorticosteroid in the ra t 
(Malinowska et al., 1972). Plasma corticosterone concentration increases in 
pregnancy (H o lt & O liver, 1968), and m aternal levels have been reported to be tw o­
fo ld  higher than fe ta l levels (M ilkov ic  &  M ilkovic, 1963), or lower than fe ta l levels 
from  day 17 to 20 post coitum  (Dupouy et al., 1975). D iurnal varia tions in plasma 
corticosterone concentrations are seen in both the dam and fetus (Cohen, 1976).
Plasma corticosterone concentration has been reported to increase between 
days 17 and 19 post coitum  (Cohen & B rau lt, 1974; Dupouy e t al., 1975), days 17.5
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and 19.5 post coitum  (Cohen, 1973), days 18.5 and 19.5 post coitum  (Roudier e t al.,
1982), and days 18 and 20 post co itum  (H o lt & O liver, 1968). A decrease occurred 
p rio r to te rm  (Cohen, 1973; Cohen & B rau lt, 1974; Dupouy e t al., 1975; H o lt & 
O liver, 1968), or on day 20.5 post coitum  w ith  an increase on day 21.5 post coitum  
(Roudier et al., 1982).
Postnatally, a transient increase in plasma corticosterone concentration is 
usually seen (Cohen, 1976; Corbier & R o ffi, 1974; Dupouy e t al., 1975; Eguchi e t 
al., 1976, 1977; H o lt & O liver, 1968; Roudier et al., 1982), although Malinowska et 
al., (1972) reported a decrease in the f ir s t  postnatal hour, w ith  a rise a t two hours 
post partum . One study showed an increase in free plasma corticosterone 
concentration, peaking one hour a fte r delivery, i f  the pups were delivered by 
cesarian section on day 21 post co itum , but no s ign ifican t change in liv e r  
corticosterone concentration, or free, bound or to ta l plasma corticosterone 
concentration, i f  they were delivered on day 22 post coitum  (D iM arco e t al., 1978).
Corticosterone is known to  cross the placenta (Dupouy e t al., 1975), but the 
observation tha t fo llow ing adrenalectomy o f a gravid ra t on day 14 post co itum , 
m aternal plasma corticosterone level corre lated w ith  the number o f live  fetuses on 
days 19, 20 and 21 post coitum  (Dupouy et al., 1975) demonstrated th a t fe ta l 
plasma levels re fle c t secretion o f the steroid by the fe ta l adrenal, and not passage 
from  the mother. The h a lf- life  o f corticosterone in plasma in the f ir s t  e ight hours 
post partum also suggests tha t secretion occurs in the neonate, as th is could not 
resu lt from  clearance o f maternal hormone (Malinowska et al., 1972). The adrenal 
weight increases between day 17 and 20 post co itum  (Dupouy e t al., 1975) or day 18 
and 21 post coitum  (Eguchi & A riyuk i, 1963) and the ra tio  o f adrenal w e igh t to body 
weight reaches a peak in la te pregnancy (Burch, 1965). A s ign ifican t decrease in 
the weight o f the adrenal gland has been observed at b irth  (Eguchi &  A riyu k i,
1963), and the co rtica l mass o f the adrenal has been reported to decrease 
postnata lly (Josimovich, 1954). A c tive  biosynthesis o f co rtiso l and corticosterone 
in the ra t adrenal has been seen from  day 18 post coitum  (Kalavsky, 1971), and 
secretion by the adrenal has been noted from  day 19.5 post co itum , w ith  decreased 
secretion im m ediate ly a fte r b irth  (Josimovich, 1954).
C orticostero id  binding a c tiv ity  o f ra t plasma at days 3-12 post coitum  is only 
10-20% o f the adult level (H o lt & O liver, 1968), suggesting a greatly  increased 
tissue ava ilab ility  o f corticosterone in the postnatal period, compared w ith  the 
adult.
1.2.5 CATECHOLAMINES
Only three laboratories have reported plasma catecholam ine concentrations 
in the im m ediate ly postnatal period, and the findings o f these groups d iffe r . 
Ph illipe  & K itz m ille r  (1981) reported a plasma adrenaline level o f 375 pg /m l a t 
b irth , increasing to nearly three tim es th is at one hour post partum and to eleven­
fold the in it ia l value by two hours post partum . Noradrenaline levels were found in 
th is study to be nearly double the adrenaline concentration, and to show s im ila r 
massive postnatal increases, to 2.5 tim es and 7.5 tim es the sta rting  levels a t one 
and two hours post partum , respectively. Cuezva e t al. (1982a) by contrast, found 
higher adrenaline than noradrenaline concentrations in the plasma o f newly 
delivered rats, w ith  adrenaline levels o f approxim ate ly 4.5 ng/m l being more than 
ten tim es higher than those reported by P h illipe  & K itz m ille r  (1981). Adrenaline, 
noradrenaline and to ta l catecholamine concentrations were a ll seen to decrease in 
the f ir s t  postnatal hour in the study by Cuezva's group; the m inimum adrenaline 
level determined was seen at 30 minutes post partum , but noradrenaline and to ta l 
catecholamines showed a fu rthe r small decrease a t one hour post partum . An
increase in a ll three parameters, w ith  a peak at two hours post partum , and a 
steady decrease continuing u n til the fin a l determ inations a t six hours post partum  
was seen. The postnatal peak at two hours post partum resulted from  
catecholam ine levels around 40% o f those seen im m ediate ly a fte r b irth . The 
findings o f Jansen et al. (1984) were not d issim ilar to those o f Cuezva's group. 
These workers found plasma adrenaline levels o f 7.7 ng/m l a t b irth , decreasing 
rapid ly to 1.3 ng/m l in ten minutes and reading a minimum o f 0.8 ng/m l 40 m inutes 
a fte r  delivery; a secondary increase in the plasma adrenaline concentration was 
seen from  40 minutes post partum , reaching a peak o f 2.2 ng/m l at two hours post 
partum and deceasing therea fte r. Noradrenaline levels in the plasma declined from
4.4 ng/m l im m ediate ly a fte r delivery to 0.9 ng/m l in the f irs t  ten m inutes o f 
neonatal life  and continued to decrease to a plateau o f 0.7 to 0.8 ng/m l between 40 
minutes at six hours post partum . A l l o f these studies used surg ica lly-de livered 
rats; a possible explanation o f the d iffe rence is tha t the animals were taken by 
caesarian section on day 21 post coitum  by P h illipe  & K itz m ille r  (1981) and on day
21.5 post coitum  by Jansen et al., or day 22 post coitum  by Cuezva et al. (1982a). 
Ben-Jonathon (1978) has reported plasma adrenaline and noradrenaline 
concentrations on day one and two post partum  o f 10% or less o f the leve l in the 
term  fetus.
Fu lle r and Hunt (1967) reported tha t the volume o f the adrenal medulla, the 
a b ility  to form  adrenaline, and the adrenaline to noradrenaline ra tio  in the adrenal 
gland a ll increase in la te gestation; Margolis et al. (1966) also described a rapid 
increase in the adrenaline content o f the adrenals just p rio r to term .
R o ff i (1972) noted a rapid neonatal decrease in adrenal adrenaline 
concentration, w ith  the greatest loss during delivery; th is worker suggested th a t 
adrenaline is released from  the fe ta l adrenal in response to hypoglycem ic or 
anoxia. G irard and Zeghal (1975), however, fe lt  th e ir work indicated th a t neonatal
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hypoglycemia or cold exposure are not su ffic ien t s tim u li fo r adrenal release o f 
adrenaline and noradrenaline in the neonatal period, and anoxia at the tim e  o f 
pa rtu rition  is a more s ign ifican t fa c to r in stim ula ting adrenaline release from  the 
adrenal medulla. R o ff i (1972) also proposed tha t noradrenaline release, due to 
a c t iv ity  o f the sym pathetic nervous system around pa rtu rition , is physiological 
im portant.
Despite carefu l study o f the adrenal gland during the perinata l period by 
several investigators, Ben-Jonathon & Maxson (1978) have suggested tha t 
catecholamines in the fe ta l ra t are produced by extra-adrenal ch rom affin  tissue. 
DeGallardo et al. (1974) have iden tified  such tissue, known as the organ o f 
Zuckerkandl, in the periaortic  region, and have described its  postnatal involu tion.
1.3 ADRENERGIC CONTROL OF HEPATIC CARBOHYDRATE METABOLISM IN
THE RAT
1.3.1 ADRENERGIC RECEPTORS
A number o f reviews are available on the subject o f adrenoceptors (e.g. 
Goodhardt et al., 1984; Insel, 1984; Jenkinson, 1973; Lees, 1981; Le fkow itz  e t al., 
1983; Schmelck & Hanoune, 1980; Stiles et al., 1984).
C lassification
Adrenoceptors were f ir s t  classified as a or $ by v irtue  o f the re la tive  
potency o f a number o f adrenergic agonists in e lic itin g  physiological responses via 
such receptors. A t  a-adrenoceptors, noradrenaline is generally more potent than 
adrenaline, w ith  isoprenaline re la tive ly  very weakly potent. By contrast, a t B- 
adrenoceptors, isoprenaline is more potent than adrenaline, which is equipotent 
w ith , or s ligh tly  more potent than, noradrenaline (Ahlquist, 1948).
a-adrenoceptors may be fu rthe r divided in to  the a j and a2 subtype. This 
c lassifica tion has replaced the earlie r one o f 'pre-synaptic ' (now and 'post- 
synaptic (now a^) a-adrenoceptors (Le fkow itz  & Hoffm an, 1981a). R e la tive  
potencies o f pharmacological agents was the key to th is subtyping o f a - 
adrenoceptors, and has been used to id e n tify  two 8-adrenoceptor subtypes. 
Isoprenaline is more potent than adrenaline or noradrenaline a t both B- 
adrenoceptor subtypes; however, w h ils t adrenaline and noradrenaline are 
equipotent at B | -adrenoceptors, adrenaline is ten-fo ld  more potent than 
noradrenaline at 82~adrenoceptors (Lands et al., 1967).
Mechanism o f response to adrenoceptor activa tion
The e ffec ts  o f catecholamines are mediated via binding to membrane bound 
adrenoceptors, and the generation o f in tra -ce llu la r signals, or 'second messengers'
(Jakobs & Schultz, 1981). A c tiva tion  o f (3-adrenoceptors results in s tim u la tion  o f 
adenylate cyclase and fo rm ation  o f cyc lic  AMP, which in turn  produces a w e ll 
established 'cascade' o f events w ith in  the ce ll (Robison e t al., 1971). The 
mechanism by which ac tiva tion  o f a-adrenoceptors leads to the observed 
physiological responses is less w e ll characterised. Inh ib ition o f adenylate cyclase, 
and hence reduction o f in trace llu la r cyc lic  AMP levels, is believed to fo llow  
occupation o f the a 2-adrenoceptor by an agonist compound (Jakobs &  Schultz, 
1981; Jakobs e t al., 1985; Jard et al., 1981; Le fkow itz  & Hoffm an, 1981b). The 
second messenger o f a j  -adrenoceptor ac tiva tion  appears to  be unrelated to the 
adenylate cyclase-cyclic AMP system; an increase in cytosolic Ca^+ ions appears 
to  be the most s ign ifican t event triggered by activa tion  o f the a j -adrenoceptor 
(e.g. Assimacopoulos-Jeannet et al., 1977; Keppens e t al., 1977; Van de Werve et 
al., 1977a; W illiamson et al., 1985). This increase in cytosolic Ca^+ is believed to 
resu lt from  an in it ia l release o f the ion from  in trace llu la r, probably m ainly 
endoplasmic re ticu lum  stores (Shears & K irk , 1984; Somlyo at al., 1985; W illiamson 
et al., 1985), although an activa tion  o f Ca entry in to the ce ll from  ex trace llu la r 
flu id  is probably required to sustain hormonal e ffec ts  (Joseph et al., 1985). An 
increase in the hydrolysis o f phosphatidylinositol-4,5-bisphosphate is also seen when 
a^-adrenoceptors are activated, and th is has been proposed to be involved in the 
generation o f the calcium signal (Berridge, 1984; M ichell, 1975; M iche ll e t al.,
1977). One of the products o f phosphatidylinositol-4,5-bisphosphate hydrolysis is 
inosito l-1 ,4,5-trisphosphate which is believed to  in te rac t w ith  a receptor on the 
endoplasmic re ticu lum  membrane to s tim u la te  Ca^+ release in to the cytosol 
(Berridge & Irv ine, 1984).
M odifying factors
Adrenoceptors may be m odified in term s o f number, nature and coupling to  
post-receptor events by a large number o f facto rs  (Stiles et al., 1984). Regulation 
o f adrenoceptor populations both jn  vivo and in v itro  may be brought about by an
excess or defic iency o f hormones. Catecholamines themselves may produce a 
reduction in adrenoceptor responsiveness (Perkins, 1982); th is so called homologous 
regulation o f adrenoceptors may be by reduction o f receptor number ('down- 
regulation1) or decrease in the association o f receptor occupation and the ce llu la r 
response ('uncoupling'), and a ffec ts  a ll four adrenoceptor subtypes, but is tissue 
specific (Insel, 1984). Desensitisation o f B-adrenoceptors by catecholamines 
producing uncoupling has been shown to  involve phosphorylation o f the receptor 
molecule (Stadel e t al., 1983). Adrenocorticostero ids and thyro id hormones are w e ll 
known to  produce heterologous regulation o f adrenoceptors (e.g. Exton e t al., 1981; 
La i et al., 1982; Malbon, 1980; P re iksa itis  et al., 1982; Storm et al., 1984). The 
type or subtype o f adrenoceptor expressed on cells has been shown to  change during 
carcinogenic transform ation (Lacombe et al., 1976) or on ce ll cu ltu re  (Nakamura et 
al., 1983; Okajima & U i, 1982); incubation o f ra t hepatocytes fo r as l i t t le  as four 
hours has been shown to produce a change in adrenergic receptor subtype 
spec ific ity  (Kunos et al., 1984; Ishac & Kunos, 1986).
In view o f the nature o f the current study, probably the most re levant fa c to r 
m odifying ce llu la r adrenergic systems is tha t o f age. Changes in the number, type 
and coupling o f adrenoceptors during development have been reported fo r  a range 
o f tissues: ra t hepatocytes (B la ir e t al., 1979a, 1979b; Morgan et al., 1983a), mouse 
adipocytes (Lai e t al., 1981), ra t erythrocytes (L im b ird  et al., 1980), rabb it ske leta l 
muscle (Smith, 1984) and ra t lung (W hitsett e t al., 1981).
1.3.2 ADRENERGIC EFFECTS ON HEPATIC CARBOHYDRATE 
METABOLISM IN THE ADULT RAT
Glycogen synthesis
Catecholamines cause a reduction in glycogen synthesis by the liv e r  jn  v itro  
(Hornbrook, 1970). 10"^M adrenaline and 10”^M  phenylephrine did not inactive  
glycogen synthase in hepatocytes from  fed rats (Hutson e t al., 1976), although
adrenaline did inactiva te  glycogen synthase fo llow ing exposure to 30 mM glucose in 
hepatocytes from  fed animals (Taniguchi et al., 1980), or 40 mM glucose in 
hepatocytes from  fed or fasted animals (Hutson e t al., 1976).
Glycogenolysis
Increased hepatic glycogenolysis has been reported to be induced by a number
-8o f adrenergic agents. Concentrations o f 10” M adrenaline or noradrenaline cause 
hepatic glycogenolysis in starved rats or in m v itro  preparations from  adult ra t 
liv e r (Hems, 1977b; Hems & W hitton, 1980). Adrenaline and noradrenaline cause 
glycogenolysis in isolated adult ra t hepatocytes (e.g. B la ir e t al., 1979a; Exton & 
Harper, 1975); adrenaline shows a ha lf-m axim al e ffe c t a t 10”^ M (Feliu e t al., 1976; 
Hutson et al., 1976). Phenylephrine also promotes glycogenolysis in isolated adu lt 
hepatocytes (e.g. Assimacopoulos-Jeannet e t al., 1977; Exton &  Harper, 1975;
Pointer et al., 1976) w ith  a ha lf-m axim al e ffe c t a t 10”^M (Hutson e t al., 1976), and
-5 -5m axim al s tim ula tion a t 10 M (Cherrington et al., 1976). Isoprenaline a t 10 M
(B la ir ^ t  al., 1979a) or 1.5 x 10’ ^M  (Pointer e t al., 1976) increased glycogen
breakdown in isolated hepatocytes. Glycogenolysis in perfused liv e r was seen to  be
stim ulated by adrenaline, noradrenaline and phenylephrine (Exton & Harper, 1975).
Glucose output from  perfused live r was increased by adrenaline, noradrenaline,
phenylephrine and isoprenaline (Sherline et al., 1972).
Increased glycogen phosphorylase a c tiv ity  was seen two seconds a fte r
exposure o f hepatocytes from  fed adult male rats to adrenaline (B lackmore e t al.,
1983), or fo llow ing a one m inute exposure o f hepatocytes isolated from  adu lt 
-6 -5female rats to 10” - 10" M adrenaline (Birnbaum & Fain, 1977). Phenylephrine 
(Assimacopoulos-Jeannet et al., 1977; Birnbaum & Fain, 1977; Hue e t al., 1978; 
Hutson et al., 1976; Van de Werve et al., 1977a) and isoprenaline (Birnbaum & Fain, 
1977; Van de Werve et al., 1977a) also ac tiva te  phosphorylase in isolated
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hepatocyes. Adrenaline, noradrenaline, phenylephrine and isoprenaline a ll ac tiva te
glycogen phosphorylase in isolated perfused liv e r (Sherline e t al., 1972) and
-8adrenaline and noradrenaline a t concentrations o f 10" M or higher, increase 
phosphorylase a in the live r o f starved rats (Hems, 1977b). The phosphorylation o f 
glycogen phosphorylase which induces its  activa tion  is caused by both a and B- 
adrenergic agonists by s tim ula tion o f the enzyme phosphorylase b kinase (Exton et 
al., 1983).
Gluconeogenesis
Numerous reports document stim u la tion  o f gluconeogenesis by 
sym pathom im etic substances. Adrenaline (e.g. Exton & Harper, 1973; Fe liu  e t al., 
1976; Tolbert et al., 1973; To lbert & Fain, 1974), noradrenaline (e.g. Exton & 
Harper, 1975; To lbert et al., 1973) and phenylephrine (e.g. Exton & Harper, 1975; 
T o lbert et al., 1973) increase gluconeogenesis in isolated adult ra t hepatocytes. 
Increased glucose form ation from  lac ta te  (Fain e t al., 1975; Hutson e t al., 1976; 
Kemp & C lark, 1978; Rognstad & Katz, 1977), pyruvate (Fain jst al., 1975; Hue et 
al., 1978) and alanine (Fain et al., 1975) is induced by adrenaline and phenylephrine 
in isolated hepatocytes. Phenylephrine also stim ulates gluconeogenesis from  
fructose (Hue et al., 1978). The increase in gluconeogenesis due to adrenaline and 
phenylephrine is dose-dependent; ha lf-m axim al s tim u la tion  has been seen at 10"^M 
adrenaline or 10 phenylephrine (Hutson et al., 1976). M axim al s tim u la tion  has 
been reported w ith  10 phenylephrine (Cherrington et al., 1976) and 10 
adrenaline (Claus & P ilk is, 1978). The B-agonists isoprenaline and salbutam ol have 
been reported to stim ulate gluconeogenesis (Exton & Harper, 1975) or to  have no 
e ffe c t on this process in isolated hepatocytes (Fain e t al., 1975; T o lbe rt e t al.,
1973). Adrenaline, noradrenaline, phenylephrine and isoprenaline cause ac tiva tio n  
o f gluconeogenesis in perfused live r preparations (Exton & Harper, 1975). 
Adrenaline stim ulates the conversion o f lac ta te  (Exton e t al., 1972), and
phenylephrine tha t o f lac ta te , pyruvate, alanine, g lycero l, sorb ito l, 
dihydroxyacetone or fructose (Taylor et al., 1983), to glucose in th is preparation.
Inactiva tion  o f pyruvate kinase has been observed in isolated hepatocytes 
exposed to adrenaline (Chan & Exton, 1978; Feliu  et al., 1976; Garrison & Borland, 
1979; Kemp & C lark, 1978; Soling e t al., 1978), phenylephrine (Chan & Exton, 1978; 
Garrison & Borland, 1979; Kemp & C lark, 1978) and isoprenaline (Kemp & C lark,
1978). However, in other studies, a lack o f e ffe c t o f phenylephrine on pyruvate 
kinase a c tiv ity  has been reported (Hue et al., 1978; Thomas & Halestrap, 1981),
2 +
although absence o f Ca + rendered the enzyme sensitive to phenylephrine 
inactiva tion  (Hue et al., 1978). Adrenaline has been reported to produce no 
s ign ifican t decrease in the flux  through pyruvate kinase in hepatocytes from  fasted 
rats, and to increase the flux  through this enzyme in hepatocytes from  fed rats 
(Rognstad & Katz, 1977). Adrenaline and noradrenaline stim ula te  m itochondria l 
ATPase, and have therefore been proposed to have an analogous action to glucagon 
in increasing the ATP to ADP ra tio  and thus promoting pyruvate carboxylation 
(Titheradge et al., 1979). Kneer et al. (1974) concluded from  his studies th a t 
s tim ulation o f gluconeogenesis from  galactose and fructose by adrenaline is due to  
a decreased flux  through phosphofructokinase and an increased flu x  through 
fructose 1,6-bisphosphatase.
Adrenoceptor mediating e ffe c t
I t  appears from  a number o f observations tha t adrenergic e ffec ts  on hepatic 
carbohydrate metabolism are mediated by d iffe re n t receptors in adu lt male and 
female rats. Birnbaum & Fain (1977) and Studer & Borle (1982) concluded th a t 
s tim ulation o f glycogenolysis by adrenergic agonists in the live r o f the m ature 
female ra t is mediated by both a - and 3 -adrenergic pathways, while in the male 
only the a-adrenergic path is o f any significance.
1.3.3 ADRENERGIC EFFECTS ON HEPATIC CARBOHYDRATE 
METABOLISM IN THE IMMATURE RAT
Glycogen synthesis
Isoprenaline at 10 ^or 10 ^M inh ib ited the synthesis o f glycogen by 45% and 
26%, respectively, in hepatocytes isolated from  day 20 post co itum  fe ta l rats and 
cultured fo r  three days (Freemark & Handwerger, 1984). In the same study, 
phenylephrine a t 10"^M produced only a 20% inh ib ition  o f glycogen synthesis, and 
a t 10~^M had no s ign ifican t e ffe c t. When two subcutaneous doses o f 20 ug/100 g 
adrenaline were given to pregnant rats on day 18.5 post co itum , and fetuses 
obtained by caesarian section one or three hours la te r, fe ta l liv e r glycogen was 
reduced to 10-15% o f contro l levels (Goldwater & S tetten, 1974). As active  
synthesis o f glycogen would be expected in the fe ta l liv e r a t th is stage o f 
gestation, the e ffe c t o f adrenaline is proably at least pa rtly  due to  inh ib ition  o f 
glycogen synthesis.
Glycogenolysis
0.5 ug/g bodyweight adrenaline adm inistered subcutaneously im m edia te ly or
one hour a fte r natural b irth  produced a decrease in the glycogen content o f the
liv e r a t six hours post partum  (Kotoulas & Phillips, 1971). In hepatocytes fresh ly
isolated from  term  fe ta l rats, 10"^M phenylephrine produced a 22% or 33%
increase, and 5 x 10~^M isoprenaline a 68% or 83% increase, in glycogen breakdown
(H‘uhn e t al., 1983; Schulze e t al., 1984). In hepatocytes freshly isolated from
'young' (27-35 days old) rats, 10“^M adrenaline, isoprenaline or phenylephrine a ll
increased glucose production from  glycogen, and a com bination o f a -  and (3-
antagonists was required to block th is e ffe c t (B la ir et al., 1979a). In hepatocytes
-8isolated from  fe ta l rats on day 18 post co itum , and cultured fo r three days, 10” M 
adrenaline produced maximum glycogenolytic e ffec ts  a fte r 4 hours; 60% o f 
glycogen was degraded, w ith  newly-synthesised glycogen being broken down 
p re fe ren tia lly  (Moncany &  Plas, 1980). Adrenaline has also been shown to reduce
the glycogen content in live r explants made from  term  fe ta l rats and incubated fo r 
18 or 40 hours (Eisen e t al., 1973a). Adrenaline a t 2 x 10~^M or higher 
concentrations or 10"^M isoprenaline activa ted glycogen phosphorylase in te rm  
fe ta l live r explants a fte r 18 hours incubation; 10"^M phenylephrine had very l i t t le  
e ffe c t on this enzyme (Sherline e t al., 1974).
Gluconeogenesis
A three to fou r-fo ld  increase in hepatic PEPCK a c tiv ity  has been reported in 
isolated fe ta l live r explants exposed to 10~^M isoprenaline (Wicks, 1969). The 
appearance o f th is enzyme in the perinata l period may be induced from  day 16 post 
coitum  onwards by the in trau terine  adm in istra tion o f 3 or 10 pg adrenaline or 
noradrenaline to fetuses (Yeung & O liver, 1968a).
Adrenoceptor mediating e ffec ts
A number o f workers have proposed that, in the perinata l ra t, adrenergic 
e ffec ts  on hepatic carbohydrate metabolism are mediated predom inantly, i f  not 
exclusively, by 8-adrenoceptors (e.g. Itoh et al., 1984; M cM illian  e t al., 1983; 
Moncany & Plas, 1980; Sherline et al., 1974). However, studies c ited  in favour o f 
such a conclusion often have used isolated liv e r tissue, and have studied adrenergic 
e ffec ts  a fte r a long incubation period or a period o f cu lture ; in view o f the known 
emergence o f 8^adrenoceptor mediated e ffe c ts  on culture, or even fo llow ing  a four 
hour incubation, o f adult liv e r tissue (see the description o f m odify ing fac to rs  in 
section 1.3.1), some caution must be exercised before reaching such a conclusion. 
In studies using freshly isolated term  fe ta l hepatocytes, isoprenaline was seen to  
produce a greater s tim ula tion o f glycogen breakdown and glucose release than 
phenylephrine (Hiihn e t al., 1983; Schulze et al., 1984), but as the 8 -adrenergic 
agonist was present at a fiv e -fo ld  higher concentration than the a -s tim u la tin g  
compound, th is does not provide evidence fo r a more s ign ifican t 8 -m ediated 
pathway than a-mediated. The work o f B la ir et al. (1979a), would seem to  ind ica te
a s ign ifican t contribu tion  o f 8-adrenoceptor ac tiva tion  in adrenergic stim u la tion  o f 
glycogenolysis in fresh hepatocytes from  young rats, w ith  a decrease in th is 
contribu tion  w ith  ageing. However, there is no study reported in the lite ra tu re  
which gives clear evidence o f a 8-adrenergic pathway modulating hepatic 
carbohydrate metabolism in the perinata l ra t.
1.4 AIMS OF THE STUDY
1.4.1 To characterise the hepatic adrenoceptor population during the 
im m ediate ly perinata l period in the ra t.
1.4.2 To assess the e ffec ts  o f adrenergic agents on carbohydrate metabolism in 
hepatocytes freshly isolated from  the perinata l ra t.
1.4.3 To investigate the e ffec ts  o f adrenergic agents, when adm inistered in v ivo , 
on carbohydrate metabolism in the im m ediate ly postnatal period in the ra t.
1.4.4 To draw conclusions, from  the above, regarding the contribu tion  o f hepatic 
adrenergic pathways in the recovery from  postnatal hypolgycemia in the 
laboratory ra t.
CHAPTER 2
CHARACTERISATION OF THE HEPATIC ADRENOCEPTOR 
POPULATION IN  THE PERINATAL RAT
2.1 INTRODUCTION
2.1.1 RECEPTOR THEORY
Paul Ehrlich (1913) is believed to have been the f ir s t  worker to use the term  
’receptor1 to describe the structure  on a ce ll surface w ith  which a substance (in his 
work, a chemotherapeutic drug) must react to produce a ce llu la r response, although 
Langley's (1906) description o f a ’receptive substance' mediating the response o f 
muscle to  curare s ligh tly  predated th is. In 1937, C lark attem pted the f ir s t  
m athem atical analysis o f a drug-receptor in te raction . The concept th a t a drug 
showing agonist a c tiv ity  must, as w e ll as binding to  the receptor, have some 
inherent feature which an antagonist compound lacks and which produces a 
b io logical response was discussed in the lite ra tu re  some tw enty years la te r (Ariens, 
1954; Stephenson, 1956). The term s 'in tr in s ic  a c tiv ity ' and 'e fficacy ' were proposed 
to describe this feature o f an agonist drug by Ariens and Stephenson, respective ly.
Today, a receptor may be defined as a ce llu la r macromolecule w ith  which a 
drug in te racts  to bring about a characte ris tic  b io logical response. Schem atically, 
this may be represented as:
D + R
D R * —  CELLULAR RESPONSE
where: D : free drug
R : free receptor
DR : drug-receptor complex
D R * : drug-receptor complex w ith  receptor in activated fo rm
The a ff in ity  o f D fo r R w ill influence the form ation o f DR and D R * equally, 
the e fficacy  o f D w ill in fluence the proportion o f drug-receptor complex o f the 
form  D R *. Thus, response depends on both a ff in ity  and e fficacy.
2.1.2 TECHNIQUES OF RECEPTOR CHARACTERISATION
Pharm acological approach
In early work concerned w ith  the characterisation o f receptors, in fo rm ation  
was obtained by the use o f an ind irec t approach. Understanding o f the nature o f 
receptors was gained by study o f the b io logical response to drugs and establishment 
o f s tru c tu re -a c tiv ity  relationships (fo r review see A lbe rt, 1971). As discussed in 
Chapter 1 (section 1.3.1), i t  was this approach which allowed the in it ia l 
c lassifica tion and subclassification o f adrenoceptors.
The potency orders o f highly-subtype selective agonist and antagonist drugs is 
s t i l l  a very useful too l in investigation o f the nature o f adrenoceptor populations, 
but there are a number o f drawbacks to the use o f a purely pharm acological 
approach to receptor characterisation. Because this technique makes use o f a 
b io logical response in receptor characterisation, i t  fo llows tha t receptors may be 
-investigated only in an environment in which the response pathway is in tac t. Thus, 
i t  is essential to establish tha t the response studied results solely from  in te rac tion  
w ith  the receptor o f in terest, and tha t any influences o f other e ffe c to r systems are 
elim inated or recognised. A second point o f note is tha t this approach may provide 
a great deal o f qua lita tive  in form ation, but is lim ite d  in the quan tita tive  data 
which may be obtained. A lthough re la tive  receptor populations in d iffe re n t tissues 
may be established by means o f re la tive  potencies o f a drug in these tissues, no 
in form ation on the absolute number o f receptor molecules per un it mass o f tissue 
can be obtained.
P u rifica tion
The most d irec t way to  classify a receptor is to isolate the receptor p ro te in  
in a pure form . A number o f ce ll-surface hormone receptors have been isolated,
and detailed in fo rm ation  o f th e ir prim ary, secondary and te rt ia ry  s tructu re  
obtained. Both a -  and $ -adrenoceptors have been isolated using membrane 
solubilisation w ith  detergent, followed by pu rifica tion  by a ff in ity  chromatography 
(Kunos, 1984; Stiles et al., 1984; Strosberg et al., 1981). Covalent labelling and 
sodium dodecyl sulphate-polyacrylam ide gel electrophoresis (SDS-PAGE) have also 
been used to investigate the m olecular nature o f adrenoceptors (Kunos, 1984; 
Strosberg et al., 1981).
A lthough this approach may provide a great deal o f detailed in fo rm ation  
regarding the structure o f receptors, down to the level o f the constituent amino 
acids, i t  is technica lly demanding and great care is rquired in the extrapo la tion o f 
findings to the nature and function o f receptors in in tac t tissues and cells. 
Proteolysis o f receptor molecules during th e ir isolation and p u rifica tio n  can 
produce erroneous data, and any influence o f the membrane environm ent on 
receptory te rt ia ry  structure  is lost. Unlike the pharmacological approach, 
in form ation regarding the size o f a receptor population in a pa rticu la r tissue may 
be gained by this technique.
A ff in ity  labelling
A re la tive ly  new approach to investigating adrenoceptor structure  is a f f in ity  
labelling (Stiles e t al., 1984). A f f in ity  labelling reagents are analogues o f
n. 25physiological ligands, containing reactive  groups. The pho toa ffin ity  probe [  i ]  -  
p-azidobenzylcarazolol has been used in id en tifica tio n  o f the polypeptide s truc tu re  
o f 8-adrenoceptors (Caron e t al., 1985).
Radioligand binding
The nature and number o f ce ll-surface receptors may be investigated by the 
use o f the radioligand binding technique (fo r review see Le fkow itz  &  H offm an,
1981a). This involves incubating membranes containing the receptor(s) o f in terest 
w ith  a rad ioactive ly labelled compound (the 'radioligand’) w ith  known a ff in ity  fo r 
the receptor. Radioligand not bound to the membrane is then removed, usually by a 
process o f rapid f ilt ra t io n  under vacuum and extensive washing. Measurement o f 
the rad io ac tiv ity  associated w ith  the membrane then allows determ ination o f the 
size o f the receptor population and in terference w ith  the binding o f the radioligand 
by compounds w ith  w e ll-defined a ff in ity  fo r  various types o f receptor indicates the 
nature o f the receptor. One lim ita tio n  o f th is technique is tha t i t  provides no 
in fo rm ation  regarding the m olecular structure  o f the receptor under investigation.
ASSAY TECHNIQUES AND ANALYSIS
Radioligand binding assays may be considered to be o f two basic types: 
equilibrium  (prote in d ilu tion  p ro file , inh ib ition  p ro file  and saturation assay) or 
k ine tic  (association and dissociation tim e course).
Prote in d ilu tion  p ro file
This is usually the f ir s t  type o f assay perform ed w ith  any radioligand, in order 
to determ ine a working concentration o f prote in to  be used in subsequent assays. 
Varying amounts o f membrane are incubated w ith  a fixed concentration o f 
radioligand; to ta l binding and 'non-specific ' binding (tha t remaining in the presence 
o f an excess o f an agent competing fo r  the ligand binding site) are determ ined at 
equilibrium  fo r each prote in concentration. Any prote in concentration w ith in  the 
range at which the concentration o f ligand specifica lly  bound is linearly  re la ted  to 
prote in concentration is considered to be a suitable working concentration.
Inh ib ition  p ro file
This approach is a means o f characterising the radioligand binding s ite  in 
term s o f in te raction  w ith  a range o f unlabelled compounds. Thus, both compounds
w ith  known a ff in ity  fo r adrenoceptors, and compounds w ith  no known a ff in ity  fo r 
such receptors, may be investigated. Hofstee plots (see Fig. 2.1a) o f the data can 
be made, and the concentration o f agent required to displace 50% o f the bound 
radioligand (IC^g) calculated. From th is, the equilibrium  dissociation constant o f 
the displacing agent (K j) may be calculated using the Cheng and P ruso ff equation 
(Cheng & Prusoff, 1973):
where L = concentration o f radioligand (M)
K q  = equilibrium  dissociation constant
o f radioligand (M)
From the ir K. values, the re la tive  potencies o f compounds in displacing a 
radioligand can be established, and thus the receptor type and subtype being 
labelled can be in ferred. The amount o f radioligand bound at equ ilibrium  to a fixed 
concentration o f protein, in the presence o f varying concentrations o f the 
compound under study, is measured.
Saturation assay
Data from  this assay may be used to calculate the equilibrium  dissociation 
constant (K q ) fo r the radioligand and the receptor concentration (Bmax)> these are 
usually obtained from  a Scatchard representation o f the data (see Fig. 2.1b). The 
assay is carried out by incubating a fixed concentration o f prote in w ith  varying 
concentrations o f radioligand, and measuring to ta l ligand bound, and tha t bound in 
the presence o f excess o f an agent competing fo r the ligand binding site  (non­
specific  binding) when the reaction has reached equilibrium . Specific  binding is 
calculated as the d iffe rence between to ta l and non-specific binding.
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Association tim e course
This type o f assay demonstrates the tim e taken to reach equilibrium  and 
allows calculation o f the association rate constant (k^) ( fo r details see section 
2.3.4). Fixed concentrations o f ligand and protein are incubated together fo r 
various tim e periods; to ta l and non-specific binding are determined, and specific  
binding calculated, a t each tim e point.
Dissociation tim e course
From this type o f assay, the dissociation rate constant (k ^  can be calculated 
( fo r details see section 2.3.4). Using this approach, excess competing ligand is 
added to a fixed concentration o f radioligand and prote in a t equ ilibrium . 
Measurements are made o f to ta l and non-specific binding a t zero tim e and varying 
tim es a fte r addition o f the com petitive  compound. The specific  binding is 
calculated and used in calcula tion o f k y
When association and dissociation ra te  constants are known, the association 
constant (K ^ ) and dissociation constant (K ^ )  may be calculated:
K A  = A  , K  = J _
k K-1 KA
RADIOLIGANDS FOR ADRENOCEPTORS
Radioligand binding assays o f adrenoceptors have been carried out fo r some 
years now (fo r review see Hoffm an & Le fkow itz , 1980). The va rie ty  o f ligands 
available fo r such assays has increased enormously, w ith  many o f the more recen tly  
developed compounds having the advantages o f good sp e c ific ity  fo r the receptor, 
and/or high specific  a c tiv ity  (Nahorski, 1981; Le fkow itz  & Hoffm an, 1981b). One 
difference between a -  and 8 -adrenoceptors is tha t w h ils t radioligands are available 
w ith  se lec tiv ity  fo r one or the other a-adrenoceptor subtype, only non-subtype
selective 8-adrenoceptor radioligands are available. Therefore, in characteris ing 
the subtypes present in the a-adrenoceptor population o f a tissue, both labelling o f 
d iffe re n t subtypes d irec tly  by use o f selective ligands or non-selective labelling o f 
both subtypes and displacement from  one subtype by inclusion o f an excess o f an 
unlabelled subtype-selective com petitive  agent, may be used. In radioligand binding 
assays o f 8-adrenoceptors, however, only the la tte r  approach is possible.
[^H] -D ihydroergocryptine is the most commonly used non-subtype selective 
a-adrenoceptor radioligand (e.g. Aggerbeck e t al., 1978; E l-R e fa i & Exton, 1980; 
Guellaen et al., 1978). ?H ] prazosin, an a^-se lective  antagonist is the ligand
usually employed to label a^-adrenoceptors (e.g. Goodhardt e t al., 1982; H offm an 
et a l., 1981), although the tr it ia te d  antagonist compound WB-4101 has also been 
used (Le fkow itz  & Hoffm an, 1981b, U 'P ritchard et al., 1977). For d ire c t selective 
labelling o f a2~adrenoceptors, t ^ H l  yohimbine, also an antagonist a t its  pre ferred 
receptor, is available (Hoffm an et al., 1981).
The f ir s t  reports o f successful labelling o f 8-adrenoceptors were made in
3 1231974; ligands used were [ H ] -d ihydroalprenolol (Le fkow itz  e t al., 1974), [ I ]  -
hydroxybenzylpindolol (Aurbach et al., 1974) and [ ^H ] -propranolol (A tlas  e t al.,
1974). O ther ligands available fo r radioligand binding assays o f 8-adrenoceptors are 
125 1?5[ I ] -iodocyanopindolol (Engel e t al., 1981), [ I ] -p indolo l (Barovsky & 
Brooker, 1980) and [ ^H ] isoprenaline (Hadjiivanova e t al., 1984).
T ritia te d  form s o f adrenaline and noradrenaline are available fo r  radio ligand 
binding assay, and some workers have argued tha t the corre la tion  o f binding o f 
these ligands w ith  physiological parameters indicates th e ir superio rity  in such 
assays (E l-R efa i et al., 1978, 1979). However, antagonist compounds are generally 
preferred as radioligands due to the commonly held view tha t, unlike agonists, th e ir
41
a ff in ity  fo r adrenoceptors is not a ffec ted  by guanyl nucleotides (see section 2.4.3). 
The physiological ligands fo r adrenoceptors also have the disadvantage o f re la tive ly  
poor type and subtype se lectiv ity .
2.1.3 AIMS OF THE EXPERIMENTS
Carbohydrate metabolism in the ra t liv e r has been shown to  be a ffec ted  by 
adrenergic compounds via activa tion  o f both a-adrenoceptors (e.g. Exton &  Harper, 
1975; Kemp & Clark, 1978) and $ -adrenoceptors (e.g. B la ir  et al., 1979a; Studer & 
Borle, 1982). Such e ffects  are predom inantly -mediated in the adult male ra t 
(see section 1.3.1). E ffec ts  o f adrenergic agents on hepatic carbohydrate 
metabolism during the perinatal period must involve activa tion  o f adrenoceptors; 
characterisation o f the adrenoceptor population in the live r during the period 
around the tim e o f b irth  would therefo re  be useful in determ ining the po ten tia l ro le  
o f the adrenergic system in the modulation o f fe ta l and neonatal carbohydrate 
metabolism.
The aim o f the experiments described in this chapter was to  determ ine the 
number, type and subtype o f hepatic adrenoceptors in the perinatal ra t. Membranes 
were prepared from  fe ta l ra t livers at one and two days p rio r to te rm  (days 20 and 
21 post coitum ) and at term  (day 22 post coitum ) and from  neonatal rats a t 24 and 
48 hours a fte r delivery. Thus, any change in the size or nature o f the hepatic 
adrenoceptor population during this cruc ia l developmental period could be 
demonstrated.
2.2 MATERIALS &  METHODS
2.2.1 MATERIALS
NaCl, MgCLj, KHCO^, the disodium salt o f e thylenediam inete traacetic  acid 
(EDTA Na2) and sucrose were a ll obtained from  BDH Chemicals L td ., Poole, Dorset 
and were ana lytica l (AR) grade. MgSO^ was from  Fisons, Loughborough and was 
also AR grade. Trizm a base, C-)isoprenaline(+)bitartrate, (+)adrenaline, 
(+)noradrenaline HC1, yohimbine HC1 and DL-propranolo l HC1 were from  Sigma 
Chemical Company, Poole, Dorset. A teno lo l, IC I 118 551, prazosin HC1, 
phentolamine mesylate, ketanserin, atrophine sulphate, spiperone, mepyramine, 
ran itid ine  HC1, and syrosingopine were supplied by the Biochem ical Pharmacology 
Departm ent, Glaxo Research L td ., Ware, Herts. P ico -fluo r 30 s c in tilla n t flu id  was 
obtained from  United Technologies Packard, Illino is , USA. Glaxo Operations UK 
supplied ascorbic acid.
(-)!_-[P ropyl-2 ,3-^H  ]-dihydroalprenolol ( t^ H l-D H A ), [ [ 9,10(n)-^H ]9,10-1
dihydroergocryptine ( [^ H ]-D H E ), and (-) [^ ^ 1  ]-iodocyanopindolol ( J- I CYP)
125were obtained from  Amersham In te rna tiona l pic, Amersham, Bucks. ( - ) [  I I -  
125iodopindolol ( [  I ] - IP )  was synthesised by N ia Cook at the D epartm ent o f
Pharmacology and Therapeutics, U n ivers ity  o f Leicester, using the method o f
125Barovsky and Brooker (1980). [ I ] -N a l fo r the synthesis was obtained from  
Amersham In te rna tiona l pic and pindolol from  the B iochem ical Pharmacology 
Departm ent, Glaxo Research Ltd .
2.2.2 ANIMALS
AH A stra in  rats from  the breeding un it o f Glaxo Research L td . were used. 
'A d u lt1 male and female rats weighed 200-300g, 'young adult' ra ts weighed 140- 
160 g. 'Weanlings' were 21 days post partum , a t which age they were w ithdraw n
from  the dams. The age o f fe ta l ra ts was determ ined from  the tim e o f m ating: the 
day tha t a vaginal plug was discovered was considered to be day 1 post co itum . 
'N ear-te rm ' fe ta l rats were day 20 or 21 post co itum , the precise day o f m ating not 
being known.
P a rtu rition  usually occurred overnight between days 21 and 22 post co itum ; 
results reported fo r day 22 post coitum  are fo r natura lly-born neonates k illed  
shortly a fte r the complete l i t te r  (10 to 14 pups) had been delivered. 24 and 48 hour 
post partum neonates were obtained by caesarian delivery on day 21 o f gestation; 
um bilica l cords were broken by a sharp tug close to the body, as th is  procedure 
m im icked the 'na tura l' s ituation and prevented the blood loss seen when cords were 
cut, and also avoided the time-consuming suturing o f cords. Neonates were then 
fostered fo r the appropriate period to a la c ta ting  female. A l l neonates so trea ted 
had fed and a ll survived. Older neonates had been born natura lly. A l l animals from  
a l i t te r  were weighed together and a mean weight per fetus or pup calculated.
In one experiment to investigate the possible e ffec ts  o f catecholam ine 
depletion on ligand binding to hepatic adrenoceptors, adult female rats were dosed 
w ith  syrosingopine. 40 mg syrosingopine was mixed w ith  0.2 m l g lac ia l ace tic  acid, 
0.8 m l p ropanol-I,2-d io l, I  m l absolute ethanol and 18 m l d is tilled  w a te r to  give a 
syrosingopine concentration o f 2 m g/m l. Dosing was by the in tra -pe ritonea l route 
and 0.5 mg/kg was administered 24 hours p rio r to k illing .
A du lt, young adult and weanling rats were k illed  by cerv ica l d is location; 
fetuses and neonates were k illed  by decapitation.
A ll animals were given food and w ater ad lib itu m .
2.2.3 LIVER MEMBRANE PREPARATION
The standard method used to  prepare live r membranes is described in section 
A below. However, in an a ttem pt to overcome d iff ic u ltie s  encountered fo r  some 
assays, live r membranes were prepared by several methods, also detailed below. 
Single adult livers, pooled livers from  one l i t te r  o f weanlings or day 7 post partum  
neonates, or pooled livers from  1-4 lit te rs  o f fetuses or young neonates were used, 
to give a to ta l weight o f 10-30 g o f tissue.
A. This method was based on tha t o f W itk in  and Harden (1981). 'Homogenisation
medium' was 145 mM NaCl, 2 mM MgC^? 20 mM Tris, pH 7.5. 'Storage medium' 
was 250 mM sucrose, 5 mM MgCl^, 50 mM T ris , pH 7.5. A ll steps were carried out 
a t 4°C .
(1) L ivers were rinsed in homogenisation medium, scissor-minced where 
necessary and homogenised in about 40 volumes o f homogenisation medium 
using a Silverson type homogeniser (Vortm ix m ixer/em u ls ifie r) fo llow ed by a 
Dounce homogeniser (Jencons S c ien tific  Supplies).
(2) The homogenate was centrifuged at 2,000 g fo r 10 minutes (MSE Coolspin).
(3) The pe lle t was discarded and the supernatant centrifuged at 40,000 g fo r 15 
minutes (MSE Europa 65).
(4) The supernatant was discarded, the pe lle t resuspended in homogenisation 
medium using the Dounce homogeniser and centifuged at 40,000 g fo r  15 
minutes (MSE Europa 65).
(5) Step 4 was repeated.
(6) The supernatant was discarded and the pe lle t resuspended in storage medium 
using the Dounce homogeniser.
(7) 1 m l aliquots were taken in to capped polypropylene tubes (Sarstedt).
Membranes were used freshly prepared or were snap-frozen in liqu id  ^  and 
used a fte r storage a t -60°C  to -80°C .
This method gave a membrane yie ld o f 5-30 mg prote in /g  tissue.
B. This method was adapted from  a standard membrane preparation method used 
in the B iochem ical Pharmacology Departm ent o f Glaxo Research L td . 'M edium1 was 
50 mM Tris, 10 mM M gC ^, pH 7.4. A l l steps were carried out a t 4°C .
(1) Livers were rinsed in medium, scissor-minced where necessary and 
homogenised in about 2.5 volumes o f medium using a Silverson type 
homogeniser (Vortm ix m ixer/em u ls ifie r) fo llowed by a Dounce homogeniser 
(Jencons S c ien tific  Supplies).
(2) The homogenate was f ilte re d  through four layers o f cheese-cloth, then 
centrifuged at 8,000 g fo r 10 minutes (MSE Coolspin).
(3) The pe lle t was discarded and the supernatant centrifuged at 40,000 g fo r  20 
minutes (MSE Europa 65).
(4) The supernatant was discarded, the pe lle t resuspended in medium using the 
Dounce homogeniser and centrifuged at 70,000 g fo r 20 m inutes (MSE Europa 
65).
(5) Step 4 was repeated.
(6) The supernatant was discarded and the pe lle t resuspended in medium using 
the Dounce homogeniser.
(7) 1 m l aliquots were taken in to capped polypropylene tubes (Sarstedt). 
Membranes were used freshly prepared or a fte r  storage a t -60°C .
This method gave a membrane yie ld o f 2-3 mg prote in /g  tissue.
C. This method was based on tha t o f N ev ille  (1968). 'Medium' was 1 mM
N aH C O y A ll steps were carried out a t 4°C.
(1) L ivers were rinsed in medium, scissor-minced where necessary and 
homogenised in about 6 volumes o f medium using a Silverson type 
homogeniser (Vortm ix m ixer/em u ls ifie r) fo llowed by a Dounce homogeniser 
(Jencons S c ien tific  Supplies).
(2) The homogenate was f ilte re d  through four layers o f cheese-cloth, then 
centrifuged at 1,500 g fo r  10 minutes (MSE Coolspin).
(3) The supernatant was discarded and the pe lle t resuspended in medium using 
the Dounce homogeniser.
(4) Step 2 was repeated.
(5) The supernatant was discarded and the pe lle t resuspended in s u ffic ie n t 69% 
(w /w) sucrose in medium to give 44% (w /w) sucrose.
(6) 10 m l aliquots o f crude membrane suspension were placed in 13 m l cen trifuge
tubes and gently overlain w ith  3 m l o f 42.3% (w /w) sucrose in medium.
(7) The tubes were le f t  to stand fo r 30 minutes, then centrifuged at 100,000 g fo r
2 hours (MSE Europa 65).
(8) The membranes floa ting  on the top o f the sucrose gradient were aspirated,
resuspended in medium using the Dounce homogeniser and cen trifuged  at
8,000 g fo r 10 minutes (MSE Coolspin).
(9) The supernatant was discarded and pe lle t resuspended in medium using the 
Dounce homogeniser.
(10) 1 m l aliquots were taken in to capped polypropylene tubes (Sarstedt).
Membranes were used freshly prepared or a fte r  storage a t -60°C.
Very low membrane yields (< 0.1 mg pro te in /g  tissue) were obtained w ith  th is
method.
D. This method was based on tha t o f Kaumann and Birnbaumer (1974). 'Medium'
was 1 mM KHCO^. A ll steps were carried out a t 4°C .
(1) L ivers were rinsed in medium, scissor-minced where necessary and
homogenised in about 40 volumes o f medium using a Silverson type 
homogeniser (Vortm ix m ixer/em uls ife r) fo llowed by a Dounce homogeniser 
(Jencons S c ien tific  Supplies).
(2) The homogenate was f ilte re d  through two layers o f gauze then centrifuged at
2,000 g fo r 10 minutes (MSE Coolspin).
(3) The pe lle t was discarded and the supernatant centrifuged at 40,000 g fo r 15 
minutes (MSE Europa 65).
(4) The supernatant was discarded, the pe lle t resuspended in medium using the 
Dounce homogeniser and filte re d  through two layers o f gauze, then 
centrifuged at 40,000 g fo r 15 minutes (MSE Europa 65).
(5) Step 4 was repeated.
(6) The supernant was discarded and the pe lle t resuspended in medium using the 
Dounce homogeniser.
(7) 1 m l aliquots were taken in to capped polypropylene tubes (Sarstedt). 
Membranes were used freshly prepared or a fte r  storage a t -60°C.
This method gave a membrane yie ld o f about 10 mg pro te in /g  tissue.
2.2.4 RADIOLIGANDS USED IN BINDING ASSAYS 
f ^H l -D ihydroalprenolo l
An aliquot o f live r membrane preparation containing 0.05 -  2.0 mg o f p ro te in  
was incubated w ith  [^H ] -DHA at ligand concentrations in the range 0.15 -  20.0 nM 
fo r saturation assays and 1.5 - 3.0 nM fo r tim e course, pro te in  d ilu tio n  and 
displacement assays. A to ta l volume o f 400 p i was incubated in the presence o f
50 mM Tris, 10 mM M gC ^ and 100 pg /m l ascorbic acid at pH 7.4. Phentolamine 
was included in a ll incubations (usually at 0.1 mM) to reduce binding to  a - • 
receptors. Displacing drugs were dissolved in the incubation m ixture . Specific 
binding was defined as tha t binding displaced by 2 x 10~^M isoprenaline.
Disposable polypropylene tubes (Sarstedt) were used fo r a ll incubations. 
Incubation was always in tr ip lic a te  and was started by addition o f membranes, 
except in prote in d ilu tion assays when addition o f ligand started the incubation. 
Incubation was fo r 20 minutes, or fo r varying tim es up to  20 m inutes when the tim e 
course o f association was being investigated, and was always a t 30°C. Incubation 
was term inated by addition o f 3 m l o f ice-co ld 50 mM Tris  bu ffe r a t pH 7.4, 
fo llowed im m ediate ly by f ilt ra t io n  under vacuum through GF/B glass m ic ro fib re  
f ilte rs  (Whatman); a M illipo re  1225 sampling manifold was used. Assay tubes were 
washed w ith  3 m l ice-cold bu ffe r and the f ilte rs  washed w ith  a fu rth e r 2 x 5 m l ice - 
cold bu ffe r.
F ilte rs  were placed in disposable sc in tilla tio n  vials (Packard, Illino is , USA) 
and 10 m l o f P ico -fluo r 30 sc in tilla n t flu id  added. Bound [^H  ] -DHA was counted 
in a sc in tilla tion  counter (Mark III, Model 688, Tracor A na ly tic ). A liquots o f I^H  ] - 
DHA were counted to allow calcula tion o f the concentration o f ligand present in 
incubations.
[ ^H ] -D ihydroerqocryptine
An aliquot o f live r membrane containing 0.1 -  0.5 mg prote in was incubated 
w ith  [^H ]-DH E at ligand concentrations in the range 4.5 - 15.0 nM. A to ta l volume 
o f 400 p i was incubated in the presence o f 50 mM Tris  and 10 mM M gC ^ at pH 7.6. 
Displacing drugs were dissolved in the incubation m ixture  (in the presence o f 
ascorbic acid where appropriate).
Disposable polypropylene tubes (Sarstedt) were used fo r  a ll incubations. 
Incubation was always in tr ip lic a te  and was started by addition o f membranes, 
except in prote in d ilu tion  assays when addition o f ligand started the incubation. 
Incubation was fo r 10 minutes, or fo r varying tim es up to 15 minutes when the tim e  
course o f association was being studied, and was always at 37°C. Incubation was 
term inated by the addition o f 3 m l ice-cold 50 mM T ris  bu ffe r a t pH 7.6 fo llowed 
im m ediate ly by f ilt ra t io n  under vacuum through GF/B glass m ic ro fib re  f ilte rs  
(Whatman); a M illipo re  1225 sampling m anifo ld was used. Assay tubes were washed 
w ith  3 ml ice-cold bu ffe r and the f ilte rs  washed w ith  a fu rthe r 2 x 5m l ice-cold 
bu ffe r.
F ilte rs  were placed in disposable sc in tilla tio n  vials (Packard) and 10 m l o f 
P ico -fluo r 30 sc in tilla ltio n  flu id  added. Bound [^H  ] -DHE was counted in a 
sc in tilla tion  counter (Mark III, Model 688, Tracor A na ly tic ). A liquots o f [ ^H ] -DHE 
were counted to allow  ca lcu la tio n  o f the concentration o f ligand present in 
incubations.
125[ I ]-Iodocyanopindolol
An aliquot o f live r membrane containing 0.10 - 0.15 mg prote in was incubated 
125w ith  [ I ]  -ICYP at ligand concentrations in the range o f 12-500 nM fo r 
saturation assays and 70-115 nM fo r tim e course and displacement assays. A to ta l 
volume o f 150 p i was incubated in the presence o f 120 mM Tris, 5 mM MgSO^ and
1.3 mM EDTA at pH 7.6. Displacing drugs were dissolved in the incubation medium 
(in the presence o f ascorbic acid where appropriate). Specific binding was defined 
as tha t binding displaced by 2 x 10"** M isoprenaline.
Disposable polypropylene tubes (Sarstedt) were used fo r a ll incubations. 
Incubation was always in trip lica te , and was started by addition o f membranes. 
Incubation was fo r 30 minutes, or fo r varying tim es up to 45 minutes when the tim e
course o f association was being studied, and was at 37°C . Incubation was 
term inated by addition o f 1 m l o f ice-cold washing bu ffe r (10 mM Tris, 5 mM 
M gC ^, pH 8.0) fo llowed by im m ediate f ilt ra t io n  under vacuum through GF/B glass 
m icro fibres (Whatman); a M illipo re  1225 sampling m anifold was used. Assay tubes 
were washed w ith  2 x 1 m l ice-cold washing b u ffe r and the f ilte rs  washed w ith  a 
fu rth e r 2 x 5 ml ice-cold washing bu ffe r.
F ilte rs  were folded in to sem i-circles and placed in disposable polypropylene
125tubes (Sarstedt). Bound [ I ] -ICYP was counted in a gamma-counter (Model 
1185R, Searle A n a ly tic  Inc.). A liquots o f [ I ]  -ICYP were placed in 2 m l
polystyrene tubes, capped and counted to allow calculation o f the concentration o f 
ligand present in incubation.
[ ~ ^ I  ] Iodopindolol 
125[ I ] -IP binding was assayed using a method adapted from  th a t o f
M cM illian  et al. (1983). An aliquot o f liv e r membrane containing 0.09 -  0.40 mg
125prote in was incubated w ith  [ I ]-IP at ligand concentrations in the range 10 - 
600 pM fo r saturation assays and 40 - 90 pM fo r a ll other assays. A to ta l volume o f 
150 p i was incubated in the presence o f 145 mM NaCl, 20 mM Tris, 2 mM M gC ^ 
and 1 mM ascorbic acid a t pH 7.5. D isplacing drugs were dissolved in the incubation
m ixture . Specific binding was defined as tha t binding displaced by 2 x 10~^M
-7 8isoprenaline. In some saturation assays 5 x 10 M atenolol or 5 x 10 M IC I 118 551
was present; these concentrations were calculated to occupy 90 - 100% o f or B2
adrenoceptors respectively (Cook et al., 1984).
Disposable polypropylene tubes (Sarstedt) were used fo r a ll incubations. 
Incubation was at 25°C, was always in tr ip lic a te  and was started by add ition o f 
membranes, except in prote in d ilu tion assays, when addition o f ligand started  the 
incubation. Incubation was fo r 45 minutes when prote in d ilu tion  pro files, satura tion
assays or inh ib ition  assays were being perform ed, fo r varying tim es by up to 45 
m inutes when the tim e course o f association was being studied, or fo r 45 m inutes 
followed by varying tim es up to 20 m inutes a fte r addition o f isoprenaline to  give a 
concentration o f 5 x lCf**M when the dissociation tim e course was being studied. 
Incubation was term inated by addition o f 2 m l ice-cold washing b u ffe r (145 mM 
NaCl, 10 mM Tris, pH 7.5), fo llowed by im m ediate f ilt ra t io n  under vacuum through 
GF/B glass m icro fib re  f ilte rs  (Whatman); a M illipo re  1225 sampling m anifo ld was 
used. Assay tubes were washed w ith  2 m l ice-cold washing bu ffe r and f ilte rs  were 
washed w ith  a fu rth e r 2 x 5 m l ice-cold bu ffe r.
F ilte rs  were folded in to sem i-c irc les and placed in disposable polypropylene 
125tubes (Sarstedt). Bound [ I ]-IP was counted in a gamma counter (Model 1185R,
125Searle A n a ly tic  Inc.). A liquots o f [ I ] -IP were placed in 2 m l polystyrene tubes, 
capped and counted to allow calcu la tion o f the concentration o f ligand present 
incubations.
2.2.5 ANALYSIS OF DATA
A ll s ta tis tica l analyses were carried out using paired Student’s t- te s t.
2.3 RESULTS
2.3.1 [3H ] -DIHYDROALPRENOLOL BINDING ASSAY
[3H ] -DHA binding assays were carried out using live r membranes prepared 
by each o f the methods detailed in the ’M ateria ls and Methods’ section. A d u lt male, 
adult female, young adult male, weanling male, near-term  fe ta l, and catcholam ine- 
depleted adult female ra t live r membranes were investigated. No d iffe rence was 
apparent in results obtained when using live r membranes prepared by the various 
methods or when animals o f d iffe re n t ages or sexes were used. S im ila r results were 
obtained w ith  e ither freshly-prepared liv e r membranes or membranes used a fte r  
storage a t -60°C.
Non-specific binding was extrem ely high in a ll assays, usually representing 
between 60 and 70% o f to ta l binding, and never being less than 40%.
Prote in  d ilu tion  p ro file
To ta l binding o f [3H 1-DHA increased w ith  increasing prote in concentration 
over the range studied, but corre la tion  o f specific  binding and pro te in  
concentration was generally poor due to non-specific binding being high and 
variable.
Association tim e course
Examination o f the association tim e course showed a typ ica l hyperbolic 
increase in to ta l ligand binding over the 20 m inutes studied. However, non-specific  
bnding was high and showed an e rra tic  increase w ith  tim e and thus spec ific  binding 
was low and did not show a typ ica l association tim e course (Fig. 2.2).
D issociation tim e course
Due to poor results in other assays, th is assay was not a ttem pted w ith  th is 
radioligand.
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Inh ib ition  p ro file
Displacement curves w ith  isoprenaline, adrenaline, and noradrenaline gave 
inconsistent results. The range o f K j values obtained are given in Table 2.1, but 
these were highly variable, and on some occasions no K. value could be obtained 
due to the variable degree o f binding which could be defined as specific .
Saturation assay
Only one saturation assay was a ttem pted w ith  [ 1-DHA. To ta l, non­
specific and specific  binding a ll increased w ith  increasing [ ] -DHA
concentration, but the high and variable nature o f the non-specific binding made 
any analysis o f the data impossible.
Investigation o f high non-specific binding
In an a ttem pt to reduce the high non-specific binding, the concentration o f 
phentolamine included in the assay was varied between 0.05 and 1.0 mM; a 
concentration o f 0.1 mM phentolamine resulted in the greatest reduction in non­
specific  binding. EDTA at concentrations o f 0.5 or 1.0 mM had no consistent e ffe c t 
on binding.
To investigate whether the high non-specific binding was due to  binding o f 
[■^H ] -DHA to f ilte rs , a single assay was carried out by the cen trifuga tion  method, 
in which ligand bound to membrane is separated from  free ligand by rapid 
centrifugation  to form  a membrane pe lle t. Using this method, non-specific binding 
was never less than 95% o f to ta l; th is assay method was obviously unsuitable. This 
finding suggests tha t i t  is unlikely tha t binding o f the ligand to f ilte rs  was the 
cause o f the high non-specific binding found using the f ilt ra t io n  technique.
TABLE 2.1
[^H 3-DHA displacement from rat liver membranes
K i (nM)
Experim ental results L ite ra tu re  values3
Displacing drug
(-)isoprenaline 13.5 -  52.0 12 -  60
(n = 3)
(-)adrenaline 397 120 - 484
Values obtained from  inh ib ition  pro files  (see te x t fo r details).
a Aggerbeck et al., 1978 and 1980; Dax e t al., 1981; Guellaen e t al. 
1978; M cM illian  e t al., 1983; Malbon, 1980 and 1981; Munnich e t al. 
1981.
TABLE 2.2
[^H 3-DHA binding data in ca t ven tric le  membranes
Published values
Experim ental
results - cat heart3 other tissues
cat heart
K D (nM) 1.9, 1.5 4.34 1-3.5
Bmax (fm oles/m g 29.3, 26.6 80 + 6 NA
protein)
Values obtained from  saturation assays (see te x t fo r details), 
a Sharma and Corr, 1983.
b Dax et al., 1981; Kawai and A rinze, 1983; Minneman and M o lin o ff
1980; Munnich e t al., 1981.
NA N ot applicable
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To investigate the possib ility  th a t uptake o f the ligand by the incubation tube ■ 
was leading to high non-specific binding, a fixed amount o f ligand in incubation 
bu ffe r was placed in the tube and incubated fo r varying tim es up to 40 m inutes at 
30°C. A fixed aliquot was removed from  the tube a t the end o f the incubation, and 
counted. The absence o f any dependence o f the recoverable rad io ac tiv ity  on the 
length o f incubation confirm s tha t there is no s ign ifican t uptake o f t 3H l  -DHA by 
the tube.
In order to ascertain whether the problems encountered w ith  [3H ] -DHA 
binding assays in live r membranes were due to the nature o f liv e r tissue or to  poor 
experim ental technique, [ 3H ] -DHA binding assays were carried out using 
membranes prepared from  cat ven tric le  by method D described in section 2.2.3 o f 
M ateria ls and Methods. Using cat heart membrane, non-specific binding was s t i l l
high, but was always less than 30%, and in saturation assays increased linea rly  w ith
3 3increasing [ H ] -DHA concentration. Results o f Scatchard analysis o f [ H ] -
DHA saturation binding data in cat ven tric le  membranes are given in Table 2.2.
values found were somewhat lower than the only published value found fo r th is
ligand in heart membranes (Sharma and Corr, 1983) but were o f the same order as
published values fo r other tissues and were in close agreement w ith  values found
fo r th is tissue by other workers in the B iochem ical Pharmacology D epartm ent o f
Glaxo Research L td  (unpublished results). values were considerably low er
than the value reported by Sharma and C orr (1983) fo r th is tissue, but were in good
agreement w ith  results obtained previously by other works a t Glaxo.
2.3.2 [ 3H ] -DIHYDROERGQCRYPTINE BINDING ASSAY
[ 3H ]-DHE binding assays were carried out using live r membranes prepared 
by method A in section 2.2.3 o f M ateria ls and Methods. N ear-te rm  fe ta l and day 7 
post partum neonatal liv e r membranes were used. No d iffe rence was apparent in
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results obtained from  fe ta l or neonatal animals. S im ila r results were obtained w ith  
freshly-prepared live r membranes or membranes used a fte r storage a t -60°C.
Prote in  d ilu tion  p ro file
To ta l binding o f [^H  3-DHE to liv e r  membranes increased proportiona lly 
w ith  increasing prote in or ligand concentration. However, fa ilu re  to d iffe re n tia te  
specific  and non-specific binding in this assay system makes in te rp re ta tion  o f these 
results impossible. M ajor problems arose in the F*H 3 -DHE assay in defin ing any 
binding as specific. Phentolamine (a non-subtype-selective a-antagonist) is most 
commonly used to define specific binding in [^H 3-DHE binding assays reported in 
the lite ra tu re , e ithe r at 10 pM (C larke et al., 1978; E l-R e fa i & Exton, 1980; 
Hoffmann et al., 1979) or at 100 pM (Aggerbeck et al., 1978; Butlen e t al., 1980; 
Guellaen et al., 1978). In the experim ental work reported here, inclusion o f drugs 
w ith  known a ff in ity  fo r a-receptors resulted, in the m a jo rity  o f instances, in an 
increase in ligand binding to liv e r membranes.
Investigation o f the e ffec ts  o f g-antaqonists on binding
Investigation o f the e ffe c t varying phentolamine concentrations showed a
concentration-dependent change in the binding o f [^H  3 -DHE to  fe ta l or neonatal
-7 -5 3live r membranes. In one experiment, 10" -10" M phentolamine displaced [ H 3 -
DHE, but the % displacement decreased w ith  increasing drug concentration and a
maximum displacement o f 20% was obtained w ith  10"^ M; w ith  phentolam ine
concentrations o f 10 ^ -10~^M, ligand binding increased proportiona lly  w ith
increasing phentolamine concentration and was about 160% o f con tro l a t the top
phentolamine concentration (Fig. 2.3). On repeating th is experiment, only 1%
ligand displacement was seen at 10~^M phentolamine, and a concentra tion-re la ted
increase in binding, w ith  a maximum level o f 163% o f contro l, was seen fo r
phentolamine concentrations up to  10"^M (Fig. 2.3).
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The e ffec ts  o f varying concentrations o f the a^-antagonist yohimbine were 
also studied. This drug increased [ H I-DHE binding to  liv e r membranes in a 
concentration-dependent manner a t low concentrations, but a t higher 
concentrations ligand displacement was seen which was proportional to the leve l o f 
yohimbine in the incubation. Increases up to  120% and decreases down to  55% o f 
contro l binding levels were observed, but the concentrations o f yohimbine causing 
these changes varied from  experiment to experiment. However, yohimbine above 
10~^M always resulted in a displacement o f [3H 1-DHE from  liv e r membranes, 
and yohimbine below 10”^M always resulted in an enhancement o f [ 3H ] -DHE 
binding to  live r membranes. The binding changes observed were always 
concentra tion-re la ted (Fig. 2.4).
2.3.3 [ I2 3 I ]-IQDQCYANOPINDQLQL BINDING ASSAY
125[ I ]  -ICYP binding assays were carried out using adult fem ale liv e r 
membranes prepared by the method B described in section 2.2.3 o f M ateria ls and 
Methods, and day 7 post partum  neonatal live r membranes prepared by method A 
described in section 2.2.3 o f M ateria ls and Methods. No d iffe rence was apparent in 
results obtained from  neonatal or adult tissues. S im ila r results were obtained w ith  
freshly-prepared tissue or tissue used a fte r storage a t -60°C. Non-specific  binding 
was typ ica lly  15-30% o f to ta l binding.
Inh ib ition p ro file
A normal inh ib ition  p ro file  was obtained w ith  isoprenaline in one experim ent; 
analysis o f th is gave a K. fo r isoprenaline o f 2.7 nM. However, a second 
displacement assay showed very irregu la r displacement.
Saturation assay
Scatchard analysis o f saturation binding data obtained in one experim ent gave
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125a fo r [ I ]  -ICYP o f 170 pM, which is high compared w ith  published values, 
which range from  13 to 66 pM (Brodde, 1982; Brodde e t al., 1981; Engel a t al., 
1981; H e itz  et al., 1983; Wolfe &  Harden, 1981; Z in i et a l., 1983) and on repeating 
the assay the data obtained showed a scattered d is tribu tion  on a Scatchard p lo t.
Association tim e  course
125The tim e course o f association o f [ I ] -ICYP to  live r membranes was 
investigated, as the inconsistency o f the results obtained m ight have resulted from  
reactions not reaching equ ilibrium . I t  was observed th a t although the ra te  o f 
increase o f binding was fa ir ly  low by 25 minutes, a sm all increase in to ta l and 
specific binding could s t i l l  be seen up to  45 minutes. A  typ ica l graph o f the 
association tim e course is shown in Figure 2.5.
D issociation tim e course
Due to poor results in the association tim e  course, this assay was not 
attem pted w ith  th is  radioligand.
2.3.4 [ 125I ]-IODOPINDOLOL BINDING ASSAY
125[ I ]-IP binding assays were carried out using liv e r  membranes from  day 
20, 21, and 22 post coitum  fe ta l ra ts and 24 and 48 hours post partum neonatal ra ts, 
prepared as detailed in method A o f section 2.2.3 o f M ateria ls and Methods. 
S im ilar results were obtained w ith  freshly-prepared tissue or w ith tissue used a fte r  
storage a t -60°C.
Non-specific binding was low at a ll times in this assay, representing 5-15% o f 
to ta l binding in a typ ica l saturation assay.
Prote in d ilu tion  profiles, the tim e course o f association and dissociation,
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inh ib ition pro files fo r a range o f adrenergic agents and investigation o f the
inh ib ito ry  e ffe c ts  o f compounds w ith  a f f in ity  fo r receptors o ther than the
$ -adrenoceptor, were carried out using membranes from  day 20 post co itum
fetuses. L im ited  tim e and ligand ava ila b ility  prevented a complete range of assays
from  being carried out at a ll ages, but dissociation constants fo r displacing agents
125(K.) obtained from  inh ib ition  profiles, and dissociation constants fo r [ I 1-IP
(K q ) obtained from  saturation assays (Tables 2.3 and 2.4), confirm ed tha t i t  was
125reasonable to assume tha t [ I ] -IP was binding to  the same receptor population 
at each age.
P rote in d ilu tion  p ro file
To ta l and specific ligand binding increased linea rly  w ith  increasing prote in 
concentration over the prote in concentration range studied; non-specific binding 
also increased linea rly  w ith  prote in concentration, but was always < 10% o f to ta l 
binding in prote in d ilu tion  pro files (Fig. 2.6).
Association tim e course
125The tim e course o f association o f [ I ]  -IP w ith  day 20 post co itum  fe ta l 
live r membranes showed a typ ica l hyperbolic increase o f to ta l and specific  binding, 
reaching a plateau at around 25 minutes; non-specific binding showed a sharp 
increase in the f irs t  m inute, and then a s ligh t linear increase over the rem ainder o f 
the tim e studied (Fig. 2.7).
The association o f a radioligand w ith  its  receptor is a second order reaction; 
however, i f  less than 10% o f the ligand present is spec ifica lly  bound at equ ilib rium , 
the reaction becomes psuedo-first order, and is described by the ra te  equation:
TABLE 2.3
123[ I ] -IP displacement from  ra t liv e r membranes
Age:
K ; (nM)a
Day 20 p.c. Day 21 p.c. Day 22 p.c. 24 hours p.p.
Displacinq
drug
(-)Isoprenaline 210 - _ -
(n=2)
(+)Adrenaline 350 _ _
(n=2)
(+)Noradrenaline 5100 - - -
Ateno lo l 14000 14900 14600 16500
(n=2)
IC I 118 551 5.6 + 2.4 6.1 4.1 4.6
(n=3) (n=2)
Values obtained from  inh ib ition  pro files  (see te x t fo r details), 
a K. is shown as mean + SEM.
TABLE 2.4
125[ I ]  -IP binding data in perinata l ra t liv e r membranes? K p
K d  (pM)a
Age: Day 20 
P-c-
Day 21 
p.c.
Day 22 
p.c.
24 hours
p.p.
48 hours 
P»P
Tota l
8-Receptors
66.4 + 26.0 
(n=4)
85.8 + 4.7 
(n=3)
81.2 + 19.7 
(n=3)
72.9 + 10.6 
(n=3)
69.9 + 5.2 
(n=3)
82-Receptors 94.7
(n=2)
81.8 + 5.5 
(n=3)
86.2 + 20.9 
(n=3)
101.7 + 19.4 
(n=3)
76.4 + 6.1 
(n=3)
Values obtained from  saturation assays (see te x t fo r details), 
a K q  is shown as mean + SEM.
TABLE 2.5
125[ 13 -IP binding data in perinata l ra t liv e r membranes; B
B (fm oles/ng protein) max
Age: Day 20 Day 21 Day 22 24 hours 48 hours
£ ic * EiP.* ErP.t P*P* P:R
Tota l 13.0 + 2.6 18.3 + 1.3 30.4 + 2.4 21.6 + 2.4 19.9 + 1.2
8-Receptors (n=4) (n=3) (n=3) (n=3) (n=3)
* * * *  * * *  * *  *
89-Receptors 12.3 15.3 + 2.0 28.5 + 1.6 19.8 + 1.7 18.5 + 3.7
(n=2) (n=3) (n=3) (n=3) (n=3)
Values obtained from  saturation assays (see te x t fo r details).
a is shown as mean + SEM.max —
*  S ign ifican tly  d iffe re n t from  Day 22 p .c., p < 0.05
* *  S ign ifican tly  d iffe re n t from  Day 22 p.c., p < 0.01
* * *  S ign ifican tly  d iffe re n t from  Day 22 p.c., p < 0.005
* * *  S ign ifican tly  d iffe re n t from  Day 22 p.c., p < 0.001
rIGU RE 2.7 Time course of association
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Be
Be-Bt
. t L . Bmax 
Be
Where: Be
B t
L
Bmax
concentration o f ligand specifica lly  bound at equilibrium  
(moles per mg protein)
concentration o f ligand specifica lly  bound a t tim e  t  
(moles per mg protein)
concentration o f radioligand a t zero tim e (M)
receptor, concentration (moles o f ligand spec ifica lly  bound 
per mg protein)
association ra te  constant.
From th is equation, i t  can be seen tha t i f  In ls  p lo tted  against tim e  (in
seconds), a s tra igh t line is obtained o f gradient k^* (Fig 2.7 inset).
When the association tim e course data shown in Figure 2.7 was expressed in th is
7 -1 -1way an association rate constant (k^) o f 1.5 x 10 M~ s~ was obtained.
Dissociation tim e course
When isoprenaline was added to on incubation m ixture  containing membrane
125from  day 20 post coitum  livers w ith  [ I ] -IP bound at equ ilibrium , such th a t a
-6concentration o f isoprenaline o f 5 x 10" M was achieved, the ligand was displaced 
from  the membrane in a time-dependent manner (Fig. 2.8), w ith  50% o f the 
specifica lly  bound ligand displaced in approxim ately 12 m inutes. The dissociation o f 
a radioligand from  its  receptor is a f irs t  order reaction described by the equation
log Be
B t
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2.303
12
5j
]_
ip
 
bo
un
d 
(m
ol
ea
/a
g 
p
ro
te
in
 
x
lO
1
4
)
FIGURE . 8 Time cour se  of  d i s a o c l a t i o n  of
T12 3 I 1 -  i o d o p i n d o l o l
2-5
2 0
1-5
1-0
205 10 
Time (min)
zr A A
_L J
0 5 10 15 20
Time a f t e r  a d d i t i o n  of  excess i s o p r e n a l i n e  (minutes)
Legend as f o r  F i g u r e 2 . 7
Where Be = concentration o f ligand specifica lly  bound at equ ilibrium
(moles per mg protein)
B t = concentration o f ligand specifica lly  bound a t tim e  t
(moles per mg protein)
k  ^ = dissociation rate constant.
Thus, i f  log is p lo tted against tim e (in seconds), a stra igh t line is obtained o f 
-1gradient ^ 3^3 (Fig. 2.8 inset). When the dissociation tim e course data shown in
-4 -1Figure 2.8 was expressed in th is way, a dissociation ra te  constant o f 9.1 x 10 s 
was obtained.
The ha lf tim e o f dissociation may be calculated from  k ^ as fo llows:
0.693
0.3 k 1 -,-7-1 = 13 min
Calculation o f dissociation constant from  ra te  constants
Using the values determined fo r k j and k  ^ the dissociation constant (K q ) 
may be obtained:
K (m ) -  ^-1 ^D " fKA- l  -lxk j  (M s )
The dissociation constant determined from  k ine tic  analysis is there fo re
9.1 x 10"4 (s '1) = 6.07 x 10"1:1(M)
1.5 x 107 M 'V1
or 60.7 pM
Inh ib ition  p ro file
125Compounds w ith  known a ff in ity  fo r 8-adrenoceptors displaced [ I ]  -IP 
from  fe ta l and neonatal live r membranes in a concentration-dependent manner and 
when a fu ll range o f compounds was investigated using day 20 post coitum  
membranes, these showed re la tive  potencies consistent w ith  82~adrenoceptor 
binding (Table 2.3) (fo r review, see Le fkow itz  and Hoffm an, 1981a).
125A typ ica l sigmoidal displacement curve o f [ I ]-IP  by isoprenaline, and the 
Hofstee plot o f these data, are shown in Figure 2.9. Displacement curves obtained 
using the 82-subtype selective antagonist atenolol or the 82“ subtype-se lective  
antagonist IC I 118 551 showed s light in flections, and Hofstee plots o f the same 
data were curved (e.g. Fig. 2.10); the significance o f these findings w ill be 
considered in the Discussion section o f th is Chapter.
125As a fu rthe r confirm ation  tha t [ I ]-IP  was binding 8 -adrenergic receptors, 
compounds w ith  pharmacological a c t iv ity  other than fo r 8-adrenoceptors were 
investigated fo r th e ir a b ility  to displace the ligand. The fo llow ing antagonistic 
compounds (the receptors at which they act is given in brackets) had no s ign ifican t 
e ffe c t on [ ^ ^ 1 ]  -IP binding when present a t 10"^ or 10^M: phentolam ine (a - 
adrenoceptor), ketanserin (5HT receptor), atropine sulphate (muscarinic cholinerg ic 
receptor), spiperone (D2 dopamine receptor), mepyramine (H j histam ine receptor), 
ran itid ine  (H2 histamine receptor).
Saturation assay
125A typ ica l saturation p ro file  o f [ I ]-IP  binding is shown in F igure 2.11, 
together w ith  the Scatchard p lo t o f these data. K p  and Bmax values obtained by 
Scatchard analysis o f saturation assays are shown in Tables 2.4 and 2.5. Values fo r 
^ - re c e p to rs ’ were obtained using data from  assays in which 5 x lCT^M atenolo l
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125(calculated to displace 90-100% o f 8 j  -adrenoceptor-bound [ I ]-IP) was included
-8in a ll incubations. The inclusion o f IC I 118 551 a t 5 x 10” M (calculated to displace
90-100% o f 82-adrenoceptor-bound ligand) resulted in very low binding levels and
125very high values fo r [ I ] -IP, and saturation assays to obtain and &max 
values fo r 8 j  adrenoceptors were therefore not attem pted. K q  values obtained 
ranged from  66.4 pm (at day 20 post co itum ) to 85.8 pm (at day 21 post co itum ) fo r 
to ta l 8-receptors and from  76.4 pm (at 48 hours post partum ) to 101.7 pm (a t 24 
hours post partum ). No s ta tis tica lly  s ign ifican t d ifference was found fo r the 
value obtained fo r to ta l 8 -adrenoceptors, compared w ith  82~adrenoceptors, a t any 
age studied, or fo r the value obtained at d iffe re n t perinatal ages, and there was 
no obvious age-related trend in the K q  values obtained. The varia tion  in K q  
observed was probably due to the small numbers o f assays perform ed at.each age. 
BmaX values, however, showed a very clear age-dependent varia tion. Both to ta l 8 - 
and 82-adrenoceptors reached a maximum concentration a t te rm  (day 22 post 
co itum ), w ith  Bmgx values fo r 8 - and 82_adrenoceptors at a ll other ages studied 
being s ta tis tica lly  s ign ifican tly  less than the Bmgx value a t day 22 post co itum  
(Table 2.5).
2.4 DISCUSSION
2.4.1 OVERVIEW 
125[ I I-Iodopindolol proved a suitable ligand fo r labelling 8-adrenoceptors in
fe ta l and neonatal live r membranes. The high specific  a c tiv ity  and the se lective 
125nature o f [ I ]-IP  probably accounts fo r the successful use o f th is ligand.
A ttem p ts  to quantify  ra t hepatic adrenoceptors using [ 3H3 -dihydroalprenolo l or
125 3[ I ]-iodocyanopindolol fo r 8 -receptors or [ H 3-dihydroergocryptine fo r a -
receptors, were unsuccessful. I t  seems probable tha t the re la tive ly  sm all number o f
publications concerning radioligand labelling o f hepatic adrenoceptors, commented
on by Kawai & A rinze  (1983), re flec ts  the d iff ic u lt ie s  encountered w ith  these more
commonly used radioligands in the live r.
Four methods o f preparation o f live r membranes fo r use in binding assays
w ith  [3H]-DHA were investigated. None o f these methods resulted in preparations
showing reduced non-specific binding o f [ -DHA. Method A detailed in section
2.2.3 was used to prepare membranes fo r the m a jo rity  o f the work reported in th is
125chapter, including all o f tha t using [ I 3-iodopindolol . This is a fa ir ly  crude 
method o f preparation, but gives the highest yield o f membrane pro te in  per un it 
weight o f live r, and avoids the problem o f varia tion  o f recovery o f membrane 
prote in w ith  age which can occur using more extensive pu rifica tio n  methods 
(M cM illian  et al*, 1983).
2.4.2 [3H] -DIHYDROALPRENOLOL BINDING ASSAY
Although Aggerbeck et al. (1978), Guellaen et al. (1978) and Munnich e t al.
3
(1981) have described the use o f [ H 3-DHA to characterise 8 -adrenoceptors in 
adult ra t live r membranes, an acceptable binding assay could not be established in 
the present experimental work, even when the reported methodology was fo llow ed 
closely. Reports concerning the problems o f using [ H I -DHA in binding assays
have appeared in the lite ra tu re ; however, none o f the sources o f erro r discussed in 
these publications appears to provide an explanation o f the findings reported here. 
Nahorski & Richardson (1979) described how the use o f the $ -adrenergic 
antagonists (-)alprenolo l or (-)propranolol fo r the determ ination o f the specific  
element o f the binding o f [^H ]-D H A  to bovine lung membrane resulted in 
displacement o f the radioligand from  more than one binding site. The 8 -adrenergic 
agonist (-)isoprenaline was used to determ ine specific  binding in the assays using 
[ ]-D H A  reported in this chapter; Nakorski & Richardson showed this compound
to displace ?H  ]-D H A  from  a single, homogeneous binding site. The occurrence o f 
binding o f ] -DHA to membrane sites from  which i t  may be displaced
nonstereospecifically has been described in cardiac tissue (K raw ie tz  & Erdmann, 
1979) and in liv e r tissue (Dax e t al., 1981). Dax e t al. (1981) concluded th a t 
quantita tion  o f liv e r 8 -adrenergic receptors in normal rats is impossible using 
?H  3-DHA; however these workers found tha t two re levant facto rs influenced the 
incidence o f sites binding t ^ H ]  -DHA in a nonstereospecific manner: anim al age 
and the presence o f the a-adrenergic antagonist phentolamine. The non­
stereospecific element o f radioligand binding increased w ith  age, and was there fo re  
probably o f re la tive ly  m inor significance in the liv e r membranes used in those 
experiments discussed here, in which membranes were prepared from  ra ts during 
the perinatal period, but problems were s t i l l  encountered w ith  these preparations. 
Dax and coworkers found tha t addition o f phentolamine at a concentration o f 5 x 
10 or higher e lim inated a large proportion o f the nonstereospecifica lly
displaceable binding; the assays carried out w ith  l?H 3-DHA in the curren t work 
a ll included phentolamine a t 10~^M. As the values fo r l?H 3-D H A binding 
parameters in cat ven tric le  membranes were o f the order expected, i t  would 
appear tha t the fa ilu re  to obtain sa tis factory  binding data fo r ? H l -D H A in ra t 
live r membranes is due to the nature o f the tissue ra ther than to any techn ica l 
problems.
2.4.3 [ 3H]-D IHYDRO ERGO CRYPTINE BINDING ASSAY
Findings made when investigating [ 3H l-D H E  binding to live r membranes 
were unexpected; there is no report in the lite ra tu re  o f a-antogonists enhancing 
[ 3H ]-DHE binding. Butlen et al. (1980) used [ 3H l -DHE to label hepatic ot- 
adrenoceptors in tissue from  perinata l rats, and reported no d iffic u ltie s , although 
non-specific binding did represent up to 40% of to ta l binding. No displacement 
curves were shown in this paper. Aggerbeck e t al. (1978, 1980), C larke et al. (1978) 
and Guellaen et al. (1978) investigated a-adrenoceptors in liv e r membranes from  
adult rats using [ 3H ] -DHE, and presented plots showing dose-related 
displacement o f [3H ] -DHE by a-adrenergic agents. Non-specific binding was 20- 
25% o f to ta l in the assays reported by Aggerbeck and Guellaen and coworkers, and 
was reported to be 35-40% o f to ta l by Clarke's group.
No obvious explanation can be found as to why the present results d iffe r  so 
grea tly  from  those published, however the concentration-dependence o f the e ffe c ts  
o f phentolamine and yohimbine in increasing [ 3H ] -DHE binding together w ith  the 
e ffec ts  o f phentolamine on glucose production by perinata l hepatocytes jn  v itro  
(see Chapter 3), suggest tha t the e ffec ts  seen were not simply a rte fac tua l. 
Increased ligand binding due to conform ational changes in a-receptors fo llow ing  
binding o f the a-antagonists to adjacent adrenoceptors is one possible explanation 
fo r the observed phenomenon, but no evidence is available o f such coopera tiv ity . 
The possible involvement o f nucleotides in a f f in ity  changes must also be 
considered. Reduction in the a ff in ity  o f agonists fo r 8 -adrenoceptors, resulting 
from  the binding o f guanine nucleotides to the receptor, was f ir s t  recognised by 
Rodbell et al. (1971) and is now w e ll documented (fo r review see L e fk o w itz  & 
Hoffm an, 1981a). Goodhardt et al. (1982) reported a s im ila r regulation o f agonist 
binding to hepatic -adrenoceptors, and Hoffm an et al. (1980a, 1981) to  hepatic 
o^-adrenoceptors by guanyl nucleotides. GTP may be included in a binding assay to
ensure a constant high level o f nucleotide; although i t  was not included in the 
[ 3H ] -DHE binding assay, the ligand and displacing drugs were a ll antagonists. 
Nucleotides have been w idely shown to have no e ffe c t on the a ff in ity  o f 
antagonists fo r $ -adrenoceptors (Le fkow itz  & Hoffm an, 1981a). A lthough W olfe & 
Harden (1981) reported an increase in the a ff in ity  o f antagonists fo r B- 
adrenoceptors by GTP, no confirm ation  o f this observation has appeared in the 
lite ra tu re .
2.4.4 [123I 1-IQDOCYANOPINDOLOL BINDING ASSAY
IOC
In it ia l work w ith  [ I ] -ICYP produced promising results, but gave an
unexpectedly high value fo r the ligand, a ra ther low K j value fo r isoprenaline,
and rep lica tion o f findings was poor. The association tim e course showed tha t
125specific  binding o f [ I ] -ICYP had not reached a plateau a fte r  45 m inutes o f
incubation (Fig. 2.7), and thus i t  is like ly  tha t fa ilu re  to reach equ ilib rium  during
the tim e of the assay was responsible fo r the poor results obtained. Engel e t al.
(1981) and Brodde et al. (1981) found tha t [ ^ 23l ] - IC Y P  binding reached
equilibrium  only a fte r one hour; even longer delays in a tta in ing  equ ilib rium  have
been encountered by other workers using this ligand (S. Nahorski, personal
communication). Engel e t al. (1981) have also reported a slow component o f the
dissociation o f th is ligand w ith  less than 50% dissociation in e ight hours. The large
125cyano grouping on the [ I ] -ICYP molecule may impede its  access to the binding
site on the B-adrenoceptor, thus increasing the tim e to reach equ ilib rium . This
delay in reaching equilibrium  must produce some doubt as to the physio logica l
125significance o f findings made w ith  t I J-ICYP.
2.4.5 [125I 1-IOD OPINDQLOL BINDING ASSAY
Summary o f findings 
2 25[ ]-IP  has been described as a useful radioligand fo r  characteris ing B- 
adrenoceptors in tissues in which other ligands have proved unsuitable (Ezrailson e t
125al., 1981). The binding o f [ I ] -IP to perinata l ra t liv e r membranes was rapid,
saturable, reversible and showed displacement characteristics typ ica l o f binding to
B-adrenoceptors. This radioligand showed no se lec tiv ity  fo r B j-  or &2"
125adrenoceptors. The reaction between [ I ]  -IP and its  binding site was 
characterised as a second order reaction between a univalent, homogeneous ligand 
and a homogeneous , non-in teracting receptor population by the lin e a rity  o f the 
Scatchard plots (mean + SEM o f regression coe ffic ien ts  = 0.99 + 0.01) and the 
p rox im ity  o f the H il l  co e ffic ie n t to un ity  (mean + SEM o f H ill coe ffic ien ts  = 1.00 + 
0.1) (Weiland & M o lino ff, 1981). The dissociation constant (K q ) was very s im ila r 
whether obtained by Scatchard analysis o f saturation assays (mean + SEM = 75 + 
7pM) or by k ine tic  analysis (61 pM) and was o f the same order as published values, 
which range from  30-100 pM, (Brooker and Barovsky, 1981; Wolfe and Harden, 
1981; Moylan et al., 1982; Hedberg et al., 1983; M cCarthy, 1983; M cM illian  e t al., 
1983; M ore tti-R a jas et al., 1983), although only one o f these published values (68 + 
4 pM) was obtained in liv e r (M cM illian  e t al., 1983).
Type and subtype o f adrenoceptors
The classifica tion o f adrenergic receptors is discussed in Chapter 1 (section
1.3.1). As potency orders are used in the c lassifica tion o f adrenoceptors, and the
a ff in ity  o f a compound fo r a receptor is a fa c to r in the potency o f th a t compound,
the re la tive  ab ilities  o f adrenergic agents in displacing a radioligand from  an
adrenoceptor indicate the type and subtype o f the receptor. The potency order o f
125adrenergic agonists in displacing [ I 1-IP bound to membranes prepared from
fe ta l ra t live r on day 20 post coitum  (Table 2.3) was characte ris tic  o f binding to
B2” 3drenoceptors. The re la tive  ab ilities  o f the B j-adrenerg ic antagonist, atenolo l,
125and the B2"adrenergic antagonist, IC I 118 551 to displace [ I 1-IP con firm  th a t 
radioligand binding was to predom inantly B2-adrenoceptors. However, the 
observation o f in flections in displacement curves obtained w ith  subtype-selective
3-antagonists together w ith  non-linearity  o f Hofstee plots o f such displacement 
data (Fig. 2.10) suggest tha t binding was to both subtypes o f 3 -adrenoceptors, 
although 82_adrenoceptors were fa r more numerous.
Size o f adrenoceptor population
A number o f approaches were used to assess the re la tive  population sizes o f
the receptor subtypes. As described in Section 2.2.4 o f M ateria ls and Methods,
125some saturation assays w ith  [ I I-IP were perform ed in the presence o f 
concentrations o f the 82“ adrenergic antagonist atenolol or the 32_adrenergic
T O C
antagonist IC I 118 551 calculated to displace [ I 3-IP from  more than 90% o f
3j - o r  32" adrenoceP t°rs respective ly, so tha t the 3 -adrenoceptor population being
assayed was e ffe c tive ly  purely 82 or However, when ICI 118 551 was included 
-8at 5 x 10" M, such a large proportion o f the receptors was occupied by th is  82" 
125antagonist tha t [ I I-IP  binding characteris tics were to ta lly  a ltered and no
s ign ifican t data could be obtained. The binding characteristics o f the radio ligand
did not appear to be s ign ifican tly  a ffec ted  by blocking S j-odrenoceptors w ith
5 x 10 ^M  atenolol, as evidenced by the lack o f s ign ifican t d iffe rence in values
obtained in the absence or presence o f the S j-s^ tago n is t (Table 2.4). By comparing
Bmax values obtained in saturation assays perform ed w ith  and w ithou t the inclusion
o f atenolol, the proportion o f the to ta l 8 -adrenoceptor population which consisted
o f 82 adrenoceptors could be calculated (Table 2.6, column [ 1 ] ) .  An a lte rna tive
approach was to use a computerised c u rv e -fitt in g  program fo r the analysis o f the
125inh ib ition  pro files o f I I I- IP  resulting from  incubating the radio ligand w ith  
live r membranes in the presence o f increasing concentrations o f 82-o r 82-se lec tive  
antagonists. In th is program, the theore tica l curve obtained fo r a one, two or three 
site binding model, w ith  re la tive  proportions and dissociation constants fo r each 
binding site entered during the analysis, is compared w ith  the expe rim en ta lly - 
obtained curve (DeLean et al., 1978). The model producing the closest f i t  to  the 
experim ental curve is identified  and thus the re la tive  population sizes o f the
TABLE 2.6
Bp-Adrenoceptors as % o f to ta l B-adrenoceptors in 
perinata l ra t live r
[1] From  B From  com puter analysis o f inh ib ition  pro files
• IJ l a X
eS [2 ] A teno lo l [ 3 ] IC I 118551
Age
Day 20 p.c. 95 - -
Day 21 p.c. 84 82 80
Day 22 p.c. 94 93 90
24h p.p. 92 93 90
48h p.p. 93 - -
The % o f to ta l B-adrenoceptors comprising B2~adrenoceptors was determ ined 
experim enta lly from  saturation assays or by computer analysis o f inh ib ition  pro files  
(see te x t fo r details).
TABLE 2.7
B-Adrenoceptor population in the perinatal ra t liv e r
Bmax (fm oles/m g prote in )3
Age:
Day
17.5p.c.
Day
2Dp.c.
Day
2Q.5p.c.
Day
21p.c.
Day
22p.c. 12h p.p 24h p.p. 48h p.p.
M cM illian  
e t al. 37+14 N.D. 26+8 N.D. N.D. 17+3 N.D. N .D .
Present
study N.D. 13+3 N.D. 18+1 30+2 N.D. 22+2 20+1
Values obtained from  saturation assays and from  M cM illan e t al. (1983).
a B is shown as mean + SEM. max -
ND N ot determined.
binding sites in the experim ental tissue are obtained. Using th is c u rv e -fitt in g  
program to analyse displacement data obtained w ith  atenolol and IC I 118 551 
confirm ed the presence o f two binding sites. Assuming these to  be 8 |  ar|d 82" 
adrenoceptors, the re la tive  subtype population sizes (Table 2.6, columns [2 ] and
[3] ) were in good agreement w ith  those obtained by comparing B mg>< values, f ^ - 
adrenoceptors therefore appear to  fo rm  approxim ately 85-95% o f the to ta l B- 
adrenoceptor population in the perinata l ra t live r.
2.4.6 PUBLISHED STUDIES OF HEPATIC ADRENOCEPTORS IN THE 
PERINATAL RAT
The work reported in this chapter was carried out to investigate the type and 
number o f adrenoceptors in the ra t liv e r around the tim e o f pa rtu rition . The only 
previous published work on this top ic are the papers by Butlen et al. (1980) and by 
M cM illian  et al. (1983)
Investigation o f g-adrenoceptors
The work by Butlen was concerned w ith  a-adrenoceptors in perina ta l ra t
3
live r, and was referred to earlie r in th is Discussion, when considering the [ H ] - 
DHE binding assay. These workers found tha t a-adrenoceptors in the fe ta l ra t  liv e r  
were mainly o f the a ( subtype; tha t these were homologous w ith  a-adrenoceptors 
found in the adult ra t liv e r was strongly suggested by the identica l dissociation 
constants o f [ ^H ] -DHE at the d iffe re n t ages. The number o f a-adrenoceptors was 
seen to decrease 4 -fo ld  between the la te  fe ta l and early postnatal period, fo llow ed 
by an increase in the neonatal live r.
In contrast to the findings o f Butlen's group, M cM illan et al. reported th a t 
a2-adrenoceptors were more numerous than the a j-sub type  during la te  gestation. 
Binding o f the a^-se lective  ligand [ ^H ]-prazosin indicated changes in the a ^ - 
adrenoceptor number around the tim e o f b irth  very s im ila r to those observed by
Butlen et al.: decrease a t b irth  fo llowed by an increase during the postnatal period. 
Labelling o f c^-adrenoceptors w ith  I^H  ] -rauwolscine showed at ten -fo ld  decrease 
in o^-adrenoceptor number between day 17.5 post coitum  and day 0.5 post partum , 
w ith  this trend continuing throughout the postnatal period.
Investigation o f B -adrenoceptors
The paper by M cM illian  e t al. is the only published investigation o f B-
adrenoceptors in the perinata l ra t live r. The dissociation constant (K q ) fo r the 
125binding o f [ I 1-IP to liv e r membranes prepared from  fe ta l or neonatal ra ts
reported from  this study by M cM illian 's group (68 + 4 pM) is not s ig n ifica n tly
d iffe re n t from  tha t found in the current work (75 + 7 pM is the mean + SEM K p
from  saturation assays fo r to ta l 8 -adrenoceptors at a ll ages studied). The mean K p
fo r to ta l B-adrenoceptors is compared w ith  the K p  value in the paper by M cM illian
125et jal., as the assays carried out by M cM illian  and coworkers using [ I ] -IP would
have determined binding to both subtypes o f 8-adrenoceptors. The assumption by
125M cM illian  et al. tha t the binding sites being labelled by [ I ] -IP were o f the 82“ 
subtype appears to . have been based on the re la tive  a b ility  o f adrenergic agonists 
and antagonists in displacing the radioligand; as discussed earlie r in th is section, 
Bj-adrenoceptors make up 5-15% o f the to ta l hepatic 8-adrenoceptor population 
during the perinata l period. The displacement characteristics o f various compounds 
reported by M cM illian 's group were in agreement w ith  those reported here (Section 
2.3A  and Table 2.3) fo r adrenaline, noradrenaline, phentolamine and atropine. The 
K. o f 33 nM fo r isoprenaline found by M cM illian 's group is, however, somewhat 
lower than tha t o f 210 nM found in the curren t investigation (Table 2.3). A possible 
explanation fo r this d ifference is discussed la te r.
I t  is not possible to make d irec t comparisons o f Bmax values determ ined in 
the present work w ith  those reported by M cM illian  e t al., as animals o f d iffe re n t
ages were used. As shown in Table 2.7, M cM illian  et al. found a steady decrease in
rceptor numbers w ith  increasing age, whereas in the present study an increase up
to term , fo llowed by a decrease a fte r b irth , was the pattern seen. B values J max
shown are the mean + SEM o f three or four determ inations a t each age fo r the 
present study and the mean + SEM (derived from  the histogram presenting the 
results) o f 'three to six' determ inations a t each age fo r the work by M cM illian  e t al.
A number o f aspects o f the methodology used by M cM illian  et al. fo r  the
125quantita tive  analysis o f [ I ] -IP binding to live r membranes are open to 
c r itic ism .
1 25
(1) [ I ] -IP binding was measured a fte r incubation fo r 20 minutes at 25°C. In
125the present study, when the tim e course o f the association o f [ I ] -IP w ith  
its  binding site was studied, equilibrium  was not reached u n til approxim ate ly 
25 minutes (also at 25°C). M cM illian  et al. do not report any k in e tic  
investigations, but i t  would appear highly like ly  tha t equilibrium  had not been 
reached at the tim e tha t ligand binding was measured; th is is p a rticu la rly  
like ly  in inh ib ition  studies, as the presence o f a displacing drug would have 
increased the tim e taken to reach equalibrium  (M o lino ff et al., 1981).
si 25(2) Only six concentrations o f f  I ] -IP were used in each saturation assay; th is 
is a small number i f  a meaningful p lo t is to be produced. By contrast, ten to 
twelve concentrations o f radioligand were used fo r each saturation assay in 
the current study. Biirgisser (1984) considered six data points to  be s u ffic ie n t 
fo r Scatchard analysis i f  the saturation binding curve is o f "good qua lity ". As 
no indication is given o f the saturation characteristics or o f the range o f 
regression coe ffic ien ts  obtained fo r the Scatchard plots o f M cM illian 's group's 
results, i t  is d if f ic u lt  to assess the extent to which this lim ite d  number o f 
ligand concentrations may have a ffected  the results obtained.
(3) Biirgisser (1984) stated tha t in order to obtain accurate parameters from
analysis o f saturation assays, a t least 90% o f the binding sites must be
occupied a t the top concentration o f radioligand. To achieve this, a
concentration o f nine to ten -fo ld  the ligand is required. The highest 
123concentration o f [ I ]  IP used by M cM illan e t al. was 200 pM, which is
approxim ately th ree-fo ld  the obtained. As can be seen in Figure 2.11,
125saturation o f binding sites was obtained only a t concentrations o f [ 13 -IP
o f around 400 pM and above in the present study. The Bmax values quoted in 
the paper by M cM illian  et al., derived from  'saturation ' assays in which 
saturated was not achieved, must be considered to be inaccurate.
(4) M cM illian  et al. quoted ind irec t H il l coe ffic ien ts  o f 0.72 + 0.04 obtained from  
ind irec t H il l plots o f inh ib ition  pro files. I f  a displacing compound is acting 
com petitive ly , an ind irec t H il l p lo t o f 1 should be obtained (Weiland & 
M olino ff, 1981). C om petitive inh ib ition  o f binding is a prerequisite fo r the 
application o f the Cheng &  P ruso ff equation (Cheng & Prusoff, 1973); the 'K .' 
values reported by M cM illian  et al. should more accurately be described as 
K q  51 values (i.e. the concentration o f inh ib ito ry  agent required to saturate 
50% o f the available receptor sites). This observation may explain the 
discrepancy o f the K. fo r isoprenaline determ ined in the present work and 
tha t reported by M cM illian  et al.
2.4.7 HEPATIC CELLULAR COMPOSITION AND ADRENOCEPTORS
D ram atic changes occur in the proportion o f the various ce ll types found in 
the liv e r during gestation and im m ediate ly postnatally (Nagel, 1968; Greengard e t 
al., 1972). The volume o f the live r made up by hepatocytes increases from  60-85% 
between day 18 post coitum  and term  (haem atopoietic and re ticu lo -endo the lia l 
cells account fo r the bulk o f the remaining cells), w h ils t the mean volume o f 
individual parenchymal cells increases th ree-fo ld . The proportion o f the liv e r  
volume composed o f hepatocytes shows no change compared w ith  term  at day 2
post partum (Greengard et al., 1972). As seen in Table 2.7, the number o f 8-
adrenoceptors (per un it weight o f protein) in membranes prepared from  live r shows
a greater than 100% increase between day 20 post coitum  and term , w ith  a
decrease o f approxim ately 30% in the two days fo llow ing b irth . I f  8 -adrenoceptors
are present on hepatocytes, then the increase in 8-adrenoceptor number seen in
la te  gestation could be at least pa rtly  accounted fo r by the increase in the
proportion o f membrane prote in derived from  parenchymal cells. As radioligand
binding assays using in tac t isolated hepatocytes are im prac tica l due to the known
endocytosis o f adrenoceptor-bound ligands in in ta c t ce ll systems (Hadjiivanova et
al., 1984; H e rte l e t al., 1983; Le fkow itz  et al., 1983; Reinhart e t al., 1984), to
investigate the possible influence o f changing hepatic ce llu la r composition fu rthe r,
attem pts were made to prepare membranes from  hepatocytes which had been
125isolated from  ra t live r during the perinata l period, and to perform  I -IP 
binding assays on these membranes. Isolation o f hepatocytes was carried out using 
the methodology described in Section 3.2.3 o f M ateria ls and Methods in Chapter 3; 
th is procedure produced a ce ll suspension in which > 95% o f the cells (by number) 
were hepatocytes. Membranes were prepared from  the isolated cells using method 
C described in section 2.2.3 o f M ateria ls and Methods. U nfortunate ly, membrane 
yields from  isolated hepatocytes were extrem ely low (< 0.01 mg pro te in /g  liv e r 
tissue), and this approach therefore required a p roh ib itive ly  large number o f 
animals. Further investigation is required to assess the potentia l e ffe c t o f changes 
in the proportion o f live r tissue consisting o f parenchymal cells on changes in the 
8-adrenoceptor population in the perinatal period.
2.4.8 SIGNIFICANCE OF FINDINGS
The presence o f a s ign ifican t population o f 8 -adrenoceptors in the fe ta l and 
neonatal ra t live r m ight be expected in view o f the reported involvem ent o f the 8 - 
adrenoceptor in the m ediation o f adrenergic e ffe c ts  on carbohydrate metabolism  in 
younger animals (Sherline et al., 1974; B la ir e t al., 1979a,b; Moncany & Plas, 1980;
Morgan et a l., 1983a). However, as discussed in Chapter 1, these observations must 
be considered care fu lly  in view o f the observed change in the adrenoceptor type o f 
adu lt ra t hepatocytes from  a to B during cu ltu ring  (Okajima & U i, 1982; Nakamura 
et al., 1983; Kunos e t j i l . ,  1984). As the e ffec ts  o f adrenergic agents were tested in 
cultured fe ta l live r explants in the work by Sherline et al. (1974), and in fe ta l 
hepatocytes cultured fo r three days in the experiments o f Moncany and Plas (1980), 
only the observations o f B la ir et al. (1979a,b) and Morgan et al. (1983), using 
freshly isolated hepatocytes can be considered tru ly  relevant. The present study 
confirm s the observation o f M cM illian  et al. (1983), th a t a substantia l number o f 
hepatic 32“ adrenoceptors are present in the perinata l ra t. This work also shows 
tha t 8 j-adrenoceptors are present in the liv e r during this period, although these 
account fo r only 15% or less o f the to ta l 8-adrenoceptor population.
The e ffec ts  o f adrenergic agents on perinata l hepatic carbohydrate 
metabolism are considered in subsequent chapters, both in isolated hepatocytes jn  
v itro  and the whole animal jn  vivo. The significance o f the findings reported in th is 
chapter fo r known changes in hepatic carbohydrate metabolism in the perina ta l 
period w ill be considered in Chapter 5.
CHAPTER 3
ADRENERGIC EFFECTS ON CARBOHYDRATE METABOLISM 
IN  HEPATOCYTES FROM PERINATAL RATS
3.1 INTRODUCTION
3.1.1 ADVANTAGES AND DISADVANTAGES OF ISOLATED CELLS
Isolated cells are a very valuable too l in the investigation o f m etabolic 
pathways. Cells jn  v itro  may be exposed to known concentrations o f agents fo r a 
fixed length o f tim e, w ith  none o f the com plications o f absorption, d is tribu tion , 
metabolism and excretion o f the agents which arise when jn  vivo adm in istra tion  is 
used. S im ila rly , measurement o f levels o f the substrates, interm ediates or products 
o f metabolism is greatly  s im p lified  in ce ll preparations. Therefore, isolated 
hepatocytes may provide a great deal o f in fo rm ation  on the po ten tia l o f the liv e r 
to metabolise carbohydrate compounds, and to respond to adrenergic agents by 
modulation o f carbohydrate metabolism.
I t  must, o f course, always be borne in mind tha t the very advantages o f 
working w ith  isolated cells jn  v itro  are also the lim ita tions  in in te rp re ta tion  o f 
observations made and extrapolation o f findings to the in vivo s ituation. In addition 
to the lack o f influences o f other tissues and organs on isolated hepatocytes, 
disruption o f the liv e r and preparation o f parenchymal cells in suspension obviously 
results in loss o f live r a rch itecture  and in tra-organ influences. The enzyme content 
and subcellular structure  o f hepatocytes from  the periporta l and perivenous zones 
o f the liv e r are known to d iffe r  in adult liv e r (Jungermann & Katz, 1982). However, 
in the present work th is  loss o f hepatic zonation on preparation o f isolated 
hepatocytes is unlike ly to  be o f significance, as heterogeneity o f the hepatocyte 
population has been reported to develop gradually during the f ir s t  weeks o f 
postnatal life  (Jungermann & Katz, 1982) and would therefore not be established a t 
the ages investigated.
3.1.2 ISOLATION OF HEPATOCYTES
Techniques fo r hepatocyte isolation from  adult rats
A d u lt ra t hepatocytes have been prepared by a range o f techniques, but the 
use o f enzymes to digest in te rce llu la r m ate ria l and thus isolate cells has been 
shown to be preferable to methods o f mechanical disruption (Lipson e t al. 1972). 
Howard e t al. (1967) reported successful iso lation o f adult ra t hepatocytes using 
collagenase and hyaluronidase to digest the in ter-parenchym al tissue o f the live r. 
Berry and Friend (1969) produced a greater yield o f hepatocytes, w ith  high 
v ia b ility , by perfusing the live r w ith  medium containing these two enzymes, and 
recycling the medium fo r maximum e ffe c t. This method has been adapted to
2 *f*include perfusion w ith  Ca -free  medium to reduce ce ll adhesion, fo llowed by the
2 j
medium containing collagenase in the presence o f Ca , which is a co fac to r in th is 
enzyme's action (Seglen, 1972 & 1973a).
Seglen (1973b) reported tha t no reduction in the dispersal o f liv e r cells 
resulted from  omission o f hyaluronidase and inclusion o f hyaluronidase has been 
shown to reduce the glycogen content o f the isolated cells (Wagle, 1974). There are 
many descriptions o f variations on the techniques o f Seglen in the lite ra tu re  (e.g. 
Capuzzi e t al., 1971; LeCam et al., 1976; Van Bezooijen et al., 1974; Zah lten & 
Stratman, 1974). Perfusion o f the live r w ith  an enzyme solution appears to  produce 
a higher yield o f cells o f be tte r v ia b ility  than liv e r slicing followed by incubation in 
an enzyme solution (Gustavsson & M/frland, 1980). Contam ination o f. the ce ll 
preparation w ith  non-parenchymal cells may be reduced to 1-2% by the use o f 
d iffe re n tia l cen trifuga tion  (Seglen, 1973b). The method used to  iso late adu lt ra t 
hepatocytes fo r use in the current investigation was based on tha t o f Seglen 
(1973b).
Techniques fo r hepatocyte isolation from  perinata l rats
Isolation o f hepatocytes from  fe ta l or neonatal rats requires a d iffe re n t
approach to tha t used fo r adults, as the size o f the animals re s tr ic ts  perfusion o f 
individual livers. Fe ta l hepatocytes have been isolated fo llow ing perfusion o f a 
lysozyme-containing perfusate in to the m aternal dorsal aorta (Hommes et al., 
1971). Perfusion o f the live r via the vena cava w ith  a collagenase solution, p rio r to 
hepatocyte isolation, has been described a t day 1 post partum (Ferre et al., 1981a) 
and day 5 post partum (Ziegler, 1980), but such a technica lly demanding procedure 
would be unsuitable fo r the frequent preparation o f hepatocytes from  large 
numbers o f fe ta l and neonatal animals.
Plas e t al. (1973) described a com bination o f enzymic and mechanical 
disruption o f livers o f day 15 post coitum  fe ta l rats, in which trypsin isa tion was 
combined w ith  shaking o f live r tissue w ith  glass beads. However, methods involving 
chopping or m incing o f the live r, fo llowed by incubation w ith  trypsin (Huhn e t al., 
1983) or collagenase (De Sante et al., 1984; Freemark & Handwerger, 1984; L e ffe r t  
& Paul, 1972) appear to  be more sa tis factory  fo r the preparation o f hepatocytes 
from  rats during the perinata l period. Therefore, a method involving chopping of 
fe ta l livers in to small pieces and shaking in media, f ir s t  in the absence o f calcium , 
and then in the presence o f calcium  and collagenase, was developed in this 
laboratory. This is described in de ta il in Section 3.2.3.
3.1.3. AIMS OF THE EXPERIMENTS
I f  adrenergic mechanisms are involved in the physiological s tim u la tion  o f 
hepatic glucose production and the consequent recovery o f plasma glucose 
concentration in the neonatal ra t, hepatocytes isolated from  ra ts around the tim e 
o f pa rtu rition  would be expected to show sens itiv ity  o f glucose production rates to  
the s tim u la tory e ffe c t o f adrenergic agonists, as shown by many workers fo r adu lt 
cells (e.g. Assimacopoulos-Jeannet et al., 1977; Exton & Harper, 1975; Rognstad & 
Katz, 1977).
By investigating the adrenergic responsiveness o f cells isolated from  fe ta l 
rats one and two days p rio r to term  (day 20 and 21 post co itum ) and a t te rm  (day 22 
post co itum ) and neonatal rats one and two days a fte r delivery, changes in the 
sensitiv ity  o f pathways o f glucose production to adrenergic stim u la tion  w ith  age 
were demonstrated. The magnitude o f the response at various concentrations o f 
adrenergic agonists was established at the five  perinata l ages to determ ine the 
suscep tib ility  o f hepatic glucose production to adrenergic influence a t these ages. 
Exposure to agonist and antagonist compounds w ith  known se le c tiv ity  fo r a -  or (3- 
adrenoceptors provided evidence o f the nature o f the adrenoceptor involved.
Hepatocytes were also prepared from  term  fe ta l rats obtained from  dams 
which have gestational diabetes. I t  is w e ll established tha t m aternal diabetes 
produces changes in neonatal carbohydrate metabolism in the ra t (e.g. Cuezva &  
Patel, 1980b; Snell, 1982b), and i t  is o f great in terest to establish whether changes 
in adrenergic sensitiv ity , pa rticu la rly  i f  th is may be shown to be o f physiological 
significance, may occur in this pathological condition.
3.2 MATERIALS & METHODS
3.2.1 MATERIALS
Phosphate buffered salt tablets (Dulbecco's form ula, m odified: w ithou t Ca^+ 
or Mg^+) and trypan blue solution (0.3% in 0.83% saline) were obtained from  Flow  
Laboratories, R ickmansworth, Herts. Collagenase was from  Sigma Chemical 
Company L td ., Poole, Dorset (Type IV), W orthington, Flow Laboratories, Irv ine, 
Ayrshire, Scotland, or Boehringer Corp., Lewes, East Sussex; no d iffe rence in ce ll 
yie ld or v ia b ility  was apparent using the enzyme from  d iffe re n t sources. 
S treptozotocin and desoxyribonuclease 1 (DNase I )  were from  Boehringer Corp., 
Lewes, East Sussex. Ethylene g lyco l-b is-(8 -amino e thy l ether) N ^ jN 'jN 1- 
te traace tic  acid (EGTA), defa tted bovine serum albumin, L (+ )lactic  acid, sodium 
pyruvate, amyloglucosidase (suspension in 3.2 M ( N H ^  SO^), type II oyster 
glycogen, Dowex-2 anion exchange resin (200-400 dry mesh), (+)adrenaline, 
(+)noradrenaline HC1, (-)isoprenaline (+ )b ita rtra te , DL-propranolo l HC1, and L -  
phenylephrine HC1 were from  Sigma Chemical Company L td ., Poole, Dorset. 
Phentolamine mesylate was from  Ciba Laboratories, Horsham, West Sussex, and IC I 
L td ., A lderley Edge, Cheshire, k indly provided the propanolol HC1, atenolo l and IC I 
118 551. Syperonic NX detergent was supplied by Durham Chemical D is tribu to rs  
L td ., B irtle y , Tyne &  Wear. Toluene and g lacia l ace tic  acid were from  May &  Baker 
L td ., Dagenham, Essex. l,4-D i-(2-(4-m ethyl-5-phenyloxazo ly l))-benzene (d im ethy l 
POPOP) was obtained from  Fisons S c ien tific  Apparatus, Loughborough, Lecis. 2,5- 
Diphenyloxazole (PPO) was from  K och-L igh t Laboratories L td ., Colnbrook, Bucks. 
L [U -^^C  1- la c tic  acid was from  Amersham In te rna tiona l pic, Amersham, Bucks. 
A l l other reagents were from  BDH Chemicals L td ., Poole, Dorset.
3.2.2 ANIMALS
Rats o f a random-bred W istar albino stra in, were obtained from  the 
U nivers ity  o f Surrey An im al U n it. Each male was housed overnight w ith  5-10
females and pregnancy was established by palpation 10 to 20 days a fte r  m ating, or 
by the presence o f sperm in a vaginal smear (when diabetes was to  be induced 
during pregnancy). The day fo llow ing overnight housing w ith  the male was taken as 
day 1 post co itum . Diabetes was induced in some pregnant animals by 
in traperitoneal in jection o f 45 mg/kg strep tozotocin  in 50 mM sodium c itra te  
buffer, pH 4.5, on day 5 post co itum . Diabetes was confirm ed by a plasma glucose 
level above 15 mM a t the tim e of k illin g  (day 22 post co itum ).
Fe ta l rats were obtained by caesarian section a t a tim e between 9 and 
10.30 a.m. on the appropriate gestational day (day 20, 21 or 22 post co itum ). 
P a rtu rition  usually occurred overnight between days 22 and 23 post co itum . 
Neonates were delivered natura lly  and were k illed  between 1.30 and 2.30 p.m. o f 
day 1 or 2 post partum . A l l  neonatal animals used had fed and appeared healthy. A l l 
the young from  a l i t te r  were weighed together and a mean weight per fe tus or pup 
calculated.
M aternal ra ts were k illed  by cerv ica l dislocation; fe ta l and neonatal rats 
were k illed  by decapitation. Anaesthesia was not used fo r any o f the animals.
A ll animals were given food and w ater ad lib itu m .
3.2.3 PREPARATION OF HEPATOCYTES FROM AD ULT RATS
Hepatocytes were prepared from  adult male and female ra ts using 
collagenase perfusion o f the liv e r (Gettings, 1985).
3.2.4 PREPARATION OF HEPATOCYTES FROM FETAL OR 
NEONATAL RATS
Solutions
(A) Phosphate buffered salt solution, pH 7.5; made from  table ts according to
2+ 2+m anufacturer's instructions; w ithou t Ca or Mg , but containing 5 mM 
glucose.
(B) As solution A but also containing 0.5 mM EGTA.
(C) 5 mg collagenase and 1 mg DNase 1 dissolved in 10 m l o f Hanks balanced salt
solution (137 nM NaCl, 5.4 m M -KC l, 0.44 mM KH2P 04, 0.34 mM Na2H P 04,
5.5 mM glucose), 0.2 m l 250 mM CaCl2 added and pH adjusted to 7.5 by
addition o f 2.8% NaHC O y
Procedure
2(1) L ivers were taken in to ice-cold solution A, then chopped in to  0.5 mm pieces 
using a M cllwain autom atic tissue chopper (M ickle Laboratory Engineering 
Company L td ., Gomshall, Surrey) and placed in a 250 m l glass conical flask 
w ith  approxim ately 10 m l o f solution A. L ive r m ateria l from  a single l i t te r
(8-14 pups) was placed in one flask.
(2) The flask was placed in a water bath a t 37°C and shaken fo r  10 m inutes a t 40 
strokes/m in; the supernatant was then decanted o ff  the liv e r  pieces and 
discarded.
(3) 10 ml fresh solution A was added to the flask.
(4) Step 2 was repeated.
(5) 10 m l solution B was added to the flask and step 2 was repeated.
(6) Step 5 was repeated.
(7) 10 m l solution C was added to the flask, which was placed in the w a te r bath
at 37°C and shaken fo r 45 minutes at 90 strokes/m in.
(8) The supernatant was poured through ’N ybo lt1 nylon bolting clo th, mesh w idth 
125 pm (John S tranier and Co., Manchester), and the remaining liv e r  m a te ria l 
agita ted gently w ith  a pasteur p ipe tte  to  loosen any detached cells. Free 
cells were then washed through the c lo th  w ith  about 20 m l o f solution A.
(9) The ce ll suspension was placed in a 50 ml Falcon tube (Benton-Dickinson,
Oxford) and centrifuged at approxim ate ly 10 g fo r two minutes, at room 
temperature, in a bench top centrifuge (MSE m inor 'S' or IEC Centra-3R). 
(10) A f te r  centrifugation  the supernatant was removed using a pasteur p ipe tte ,
and was discarded.
(11) The cells were resuspended in about 15 m l solution A by gentle sucking in
and out o f a pasteur p ipette .
(12) The washing procedure (steps 9-11) was repeated tw ice.
3.2.5 HEPATOCYTE INCUBATION 
Incubation medium
The medium fo r incubation was a Krebs-Ringer bicarbonate bu ffe r, pH 7.5, 
(118.5 mM NaCl, 4.7 mM KC1, 2.5 mM CaCl2, 1.18 mM KH2P 0 4, 1.18 mM MgS04,
2.5 mM NaHCO^) containing 2%(w/v) defa tted bovine serum albumin. 10 mM 
lacta te  and 1 mM pyruvate were present as gluconeogenic precursors. 20 pg /m l 
ascorbic acid was included when an adrenergic agent susceptible to oxidation was 
to be used. In some concentration-reponse experiments, when hepatocytes isolated 
from  day 22 post coitum  fe ta l livers were being used, the medium contained L [ U - 
"^C  ]-  la c tic  acid such tha t the specific  a c tiv ity  o f the lac ta te  pool was 
approxim ately 20 nC i/m l.
Procedure
The hepatocytes were washed a fu rth e r two times w ith  approxim ate ly 
10 m l o f incubation medium, using gentle centrifugation  and resuspension as 
detailed in steps 9-11 o f the hepatocyte iso lation procedure. The cells were 
resuspended in an appropriate volume of incubation medium (see below) and 
f ilte re d  through 'N ybolt' bolting cloth, mesh w idth 125 pm, to remove any clumped 
cells. A liquots o f the ce ll suspension were placed in 20 m l polypropylene via ls
(Packard, Illino is , USA) and incubation was carried out by placing the vials in a 
closed polythene box containing w ater at 37°C to a depth o f about two cm, 
standing in a w ater bath at 37°C. The hepatocyte suspensions were incubated in an 
atmosphere o f 95% 02/5% C 0 2 by continual gassing o f the box. The vials were 
shaken a t 50 strokes/m in and at the end o f the incubation period the ce ll 
suspensions were poured in to  7.5 m l glass tubes on ice, and centrifuged 
im m ediate ly at 2,000 g fo r 10 minutes a t 4°C  (Beckman J6B or IEC Centra-3R 
centrifuge).
An aliquot o f the supernatant obtained from  cen trifuga tion  o f the ce ll 
suspension fo llow ing incubation was retained (fo r glucose analysis) in a ll 
experiments; in some in it ia l concentration-response experiments using hepatocytes 
isolated from  fe ta l rats on day 22 post co itum , a ll o f the supernatant was reta ined
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fo r to ta l glucose and L C ] -glucose analysis. Glycogen levels were determ ined in 
most experiments in which hepatocytes were isolated from  fetuses on day 22 post 
co itum . When glycogen was to be assayed the ce ll pe lle t was reta ined. C e ll pelle ts 
and supernatants were kept on ice; i f  glycogen or glucose could not be assayed 
w ith in  24 hours, the samples were stored at -20°C.
Hepatocyte v ia b ility
In a ll experiments, two samples o f the hepatocyte suspension were taken 
during the aliquoting procedure to check ce ll y ie ld and v ia b ility . This was carried 
out in a ’Neubauer' ce ll counting chamber (Weber S c ien tific  In te rna tiona l L td ., 
Lancing, East Sussex) under a ligh t microscope, using the trypan blue exclusion 
method to assess v ia b ility . The ce ll suspension was seen to consist predom inantly o f 
hepatocytes, w ith  other ce ll types (mainly erythrocytes) accounting fo r less than 
5% o f the cells (by number). Using this method, v ia b ility  was never less than 95% in 
the freshly prepared ce ll suspension.
A number o f other methods are available fo r the determ ination o f ce ll 
v ia b ility , including m etabolic in teg rity , the a b ility  to exclude succinate (Mapes & 
Harris, 1975) , and the re tention o f lac ta te  dehydrogenase or ATP by isolated cells 
(Dickson & Pogson, 1977). As glucose production by the hepatocytes was 
determ ined in the course o f the experiments reported in this chapter, m etabolic 
in te g rity  was autom atica lly  assessed in addition to trypan blue exclusion.
Pogson et al. (1983) suggested tha t the assay o f ATP content w ith  
lu c ife rin -luc ife rase  (Stanley & W illiams, 1969) is a convenient method, giving more 
re liab le results than dye exclusion. As this method ideally requires a lum inom eter, 
which was not available in the B iochem istry Departm ent o f the U n ivers ity  o f 
Surrey, i t  could not be used routine ly. However, ce ll v ia b ility  over a four and six 
hour time-course was assessed using both the trypan blue exclusion and ATP 
content methods, to allow  comparison o f these two methods. The assay o f ATP 
was carried out in Dr. R. Paterson’s laboratory a t Wellcome Research, Beckenham, 
Kent.
The ATP content o f freshly isolated fe ta l hepatocytes was 3.7 nmoles/10^ 
cells fo r the cells prepared fo r the four-hour tim e  course, and 2.9 nmoles/10^ cells 
fo r the six-hour tim e course. ATP content o f these two preparations dropped to
3.6 and 2.6 nmoles/10^ cells a fte r 30 minutes o f incubation; the lowest level 
measured was 2.1 nmoles/10^ cells a fte r 6 hours o f incubation. Dickson & Pogson 
(1977) stated tha t 8-13 nmol ATP/m g dry w t. was an acceptable range fo r viable 
adult ra t hepatocytes. Cornell (1983) recommended tha t adult ra t hepatocytes 
w ith  an ATP content below 2 pm ol/g w et w t. should not be used. Using the figures 
o f Schulze et a l. (1984) o f 3.2mg wet w t. or 0.8mg dry w t. per lO ^ fe ta l ra t 
hepatocytes, the figures o f Dickson & Pogson equate to 6.4-10.4 nmol ATP /10^ 
cells, w ith  the level proposed by Cornell being the lowest value in th is range. 
Although the ATP levels estim ated fo r the ce ll preparations in the cu rren t work
are below this range, i t  is im portan t to remember tha t these values are fo r fe ta l 
hepatocytes; Ph ilippid is & Ballard (1970) reported ATP concentrations in fe ta l ra t 
liv e r jn  vivo to  be less than 50% o f the adult value. This, together w ith  the 
observation tha t ATP levels remained re la tive ly  constant during incubations over 
several hours, w h ils t other workers have reported a rapid loss o f ATP when 
hepatocytes were isolated from  starved rats (Dickson & Pogson, 1977) or were 
incubated in anoxic conditions (Cornell, 1983), suggest tha t those ATP levels 
indicated viable fe ta l ra t hepatocytes.
Hepatocyte v ia b ility  (expressed as the % o f the zero tim e value) over the 
tim e periods studied, as assessed by trypan blue exclusion and ATP content was:
30 min 1 hr 2 hr 4 hr 6 hr
Trypan Blue Exclusion: 97 95 93 82 75
ATP Content: 94 90 83 75 72
A lim ite d  number o f conclusions may be drawn from  these data, due to  tl
com parative assessments being made using only two ce ll preparations and 
incubations. However, i t  does appear from  these investigations tha t v ia b ility  as 
determ ined using the two methods, is not s ign ifican tly  d iffe ren t. V ia b ility  was 
always s ligh tly  higher when assessed using trypan blue exclusion, ra ther than ATP 
content, but this d ifference was never greater than 10%, and the pa tte rn  and ra te  
o f loss o f v ia b ility  during the incubations was s im ila r whichever method was used. 
The comparison o f trypan blue exclusion and ce ll ATP content as methods fo r the 
assessment o f hepatocyte v ia b ility  therefore confirm ed the fo rm er method to  be a 
valid means o f detecting loss o f v ia b ility  o f a degree which would a ffe c t the 
outcome o f experiments.
3.2.6 IN VITRO EXPERIMENTS
Concentration-reponse experiments
Concentration-response experiments were carried out using hepatocytes 
prepared from  fe ta l, neonatal and adult male and female rats. In th is series o f 
experiments, glucose production in hepatocytes freshly isolated from  ra ts and 
incubated w ith  various concentrations o f adrenergic agonists was investigated. 
Hepatocytes were incubated in the absence o f any agent or in the presence o f an 
agonist compound at one o f four or five  concentrations, over a concentration range 
o f four or five  orders o f magnitude.
The agents investigated, and the concentration ranges used were: adrenaline
(10 ^ - 1 0 ” ^M), noradrenaline (10”^-10“^M), isoprenaline 10” ^ - 1 0 ”^M), and
-7 -3 -9phenylephrine (10” -10” M) fo r fe ta l and neonatal hepatocytes; adrenaline (10 -
10”^M) and isoprenaline (10” ^ - 1 0 ” ^M) fo r adult hepatocytes. Hepatocytes were
resuspended in 70 or 90 m l o f incubation medium and 1.8 m l aliquots o f the ce ll
suspension were placed in each o f 33 20 m l polypropylene vials. 0.2 m l o f the
incubation medium alone was added to ten o f these ce ll suspensions to act as
contro l incubations. The other ce ll suspensions received 0.2 m l o f the incubation
medium containing the hormone under investigation at a concentration 10- fo ld
higher than the fin a l concentration to which the hepatocytes were to  be exposed; 5
vials were used at each concentration. In experiments in which the ra te  o f
glycogenolysis was to be determ ined as w e ll as to ta l glucose production,
hepatocytes from  day 22 post coitum  fetuses were resuspended in 90 m l o f the
incubation medium and, in addition to aliquots fo r incubation, a fu rth e r ten 1.8 m l
aliquots o f the ce ll suspension were taken in to 7.5 m l glass tubes on ice. These
were im m ediate ly centrifuged at 2,000 g fo r 10 minutes at 4°C  (Beckman J6B or
IEC Centra-3R centrifuge). The supernatant was discarded and the ce ll pe lle t
retained fo r glycogen analysis; th is allowed the glycogen content . o f the
hepatocytes p rio r to incubation to be determ ined. Incubation in these experiments
was at 37°C for 30 minutes at a shaking speed of 30 strokes/min.
C ell v ia b ility  was assessed, using the trypan blue exclusion method described 
in 3.2.5, in one contro l incubation a t the end o f the incubation period. V ia b ility  
was always greater than 90% at th is tim e.
Response-blocking experiments
In this series o f experiments, the e ffec ts  o f adrenergic antagonists on glucose 
production by hepatocytes isolated from  rats on day 21.5 post co itum , and 
incubated in the absence o f any s tim ula ting agent or in the presence o f 10”^M 
adrenaline, was investigated.
Hepatocytes were resuspended in 70 m l o f the incubation medium fo r use in 
these experiments. 1.8 m l aliquots o f the ce ll suspension were placed in each o f 35 
20 m l polypropylene vials. 0.2 m l o f the incubation medium was added to ten o f 
these ce ll suspensions to act as contro l incubations. Five vials received 0.1 m l o f 
the incubation medium containing 2 x 10” ^M adrenaline (as 10 adrenaline had 
been seen to e lic it  maximal s tim ula tion o f glucose production), plus 0.1 m l o f the 
incubation medium. Two antagonist compounds were investigated in each 
experiment o f th is series. Ten vials received 0.1 m l o f the incubation medium 
containing one o f the antagonists a t 20-fo ld  the fin a l concentration required; 
0.1 m l o f the incubation medium was added to five  o f these vials and the other five  
received 0.1 m l o f the incubation medium containing 2 x 10 adrenaline. The 
remaining ten vials contained the second antagonist under investigation, again in 
the presence or absence o f an optim al concentration o f adrenaline. Incubation in 
these experiments was a t 37°C fo r 30 minutes a t 50 strokes/m in.
Ce ll v ia b ility  was assessed, using the trypan blue exclusion method described 
in section 3.2.5, in one contro l incubation at the end of the incubation period.
V ia b ility  was always greater than 90% at th is tim e.
Time-course experiments
In this series o f experiments, the production o f glucose by hepatocytes 
isolated from  fe ta l rats on day 22 post co itum  was investigated a t tim e  in terva ls 
over two or three hours o f incubation. Incubation was fo r two hours in the absence 
o f hormone or in the presence o f 10~^M adrenaline (which was shown in 
concentration-reponse experiments to  result in maxim al s tim u la tion  o f glucose 
production), or fo r three hours in the absence o f hormone or in the presence o f 
10~^M adrenaline, noradrenaline or glucagon.
TWO HOUR TIME-COURSE
In the two hour tim e-course experiments, hepatocytes were resuspended in 
100 m l o f incubation medium and 1.8 m l aliquots o f the ce ll suspension were placed 
in each o f 40 20 m l polypropylene vials. 0.2 m l o f the incubation medium was added 
to 20 o f these ce ll suspensions to act as contro l incubations. The other 20 ce ll 
suspensions received 0.2 m l o f 10”^M adrenaline in the incubation medium, so th a t 
the hepatocytes were exposed to 10~^M adrenaline during incubation. A fu rth e r ten
1.8 m l aliquots o f the ce ll suspension were taken in to 7.5 m l glass tubes on ice. 
These were im m ediate ly centrifuged at 2,000 g fo r 10 minutes a t 4°C  (Beckman 
J6B or 1EC Centra-3R centrifuge). The supernatant was discarded and the ce ll 
pe lle t retained fo r glycogen analysis. A t  30, 60, 90 and 120 min o f incubation, five  
vials containing hepatocytes in contro l medium and five  vials containing 
hepatocytes in medium plus 10~^M adrenaline were removed from  the incubation 
bath, the ce ll suspension taken in to 7.5 m l glass tubes on ice, and trea ted  as 
described above. A l l ce ll pelle ts were reta ined fo r glycogen analysis.
THREE HOUR TIME-COURSE
In the three hour time-course experiments, during the fin a l stages o f
preparation o f hepatocytes from  day 22 post coitum  fe ta l rats, the ce ll suspension 
was sp lit in to two approxim ately equal aliquots, and these were centrifuged as 
detailed in step 9 o f the hepatocyte preparation procedure (3.2.4). The 
supernatants were removed, and one ce ll pe lle t resuspended in incubation medium 
alone, and the other in incubation medium containing lC f^M  adrenaline, 
noradrenaline or glucagon. 3 m l aliquots o f the ce ll suspensions were placed in 
20 m l polypropylene vials. A t  one, two and three hours o f incubation, three or five  
vials containing hepatocytes in contro l medium and three or five  vials containing 
hepatocytes in medium plus hormone were removed from  the incubation bath and 
the ce ll suspension taken in to  7.3 m l glass tubes on ice, and treated as detailed 
above. Supernatants were taken fo r glucose determ ination, but ce ll pelle ts were 
not reta ined fo r  glycogen analysis in this series o f experiments.
HEPATOCYTE VIAB ILITY
In both types o f time-course experiment, ce ll v ia b ility  was assessed, using the 
trypan blue exclusion method described in section 3.2.3, in one contro l incubation 
at each tim e point. V ia b ility  did not drop below 85% at any tim e point studied.
E ffe c t o f m ate ria l diabetes
In this series o f experiments, glucose production by hepatocytes isolated on 
day 22 post coitum  from  fe ta l rats o f d iabetic mothers, and incubated in the 
absence o f any agent or in the presence o f adrenaline in the concentration range 
lC f^ - lC T ^ M , was investigated.
Hepatocytes were resuspended in 70 or 90 m l o f the incubation medium fo r 
use in these experiments. 1.8 m l aliquots o f the ce ll suspension were placed in each 
o f 35 20 m l polypropylene vials. 0.2 m l o f the incubation medium was added to ten 
o f these ce ll suspensions to act as contro l incubations. The other ce ll suspensions 
received 0.2 m l o f the incubation medium containing adrenaline at a concentration
10-fo ld  higher than the fin a l concentration to which the hepatocytes were to  be 
exposed; five  vials were used fo r each concentration. In some experiments a 
fu rthe r ten 1.8 m l aliquots o f the ce ll suspension were taken in to 7.5 m l glass tubes 
on ice. These were im m ediate ly centrifuged at 2,000 g fo r 10 m inutes a t 4°C  
(Beckman J6B or IEC Centra-3R centrifuge). The supernatant was discarded and 
the ce ll pe lle t retained fo r  glycogen analysis. Incubation in these experiments was 
a t 37°C fo r 30 minutes a t 50 strokes/m in.
3.2.7 ASSAYS
Glucose assay
Glucose in the supernatant incubation medium was measured d ire c tly  using 
the hexokinase -  glucose-6-phosphate dehydrogenase method on a Cobas-Bio 
cen trifuga l autoanalyser (Roche, Welwyn Garden C ity , Herts). No deproteinisation 
was required. Reagent k its  (Glucose Vapid', Roche Diagnostics, Welwyn Garden 
C ity , Herts, or C entrifiC hem  glucose assay, Baker Instruments, A llen tow n, PA, 
USA) were used according to the manufacturer's instructions. Appropria te glucose 
standards were included fo r each set o f determ inations; these were in the range 
0.05 - 0.20 mM glucose in d is tilled  water.
Glycogen assay
The cell pe lle t was sonicated in 1 m l o f d is tilled  w ater using a sonic probe 
(type 1130A, Dawes Instruments L td ., London). A 0.2 m l a liquot o f the sonicate was 
placed in a 7.5 m l glass tube and mixed w ith  1.0 m l o f 0.2 M acetate bu ffe r, pH 4.8, 
containing 74 i.u ./m l amyloglucosidase. The tubes were shaken at 30 strokes/m in in 
a water bath a t 37°C fo r 4 hours, and were vortex mixed approxim ate ly ha lf way 
through this tim e. A d is tilled  w ater blank and 0.2 m l aliquots o f glycogen 
standards (0.1-1.0 m g/m l oyster glycogen in d is tilled  water) were trea ted  
identica lly . A t  the end o f the incubation, a ll tubes were centrifuged a t 2,000 g fo r 
10 minutes at room tem perature (Beckman J6B or IEC Centra-3R centrifuge) to
remove any sediment. Glucose in the supernatant was measured using the Cobas- 
Bio autoanalyser (see above), and the glycogen content o f the ce ll pelle ts 
calculated from  the standard curve obtained. L inear standard plots were obtained; 
using the methodology described the highest glycogen standard concentration 
resulted in a glucose concentration in the range 0.89-0.95 mM, indicating 97-100% 
o f the glycogen was hydrolysed to glucose. P re lim inary analyses showed negligible 
values o f free glucose in the ce ll sonicates, and therefore incubation o f samples in 
the absence o f amyloglucosidase was not carried out routine ly.
[14C 3 -Glucose assay
Separation o f [ ^ 4C ]la c ta te  and [^ 4C]glucose was achieved using ion 
exchange chromatography; the method was based on tha t o f Ham m erstedt (1980). 
1 m l o f the supernatant incubation medium was deproteinised by m ixing w ith  10 m l 
0.5 M NaOH and 0.84 m l o f 10% (w /v) Z n S O ^h ^O . The p rec ip ita te  was removed 
by centrifug ing a t 3,000 g fo r 15 m inutes a t room tem perature (Beckman J6B 
centrifuge). 2 m l o f deproteinised sample was added to a column o f Dowex-2 ion- 
exchange resin, in the form ate form , packed in a pasteur p ipette . 6 m l o f d is tilled  
w ater was added to the pressure-head tubing. The eluate was collected in glass 
sc in tilla tio n  vials and freeze dried. 1 m l d is tilled  w ater and 10 m l s c in tilla n t flu id  
(23g PPO, 1 g d im ethyl POPOP, 3.3 1 toluene, 1.67 1 Syperonic NX detergent) were 
added to  the vials, and [ ^ 4C ] -glucose counted using a Rack-Beta liqu id  
sc in tilla tion  counter (type 1217, LKB), a fte r  thorough m ixing.
When known amounts o f L [U - ^ 4C ] - la c tic  acid and D D*4C ]-g lucose in 
incubation medium were treated as described above, and then applied to  the 
Dowex-2 ion-exchange column, 97% o f the lac ta te  was retained, and 86% o f the 
glucose was collected in the eluate.
3.2.8 ANALYSIS OF DATA
A ll s ta tis tica l analyses were carried out using paired Student’s t- te s t.
3.3 RESULTS
3.3.1 CONCENTRATION-RESPONSE EXPERIMENTS
Glucose production
CONTROL PRODUCTION RATE
In the various experiments described below the contro l glucose production 
ra te  (in the absence o f hormonal s tim u li) in hepatocytes isolated during the 
perinata l period was greatest in those cells prepared from  fe ta l ra ts on day 22 post 
coitum  just p rio r to term  (Tables 3.1, 3.2, 3.3 and 3.4). The con tro l ra te  one day 
a fte r delivery was 30-50% o f tha t im m ediate ly before b irth , and recovered in the 
fo llow ing day by 20-30%, except in the experiments investigating the e ffe c ts  o f 
isoprenaline. The glucose production ra te  by unstim ulated hepatocytes from  day 22 
post coitum  fetuses was 26-46% of the con tro l glucose production ra te  in adult 
male hepatocytes, and 60-71% o f tha t in hepatocytes from  adult female rats.
EFFECTS OF ADRENALINE
Glucose production in hepatocytes freshly isolated from  fe ta l ra ts on day 20, 
21 or 22 post co itum , from  neonatal rats on day 1 or 2 post partum , or from  adult 
male or female rats, showed a concentration-dependent stim u la tion  by adrenaline 
(Table 3.1 and Fig. 3.1). The contro l glucose production ra te  in cells isolated from  
fe ta l ra ts on day 20 post coitum  was very low, and showed no s ta tis tic a lly  
s ign ifican t increase due to adrenaline. Because o f the problems o f measuring th is 
low ra te  o f glucose production, only two experiments were carried out using 
hepatocytes isolated from  day 20 post coitum  fetuses.
The glucose production rate showed no s ta tis tica lly  s ign ifican t increase above
-8the contro l level at adrenaline concentrations below 10” M at any age. This 
concentration was the lowest producing a s ign ifican t s tim u la tion  o f glucose
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FI GURE 3 . 1  E f f e c t  of  a d r e n a l i n e  on g l u c o s e  p r o d u c t i m
i n h e p a t o c y t e s  f r e s h l y  i s o l a t e d  f r om f e t a l .
neon a t a l  or  a d u l t  r a t s .
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C o n c e n t r a t i o n  of  A d r e n a l i n e  (M)
He p a t o c y t e s  were pr epar ed from a d u l t  male (*“ *-------*)
a d u l t  f emal e  (▼----------▼) , day 20 . c_ f e t a l  (A----------
day 21 £.».£.• f e t a l  (O "O) , day 22 £_.c_. f e t a l  (□-----
day 1 n e o n a t a l  (•---------- • )  , or day 2 $}_• 2_ n e o n a t a l
r a t s .
I n c u b a t i o n  was f or  30 mi n u t e s ,  in the absence of  any 
a d r e n e r g i c  a g e n t ,  or in the pr esence  of  a d r e n a l i n e  as shown  
( see  t e x t  f o r  d e t a i l s ) .
Gl ucose p r o d u c t i o n  r a t e  is shown as a X of  the c o n t r o l  
r a t e .
 □) ,
(■-----
production in hepatocytes isolated from  fetuses on day 22 post co itum , w h ils t 
10~^M adrenaline was the threshold concentration from  stim u la tion  o f glucose 
production in cells from  adult females, and lC f^M  was required fo r any s ta tis tic a lly  
s ign ifican t e ffe c t a t any other age studied (Table 3.1). I t  would appear from  the 
data in Table 3.1 tha t adrenaline is producing an increase in the glucose production 
rate a t concentrations below those marked as causing s ign ifican t increases, but 
tha t the large varia tion in basal production ra te  observed from  one preparation to 
another (see discussion in section 3.4.1) prevented there e ffec ts  from  being o f 
s ta tis tica l significance. For hepatocytes isolated a t a ll ages investigated, the 
maximal s tim ula tion observed was a t 10“^M  adrenaline; this was the highest 
concentration investigated (Fig. 3.1). M axim al s tim u la tion  o f the glucose 
production ra te  by adrenaline was 31-47%, depending on the age o f the animal from  
which the cells were made (Table 3.3). The adrenaline concentrations calcu la ted to 
produce 30% o f the maxim al increase in production (EC^g) varied from  13-200 nM, 
depending on age (Table 3.5).
EFFECTS OF NORADRENALINE
Noradrenaline produced a concentra tion-re la ted stim u la tion  o f the glucose 
production ra te  in hepatocytes freshly isolated from  fe ta l or neonatal ra ts (Table
3.2 and Fig. 3.2). Glucose production was not s ign ifican tly  a ffe c ted  by
-7 -7noradrenaline at concentrations below 10 M, a t any age; 10 M noradrenaline
increased the glucose production ra te  above the contro l ra te  in hepatocytes 
isolated on day 22 post co itum , or on day 2 post partum . A ten -fo ld  higher 
concentration o f the drug was required to e lic it  a s ta tis tica lly  s ign ifican t increase 
in cells prepared from  day 1 post partum neonates, and a concentration o f 10 
was the lowest producing a s ign ifican t s tim ula tion of the glucose production ra te  in 
cells prepared from  day 21 post coitum  fetuses (Table 3.2). A t  a ll ages, the 
maximal s tim ulation observed was tha t produced by 10 noradrenaline, which
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FI GURE 3 . 2 E f f e c t  of  n o r a d r e n a l i n e  on g l u c o s e  p r o d u c t i o n
i n h e p a t o c y t e s  f r e s h l y  i s o l a t e d  f r om f e t a l  or
n e o n a t a l  r a t s .
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C o n c e n t r a t i o n  of  N o r a d r e n a l i n e  (M)
He pa t oc y t e s  were pr epa r e d  f rom day 21 £..jc f e t a l ,  day 
22 £_.c,. f e t a l ,  day 1 n e o n a t a l  or day 2 £_.J2. n e o n a t a l
r a t s .
I n c u b a t i o n  was f or  30 m i n u t e s ,  in the absence of  any 
a d r e n e r g i c  agent  or in t he pr esence  of  n o r a d r e n a l i n e  as 
shown ( see t e x t  f or  d e t a i l s ) .
Glucose p r o d u c t i o n  r a t e  is shown as a % of  t he c o n t r o l  
r a t e .
was the highest concentration investigated (Fig. 3.2). The maximal s tim u la tion  o f 
the glucose production ra te  by noradrenaline was 22-73%, and the FC^g fo r 
noradrenaline ranged from  180-260 nM, depending on age (Table 3.3).
EFFECTS OF ISOPRENALINE
A concentra tion-re la ted increase in the glucose production ra te  in
hepatocytes freshly isolated from  fe ta l, neonatal and adult female rats was
observed during incubation in the presence o f the B-adrenergic agonist,
-8isoprenaline (Table 3.3 and Fig. 3.3). Isoprenaline concentrations below 10" M did
not e lic it  s ta tis tica lly  s ign ifican t increases in the glucose production ra te  a t any
-8age. A concentration o f 10" M produced a s ign ifican t s tim u la tion  o f glucose
production in hepatocytes prepared a t a ll ages except day 1 post partum , fo r  which
10~^M isoprenaline was required to produce an elevation o f the glucose production
rate , or adult male hepatocytes, when no s ign ifican t increase in glucose production
was observed at any concentration o f isoprenaline investigated (Table 3.3). For
hepatocytes prepared from  neonatal ra ts on day 1 post partum , or from  adult
male rats, the greatest response to isoprenaline was at 10 ^M, the highest
concentration investigated. However, at other perinata l ages, a decrease from  the
maximal s tim ula tion observed was seen at th is concentration; the increase in
glucose production was maximal a t 10"^ M isoprenaline fo r cells prepared on day 22
-8post coitum  or day 2 post partum and at 10" M fo r cells isolated on day 21 post 
coitum  (Fig. 3.3). Maximal increases over the contro l glucose production ra te  by 
isoprenaline varied from  29-57%, and the FC^g fo r this agent was 1.7 - 90 nM, 
depending on the age studied (Table 3.5).
EFFECTS OF PHENYLEPHRINE
The a-adrenergic agonist phenylephrine produced a concentration-dependent 
s tim ula tion o f the glucose production ra te  in hepatocytes freshly isolated from
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FI GURE 3 . 3 E f f e c t  of  i s o p r e n a l i n e  on g l u c o s e  p r o d u c t i o n
i n h e p a t o c y t e s  f r e s h l y  i s o l a t e d  f r om f e t a l ,
n e o n a t a l  or  a d u l t  r a t s .
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C o n c e n t r a t i o n  of  I s o p r e n a l i n e  (M)
He pa t oc y t e s  were pr epa r e d  f rom a d u l t  male (A----------a ) ,
a d u l t  f ema l e  (▼----------▼) , day 21 2_. c_. f e t a l  (O---------- O) ,
day 22 f e t a l  (□ □) t day 1 n e o n a t a l  (• • )  ,
or day 2 £.*H n e o n a t a l  (■---------- ■) r a t s .
I n c u b a t i o n  was f or  30 mi n u t e s ,  in the absence of  any 
a d r e n e r g i c  a g e n t ,  or in t he pr esence  of  i s o p r e n a l i n e  as 
shown ( see t e x t  f or  d e t a i l s ) .
Glucose p r o d u c t i o n  r a t e  i s shown as a % of  t he  c o n t r o l  
r a t e .
fe ta l and neonatal rats, although at a higher concentration range than the other
catecholamines investigated (Table 3.4 and Fig. 3.4). lC f^M  phenylephrine produced
a s ta tis tica lly  s ign ifican t increase in the glucose production rate in hepatocytes
prepared on day 22 post co itum , but lCT^M phenylephrine was the lowest
concentration having any s ign ifican t e ffe c t on glucose production in cells prepared
a t the other ages investigated (Table 3.4). A t  a ll ages except day 2 post partum , 
-410 M phenylephrine produced a m axim al response; in cells isolated from  neonates 
on day 2 post partum , increasing the agonist concentration ten-fo ld  caused a s light 
but non-sign ificant increase in the glucose production rate , but hepatocytes 
prepared at other ages showed s ligh tly  less stim u la tion  of glucose production when 
exposed to this higher concentration (Fig. 3.4). The maximal s tim u la tion  o f the 
glucose production ra te  was 27-61% and the ranged from  770-3000 nM,
depending on age (Table 3.5).
Glycogen breakdown
When hepatocytes were prepared from  fe ta l ra ts at term  (day 22 post co itum ) 
and used in concentration-response experiments, the glycogen content o f the cells 
before and a fte r incubation was determ ined in addition to the glucose production 
(Table 3.6 and Fig. 3.6). Glycogenolysis in hepatocytes freshly isolated from  te rm  
fe ta l rats was stim ulated in a concentration-dependent manner by catecholam ines 
(Table 3.7). A lthough a clear trend was observed in the glycogen breakdown ra te  in 
the presence o f increasing concentrations o f any o f the four adrenergic agonists 
investigated, a s ta tis tica lly  s ign ifican t decrease in the glycogen content o f the
cells a fte r incubation in the presence o f an agent, compared w ith  th a t a fte r
-5 -4incubation in contro l medium, was seen only fo r 10 M noradrenaline or 10 M
phenylephrine (Table 3.6). The lack o f s ta tis tica l significance fo r the e ffe c ts  o f the
other two agents, or fo r the response to  10~^M noradrenaline, is a ttr ib u ta b le  to the
large in te r-experim enta l varia tion  in glycogen content (Table 3.6) and con tro l
glycogen breakdown ra te  (Table 3.7). M axim al responses o f glycogenolysis to
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FI GURE 3 . 4  E f f e c t  of  p h e n y l e p h r i n e  on g l u c o s e  p r o d u c t i o n
i n h e p a t o c y t e s  f r e s h l y  i s o l a t e d  f r om f e t a l  or
n e o n a t a l  r a t a .
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C o n c e n t r a t i o n  of  P h e n y l e p h r i n e  (M)
He pa t oc y t e s  were pr epa r e d  f rom day 21 f e t a l  (O—   **0) ,
day 22 £_.c_. f e t a l  (□----------□) , day 1 n e o n a t a l  (• • )  ,
or day 2 IL.JL n e o n a t a l  (■—— — «) r a t s .
I n c u b a t i o n  was f o r  30 mi n u t e s ,  in the absence of  any 
a d r e n e r g i c  a g e n t ,  or in the pr e s e n c e  of  p h e n y l e p h r i n e  as 
shown ( see t e x t  f o r  d e t a i l s ) .
Gl ucose p r o d u c t i o n  r a t e  is shown as a % of  the c o n t r o l  
r a t e .
TABLE 3.5
S ensitiv ity  o f glucose production in freshly isolated 
ra t hepatocytes to the e ffec ts  o f adrenergic agonists
Age (days)
Age: 20 p.c. 21 p.c. 22 p.c. 1 p.p. 2 p.p A d u lt
male
A d u lt
female
Aqonist
ADRENALINE: 
Max. Stim . 31 41 35 32 39 41 47
EC k t u 50 81 200 13 14 17 60 60
NORADRENALINE: 
Max. S tim .a 22 39 60 73
EC k 50 - 260 180 200 230 - -
ISOPRENALINE: 
Max. S tim .a 29 37 52 57 6 48
EC k 50 - 1.7 2.0 3.7 2.7 - 90
PHENYLEPHRINE: 
Max. S tim .a 27 27 43 61
EC k l u 50 - 2900 770 4500 5000 - -
a Max. Stim . = Maximal s tim ula tion o f glucose production ra te  observed
(expressed as % above contro l glucose production rate).
b EC5q = Concentration o f agonist calculated to resu lt in 50% o f
the maximal s tim ulation observed (expressed as nM).
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FI GURE 3 . 5 E f f e c t  of  a d r e n e r g i c  a g o n i s t s  on g l ucos e
p r o d u c t i o n  in h e p a t o c y t e s  f r e s h l y  i s o l a t e d  
f rom term f e t a l  r a t s
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H e p a t o c y t e s  wer e i s o l a t e d  from day 22 £.*.£.• feta l rats  and 
i n c u b a t e d  for 30 m i n u t e s ,  in the a bs e n c e  of any a d r e n e r g i c  
age n t,  or in the p r e s e n c e  of v ar i o u s  c o n c e n t r a t i o n s  of 
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FIGURE 3 . 6  E f f e c t  of  a d r e n e r g i c  ■ a g o n i s t s  on g l y c o g e n
breakdown in h e p a t o c y t e s  f r e s h l y  i s o l a t e d  
f rom term f e t a l  r a t a .
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L e g e n d  as for F i g u r e  3.3.
TABLE 3.7
E ffe c t o f adrenergic agonists on glycogen breakdown ra te  in hepatocytes freshly
isolated from  term  fe ta l rats
Glycogen Breakdown Rate (pg/10^ ce lls /h )a
Concentration 
o f Catecholamine 
(M)
0
oi—
i ior—t
ON1or—1 i—i o i 0
0
10“7 10"6 10“5 10"4 10"3
Aqonist
Adrenaline 230 258 262 276 282
Noradrenaline 198 - 174 204 208 276 258 -
Isoprenaline 396 402 440 496 450 458 - -
Phenylephrine 338 - - - 404 376 444 464 440
Incubation was fo r 30 min.
a Glycogen breakdown ra te  was calculated from  the mean glycogen content 
before and a fte r incubation.
stim u la tion  by catecholamines were seen at 10”^M adrenaline or noradrenaline,
-8 -41CT M isoprenaline and 10" M phenylephrine (Fig. 3.6). The m axim al s tim u la tion
produced, together w ith  the concentration o f agent calculated to produce 30% o f
the maxim al s tim ula tion observed (EC^g), fo r each o f the agents investigated is
shown in Table 3.8.
Gluconeoqenesis
In a ll experiments investigating the production o f glucose by hepatocytes jn
v itro , 10 mM lac ta te  and 1 mM pyruvate were present in the incubation medium as
gluconeogenic substrates. In some in it ia l experiments investigating the e ffe c t o f
adrenaline or glucose production in hepatocytes isolated from  term  fe ta l rats, the
14lacta te  pool was labelled w ith  C. Using ion exchange chromatography to  remove
14
any radioactive substrate, L C J-glucose release in to the medium could be 
determ ined to allow an estim ation o f the ra te  o f gluconeogenesis. Glucose 
production via de novo synthesis from  gluconeogenic precursors was not present at 
a detectable level in hepatocytes freshly isolated from  fe ta l ra ts on day 22 p .c..
3.3.2. RESPONSE-BLOCKING EXPERIMENTS
In this series o f experiments, incubating hepatocytes isolated from  fe ta l ra ts 
on day 21.3 post coitum  in the presence o f 10~^M adrenaline stim ulated the glucose 
production rate to 141% o f the contro l ra te  (Table 3.9 and Fig. 3.7). Incubation 
w ith  the B-adrenergic antagonist propranolol alone a t lC f^M  had no s ign ifican t 
e ffe c t on the glucose production rate ; th is concentration o f propranolol e ffe c tiv e ly  
blocked the increase in glucose production e lic ited  by IC f^M  adrenaline.
Surprisingly, the a-adrenergic antagonist phentolamine alone a t 10"^M caused 
a s ign ifican t increase above the contro l glucose production rate . When ICT^M 
phentolamine was present in the incubation medium together w ith  lC f^M
TABLE 3.8
S ensitiv ity  o f glycogen breakdown in hepatocytes freshly isolated 
from  term  fe ta l rats to the e ffe c ts  o f adrenergic agonists
Max. S tim .a ^ 5 0 ^
Agonist
Adrenaline 23 1.0
Noradrenaline 39 160
Isoprenaline 25 1.1
Phenylephrine 37 3200
a Max. Stim . = M axim al s tim u la tion  o f glucose breakdown ra te
observed (expressed as % above con tro l glycogen 
breakdown rate).
Concentration o f agonist calculated to result in 50% 
o f the maximal s tim ula tion observed (expressed as 
nM).
TABLE 3.9
E ffe c t o f adrenergic antagonists on stim ula tion by adrenaline 
o f glucose production in hepatocytes freshly isolated from  
near-term  fe ta l rats
Q
Glucose Production Rate
Medium (nm ole/10^ cells/h)
C ontro l 278 + 8 (n=39)
10”^M Adrenaline
* *
391 + 17 (n=22)
10“^M Propranolol 264 + 13 (n=15)
10"^M Adrenaline + 
10”^M Propranolol 280 + 15 (n=17)
1 Q~^M Phentolamine
* *
413 + 21 (n=15)
10^M Adrenaline + 
10~^M Phentolamine b**5 6 3  + 34 (n=17)
10"5M IC I 118 531 262 + 4 (n=5)
10"^M Adrenaline + 
10 "5M IC I 118 551 288 + 7 (n=5)
10"^M A teno lo l 266 + 12 (n=5)
10~^M Adrenaline + 
10~^M A teno lo l *329 + 20 (n=5)
Incubation was fo r 30 min. n = to ta l number o f incubations from  1-4 ce ll 
preparations (see te x t fo r details).
a Glucose production ra te  is shown as mean + SEM
*  S ign ifican tly  higher than contro l, p < 0.03
* *  S ign ifican tly  higher than contro l, p < 0.001
b S ign ifican tly  higher than 10”^M adrenaline, p < 0.001
S ta tis tica l evaluation was carried out 
on the mean o f the rep lica te  values fo r ' 
separate preparations. 'I
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FI GURE 3 . 7 E f f e c t  of  a d r e n e r g i c  a n t a g o n i s t s  on 
s t i m u l a t i o n  by a d r e n a l i n e  of  g l ucos e  
p r o d u c t i o n  in h e p a t o c y t e s  f r e s h l y  i s o l a t e d  
f rom n e a r - t e r m  f e t a l  r a t s  .
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any a d r e n e r g i c
pr esence  of  v a r i o u s  a g e n t s ,  as shown ( see
t e x t  f or  d e t a i l s ) .
adrenaline, the glucose production rate was s ligh tly  more than double the contro l 
ra te , and was s ign ifican tly  higher than the ra te  in the presence o f lC f^M  adrenaline 
alone. The $2ad rene rg ic  antagonist atenolo l and the $2~adrenergic antagonist IC I 
118 551 alone, each a t lCT^M, produced no s ign ifican t change in the glucose 
production rate compared w ith  the con tro l ra te . IC I 118 551 at lCT^M reduced the 
stim u la tion  o f glucose production caused by lC f^M  adrenaline to 5% above the 
contro l level, a t which level the glucose production rate was not s ig n ifica n tly  
d iffe re n t from  the contro l ra te . A teno lo l also reduced the e ffe c t o f adrenaline, but 
glucose production in the presence o f both 10"^M  adrenaline and 10~^M atenolol 
was s t i l l  s ign ifican tly  higher than contro l rates o f glucose production.
3.3.3. TIME-COURSE EXPERIMENTS
Two hour tim e-course
GLUCOSE PRODUCTION
The amount o f glucose produced by hepatocytes isolated from  fe ta l ra ts on 
day 22 post coitum  and incubated fo r 30, 60, 90 or 120 min is shown in Table 3.10. 
The glucose production rate calculated fo r each incubation period is shown in 
Figure 3.8. The production rate was highest in the f ir s t  30 min o f incubation, and 
decreased in each subsequent 30 min tim e period throughout the two hour 
incubation when the cells were incubated in contro l medium. When 10“^M 
adrenaline was present in the incubation medium, a s im ila r pa tte rn  o f decreasing 
glucose production ra te  was seen u n til 90 min; the glucose production ra te  in the 
90-120 min tim e period in hormone-exposed hepatocytes increased compared w ith  
tha t in the previous tim e period, and was o f the same order as tha t in the 30-60 
min incubation period (Fig. 3.8).
S ign ifican tly  more glucose was produced in the presence o f adrenaline than in 
its  absence at each tim e point investigated (Table 3.10). The e ffe c t o f 10"^M
TABLE 3.10
E ffe c t o f 10” ^M adrenaline on glucose production in
hepatocytes freshly isolated from  term  fe ta l rats
Glucose Production3
Length o f (nmoles/10^ cells) Glucose produced in the 
presence o f 10" M Adrenaline 
(as % o f contro l)
Incubation
(min) Contro l
medium
.Medium +
10” M Adrenaline
30 293 + 14 
(n=15)
333 + 23 
(n=15)
114
60 434 + 23 
(n=15)
**5 4 6  + 28 
(n=15)
126
90 533 + 36 
(n=15)
*6 6 1 +  38 
(n=15)
130
120 618 + 44 
(n=15)
* * *
877 + 56 
(n=15)
142
n = to ta l number o f incubations from  3 ce ll preparations (see te x t fo r details).
a Glucose production is shown as mean + SEM
*  S ign ifican tly  higher than contro l a t this tim e point, p < 0.03
* *  S ign ifican tly  higher than contro l at th is tim e point, p < 0.01
* * *  S ign ifican tly  higher than contro l a t this tim e point, p < 0.005
Statistical evaluation was carried out
on the mean of the replicate values for
separate preparations.
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adrenaline on glucose production increased throughout the two hour tim e-course, 
w h ils t the e ffe c t o f the agent on the glucose production ra te  showed a drop in the 
60-90 min tim e period, and a large increase in the fin a l incubation period (F ig . 
3.8).
GLYCOGEN BREAKDOWN
The glycogen content o f hepatocytes from  term  fe ta l rats over a tw o hour 
tim e-course incubation is shown in Table 3.11, and the glycogen breakdown ra te  
calculated fo r  the 0-30 min, 30-60 min, 60-90 min and 90-120 min tim e  periods is 
shown in Figure 3.9. Whether the cells were incubated in the presence or absence 
o f adrenaline, the glycogen breakdown ra te  was highest in the f i r s t  30 m in o f 
incubation, and decreased during the next incubation period. An increase was 
observed during the 60-90 min incubation period in contro l incubations, b u t a 
decrease was seen in adrenaline-exposed cells, and the glycogen breakdown ra te  in 
the presence or absence o f adrenaline was lowest in the fin a l 30 m in o f incubation 
(Fig. 3.9). When incubated in con tro l medium, 24%, 33%, 45% and 56% o f the  
glycogen in it ia lly  present in the cells was degraded a fte r 30, 60, 90 and 120 m in o f  
incubation, respectively.
The glycogen content o f hepatocytes exposed to 10~^M adrenaline throughout 
the incubation was not s ta tis tic a lly  s ign ifican tly  lower than that o f  cells fro m  a 
contro l incubation at any tim e po in t investigated during the two hour tim e-course  
(Table 3.11). However, i t  is clear that adrenaline did promote glycogenolysis in 
these cells; the absence o f s ta tis tica l significance is a ttribu tab le  to the large in te r -  
experim ental varia tion in the in it ia l glycogen content o f the hepatocytes. The 
s tim u la tion  o f the glycogen breakdown ra te  by 10~^M adrenaline was greatest in
the incubation period 30-60 min; in the fo llow ing two incubation periods less 
glycogen breakdown was observed in the presence o f adrenaline than in its  absence 
(Table 3.11 and Fig. 3.9).
TABLE 3.11
E ffe c t o f lC f^M  adrenaline on glycogen breakdown in 
hepatocytes freshly isolated from  term  fe ta l rats
Length of 
Incubation 
(min)
Glycogen content3 
(p g /10^ cells)
Contro l .Medium + 
medium 10" M Adrenaline
Glycogen cogtent in the 
presence o f 10" M Adrenaline 
(as % o f contro l)
0 654 + 44 
(n=29)
654 + 44 
(n=29)
100
30 497 + 49 
(n=15)
443 + 41 
(n=12)
89
60 438 + 69 
(n=13)
33-7+ 30 
(n=13)
73
90 361 + 36 
(n=14)
291 + 31 
(n=13)
81
120 288 + 45 
(n=14)
250 + 36 
(n=13)
87
n = to ta l number o f incubations from  3 ce ll preparations (see te x t fo r details), 
a Glycogen content is shown as mean + SEM.
Statistical evaluation was carried out
on the mean of the replicate values for
i separate preparations.
Three hour tim e-course
When glucose production in hepatocytes freshly isolated from  te rm  fe ta l ra ts 
was investigated over three hours o f incubation, the glucose production ra te  
decreased in each successive incubation period, and in the period two to three 
hours was low or negative, both in cells incubated in contro l medium and cells 
incubated in the presence o f a hormone (Table 3.12). The e ffe c ts  o f three 
hormones, adrenaline, noradrenaline and glucagon, were seen to  d iffe r  g rea tly  in 
this preparation. 10’ ^M adrenaline produced an increase in glucose production at 
each tim e point studied throughout the incubation, although the greatest (and the 
only s ta tis tica lly  s ign ificant) e ffe c t was seen in the f ir s t  hour. The same 
concentration o f noradrenaline by contrast, showed an increasing s tim u la tion  o f 
glucose production during the three hour tim e-course, a tta in ing a s ign ifican t level 
only in the fin a l hour o f incubation. In contrast, lO ^ M  glucagon did not s tim u la te  
glucose production s ign ifican tly  at any tim e  throughout the three hours o f 
incubation.
3.3.4. EFFECT OF MATERNAL DIABETES
Glucose production
The contro l glucose production ra te  in hepatocytes freshly isolated from  fe ta l 
rats on day 22 post coitum  was approxim ately 70% greater when the fetuses were 
obtained from  dams in which diabetes had been induced on day 5 post co itum  than 
when the fetuses were from  normal dams (Table 3.13 vs. Table 3.1). Adrenaline 
had no s ign ifican t e ffe c t on the glucose production ra te  in hepatocytes prepared 
from  term  fe ta l rats o f gestationally d iabetic dams. Adrenaline concentrations in
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TABLE 3.13
E ffe c t o f adrenaline on glucose production in hepatocytes freshly
isolated from  term  fe ta l rats o f qestationally d iabetic dams
Concentration Glucose Production Rate 
(nmole/10 cells/h)o f Adrenaline (M)
0 (Control) 732 + 66 (n=82)
10-10 732 + 119 (n=24)
10"9 794 + 121 (n=25)
ic r 8 763 + 106 (n=24)
10"7 746 + 83 (n=45)
V—
i O
l O
N
770 + 89 (n=44)
10~5 628 + 131 (n=19)
1(T4 664 + 119 (n=19)
r-~\ioi—
i 628 + 131 (n=19)
Incubation was fo r 30 min.
n = to ta l number o f incubations from  4 or 3 ce ll preparations 
(see te x t fo r details).
a Glucose production rate is shown as mean + SEM.
Statistical evaluation was carried out
on the mean of the replicate values for
separate preparations.
the range used in concentration-response experiments w ith  hepatocytes isolated 
from  fetuses o f normal m aternal ra ts ( lC T ^M  - 10~^M), and extending to 
concentrations 10, 100 and 1000-fold higher, were investigated (Table 3.13 and Fig. 
3.10). Concentrations o f 10"^ - 10~^M adrenaline produced a slight, non-significant, 
decrease in the glucose production rate .
Glycogen breakdown
The glycogen content o f hepatocytes im m ediate ly a fte r isolation from  term  
fe ta l ra ts o f gestationally d iabetic dams was approxim ately 30% higher than the 
content o f cells fresly isolated from  fetuses o f normal dams (Table 3.14 vs. Table 
3.6). However, a fte r  30 min incubation the glycogen content o f hepatocytes from  
the offspring o f diabetic mothers had dropped to approxim ately the same as, or 
s ligh tly  less than, tha t in iden tica lly -trea ted  cells from  the young o f normal 
mothers.
Adrenaline a t concentrations from  10~ ^M  - 10"^M has no s ta tis tic a lly  
s ign ifican t e ffe c t on glycogen breakdown in hepatocytes freshly isolated from  term  
fetuses o f gestationally diabetic dams (Table 3.14 and Fig. 3.11).
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FIGURE 3 . 1 0  E f f e c t  of  a d r e n a l i n e  on g l ucose  p r o d u c t i o n
in h e p a t o c y t e s  f r e s h l y  i s o l a t e d  f rom t erm 
f e t a l  r a t s  of  nor mal  and q e s t a t i o n a l l y  
d i a b e t i c  dams.
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a d r e n e r g i c  age nt ,  or in the p r e s e n c e  of a d r e n a l i n e  aa s h o w n  
(se e t e x t  for d e t a i l s ) .
FIGURE 3 . 1 1  E f f e c t  of  a d r e n a l i n e  on g l ycog en  br eakdown i n
h e p a t o c y t e s  f r e s h l y  i s o l a t e d  f rom t er m f e t a l  
r a t s  of  nor mal  and q e s t a t i o n a l l y  d i a b e t i c  
dams.
L e g e n d  as for f i g u r e  3.10.
3.4 DISCUSSION
3.4.1 OVERVIEW
The experiments reported in th is chapter involved measuring the jn  v itro  
production o f glucose in hepatocytes isolated from  adult or perina ta l rats. The 
method fo r isolation o f hepatocytes from  rats during the perinata l period 
(described in 3.2.4) produced viable, hormone-responsive cells. A d u lt hepatocytes 
produced by a liv e r perfusion technique (see 3.2.3) were also shown to produce 
glucose a t a ra te  which was suceptible to hormonal influence. Although hepatocyte 
suspensions always showed high v ia b ility  (never less than 95% when freshly 
isolated), and 5mM glucose was present in the media throughout the preparation 
period to prevent prem ature glycogen degradation, a large in te r-p repara tion  
varia tion in the in it ia l glycogen content and contro l glucose production ra te  was 
noted fo r cells isolated from  fe ta l or neonatal animals at any one age. This 
va ria b ility  may be p a rtia lly  a ttribu tab le  to  differences in the precise age o f the 
animals, resulting from  variations in the exact tim e o f conception, as the contro l 
glucose production ra te  varied markedly w ith  age as antic ipated (see e.g. Table 
3.1). However, the magnitude o f the varia tion, and the observation o f s im ila r, 
a lbe it s ligh tly  lesser, va ria b ility  in glucose production by adu lt hepatocytes, 
excludes this from  being the exclusive cause.
Rotherm el e t al. (1984) observed variations in contro l glucose production 
rates in adult male hepatocytes. Schulze et al. (1984) noted a s im ila r va ria tion  in 
basal glucose production rates and also in glycogen content o f te rm  fe ta l 
hepatocytes prepared on d iffe re n t occasions, and suggested seasonal va ria tion  as a 
possible fac to r; th is does not appear like ly  to  be o f pa rticu la r s ignificance in the 
work reported here, as even ce ll preparations produced on consecutive days 
frequently showed marked differences. Whatever the cause o f va ria tion  in in it ia l 
glycogen content and con tro l glucose production rates, th is  resulted in large 
standard errors o f mean values, thus reducing the possib ility  o f a tta in ing  s ta tis tic a l 
significance fo r the e ffec ts  o f the agents investigated.
3.4.2 FINDINGS IN ADULT HEPATOCYTES
Contro l Glucose Production
R e la tive ly  l i t t le  has been published concerning the response o f glucose 
production in fe ta l or neonatal hepatocytes to the e ffe c ts  o f adrenergic agonists 
(see 3.4.3), and therefore  to validate the incubation and assay techniques used, 
some concentration response experiments were carried out using adult cells (Table
3.1 and Table 3.3).
Hepatocytes isolated from  adult male rats showed a mean contro l production 
rate o f 1434 nmoles glucose per 10^ cells per hour; unstimulated hepatocytes from  
adult females produced glucose at a ra te  o f 757 nmoles per 10^ cells per hour.
E ffec ts  o f Adrenergic Agents
In accordance w ith  published observations, discussed in Chapter 1 (section
1.3.2), glucose production in both adult male and female hepatocytes was
-8 -6stim ulated by adrenaline in the concentration range 10~ - 10” M, whereas only the 
glucose production rate in cells isolated from  female adult rats was increased by 
the 8-adrenergic agonist isoprenaline in the concentration range o f 10” ^  -  10 ^M. 
These findings therefore support the current view tha t 3 -adrenoceptors are o f 
functiona l importance in the adult female ra t live r, but not in the male (Birnbaum 
& Fain, 1977; Studer & Borle, 1982). A more thorough investigation o f the sex 
differences in adrenergic-responsivenss o f adu lt ra t hepatocytes was outside the 
scope o f the present study.
3.4.3 FINDINGS IN PERINATAL HEPATOCYTES
Contro l Glucose Production and Glycogen Breakdown
The only lite ra tu re  reports o f the determ ination o f glycogen degradation and 
glucose production in freshly isolated fe ta l hepatocytes, and th e ir s tim u la tion  by 
catecholamines, have come from  Dargel's group in the German D em ocra tic
Republic (Huhn et al., 3983; Schulze e t al., 1984). The in it ia l glycogen content o f 
term  fe ta l hepatocytes reported by th is group was 1.17 pmol per 10^ cells (Huhn jet 
al., 1983), which is less than 50% o f the mean value o f 2.84 pmol per 10^ cells 
found in the present study. This d iffe rence m ight be pa rtly  due to  stra in  
differences, but is probably la rge ly due to the degradation o f glycogen during 
hepatocyte isolation using the technique developed in Dargel’s laboratory. In th is 
method, based on incubation o f liv e r m ate ria l in the presence o f trypsin, no glucose 
was included in the preparative media, so tha t glycogen breakdown m ight be 
expected to commence during hepatocyte isolation. Also, the dam was 
anaesthetised p rio r to obtaining fetuses, a procedure known to induce the loss o f 
glycogen (D iM arco et al., 1976; Furner et  al., 1972). The lower in it ia l glycogen 
content o f hepatocytes provides an explanation o f the considerably lower glycogen 
breakdown and glucose release rates observed by Dargel’s group compared w ith  
those documented here:
Glycogen breakdown Glucose production 
(umole glucose/10^ cells/h)
Huhn e ta l.  (1983) 0.23 0.16
Schulze et al. (1984) 0.47 - 0.63 0.26 - 0.31
Present study 1.11 - 2.22 0.41 - 0.54
The glucose production rates reported in th is work are obtained by 
measurement o f the glucose concentration in the medium in which hepatocytes 
have been suspended during incubation. However, th is concentration is ac tua lly  the 
net resu lt o f two in trace llu la r processes - glucose production and glucose 
u tilisa tion . The production o f glucose in hepatocytes m ight be from  breakdown o f 
stored glycogen, but may also result from  de novo synthesis from  gluconeogenic 
precursors. In experiments studying glucose production by adult hepatocytes, 
animals are often starved p rio r to preparation o f cells to deplete the ce llu la r 
glycogen; i t  is then assumed tha t any glucose produced is exclusive ly via the 
gluconeogenic pathway. This technique is not suitable fo r perinata l animals, and
therefore in the work reported in th is chapter gluconeogenesis and glycogenolysis 
were measured e xp lic itly  in hepatocytes from  day 22 post co itium  animals, 
although tim e lim ita tions  res tric ted  the determ inations made at o ther ages to to ta l 
glucose production alone.
Glycogen breakdown rates in hepatocytes isolated from  term  fe ta l ra ts were
more than su ffic ien t to account fo r the glucose released in to the incubation
medium; the proportion o f degraded glycogen which was released as glucose was 
unaffected by the presence o f any agent s tim ula ting the ra te  o f glycogen 
breakdown (e.g. Table 3.1 & Table 3.6).
The absence o f detectable gluconeogenic a c tiv ity  in fresh ly isolated term
fe ta l hepatocytes m ight be predicted from  the observed delay in the onset o f 
gluconeogenesis in the im m ediate ly post partum  ra t liv e r (Ballard, 1971a; Medina 
et al., 1980).
Concentration-Response Experiments
Concentration-response curves were typ ica lly  sigmoidal (Figures 3.1, 3.2, 3.3,
3.4 & 3.6). A t higher concentrations o f some agents, a decrease in the response 
occurred; th is phenomenon is probably a ttribu tab le  to tox ic  e ffe c ts  o f the 
compounds, although no reduction was seen in v ia b ility  as determ ined by trypan 
blue exclusion.
The response to  catecholamines o f glucose production pathways in 
hepatocytes freshly isolated from  term  fe ta l rats observed in th is series o f 
experiments concurs w ith  the findings o f Huhn et al. (1983). However, the 
magnitude o f the response was somewhat lower in the current work than th a t 
reported by Huhn et al. These workers observed stim ula tion o f glycogen breakdown 
and glucose release by 10 phenylephrine to 133% and 147% o f the con tro l level,
respectively. In the present work, th is concentration o f a-adrenergic agonist 
promoted glycogen breakdown and glucose release to  111% and 115% o f contro l, 
respective ly; lC f^M  phenylephrine (the m axim ally e ffe c tive  concentration) 
produced increases in these pathways o f 37% and 27%, respectively. 5 x 10”^M  
isoprenaline was reported by Huhn et al. to s tim ula te  glycogenolysis and glucose 
release to 183% and 202% o f the con tro l values, respective ly. The highest 
concentration o f isoprenaline investigated in the current work was lC f^M , which 
caused an increase to 116% and 133% o f contro l in glycogen breakdown and glucose 
release, respectively. For both o f these processes, the concentration o f 
isoprenaline e lic itin g  the maximum response in the current study was below 10”^M. 
The response to a - and (3-adrenergic agonists found in the current study may be 
lower than those reported by Huhn et al. fo r a number o f reasons. S tra in 
d ifferences in hepatic adrenoceptor populations could cause v a r ia b ility  in 
catecholamine responsiveness between strains. Also, the lower con tro l glycogen 
breakdown and glucose production rates observed by Huhn et al. compared w ith  th is 
study, as discussed earlie r in th is section, m ight account fo r the higher 
suscep tib ility  o f these pathways to hormonal s tim ula tion. The d iffe rence in the 
incubation periods in the two studies (30 min fo r the current work and one hour fo r 
the study by Huhn et al.) m ight also be expected to resu lt in d iffe re n t responses to 
adrenergic agents in the two investigations; as reported in section 3.3.3, the 
s tim u la tion  o f glucose production by adrenaline was greater in the 30-60 min 
incubation period than the 0-30 min period.
When considering the findings from  the concentration response experiments 
(see section 3.3.1), the e ffec ts  o f any o f the adrenergic agents on glucose 
production jn  v itro  may be evaluated w ith  regard to two parameters: the greatest 
s tim ula tion above the contro l ra te  e lic ited  by an agent and the concentra tion o f 
tha t agent required to produce a certa in  level o f s tim ula tion. Table 3.5 shows the
maxim al s tim u la tion  (% increase above contro l) and the FC^g (concentration 
producing 50% o f the maxim al stim ula tion) fo r each o f the four adrenergic agonists 
used, at each o f the ages studied. From these data, the perinata l ages a t which the 
hepatocytes were isolated may be ranked to indicate age-dependent changes in 
sensitiv ity  to the four agents. Below, the ages are ordered by descending 
responsiveness (descending maximal s tim ulation, ascending FC^g values):
M AXIM AL STIMULATION:
Adrenaline: Day 21 p.c. > Day 2 p.p. > Day 22 p.c. > Day 1 p.p.
Noradrenaline: Day 2 p.p. > Day 1 p.p. > Day 22 p.c. Day 21 p.c.
Isoprenaline: Day 2 p.p. > Day 1 p.p. > Day 22 p.c. Day 21 p.c.
Phenylephrine: Day 2 p.p. > Day 1 p.p. > Day 22 p.c. Day 21 p.c.
EC50:
Adrenaline: Day 22 p.c. < Day 1 p.p. < Day 2 p.p. < Day 21 p.c.
Noradrenaline: Day 22 p.c. < Day 1 p.p. < Day 2 p.p. < Day 21 p.c.
Isoprenaline: Day 21 p.c. < Day 22 p.c. < Day 2 p.p. < Day 1 p.p.
Phenylephrine: Day 22 p.c. < Day 21 p.c. < Day 1 p.p. < Day 2 p.p.
Changes w ith  age in three facto rs m ight produce changes in the 
responsiveness o f ce llu la r processes to external agents; these fac to rs  are receptor 
number, receptor a ff in ity  and post-receptor events. In the s itua tion  where 
saturating concentrations o f drug are present, an increase in receptor number w ill 
result in an increase in the maximal stim ula tion, provided tha t post-receptor 
events are not lim itin g , but w ill also increase the FC^g fo r the drug. An increase o f 
a f f in ity  in th is situation would not a ffe c t the m axim al response, but would reduce 
the FC^g. Changes in post-receptor events would influence the m axim al response 
obtained, but would not a ffe c t the FC^g.
The concentration-response experiments reported here showed an increase in 
the m axim al s tim ula tion o f glucose production in hepatocytes jn  v itro  by 
adrenergic agents w ith  increasing perinata l age, w ith  the exception o f adrenaline 
fo r which very l i t t le  varia tion in the m axim al response w ith  age was seen. The 
ranking o f FC^g values suggests m axim al sens itiv ity  to  the e ffec ts  o f adrenergic 
agents at term  (or im m ediate ly before term  fo r isoprenaline), w ith  reduced 
sens itiv ity  to  any o f the agents investigated occurring by day 2 post partum .
Factors which m ight produce the nadir in FC^g value at term  include a la rger 
receptor population, high a ff in ity  fo r the agent under investigation, and/or a more 
e ffe c tive  linkage w ith , and execution of, post-receptor pathways. From the curren t 
work i t  is not possible to  ascertain the re la tive  im portance o f these facto rs ; 
however the pa tte rn  o f varia tion in hepatic adrenoceptor number through the 
perinata l period reported in Chapter 2 suggests tha t the size o f the adrenoceptor 
population is an im portan t parameter. As receptor numbers do not show a steady 
increase throughout the period studied, the increase in maximal s tim u la tion  w ith  
increasing age must be add itionally a ttribu tab le  to  changes in post-receptor events.
A w e ll established event which occurs im m ediate ly a fte r occupation o f a B- 
adrenoceptor by an agonist is ac tiva tion  o f the enzyme adenyl cyclase (Sutherland 
& Robison, 1969). Changes in the basal or horm one-stim ulated a c t iv ity  o f th is 
enzyme in ra t live r during development are w e ll documented (Bitensky e t al., 1970; 
Butcher & P o tte r, 1972; Christoffersen et al., 1973; Christoffersen & $ye, 1974). 
Changes in the coupling o f B-adrenoceptors and adenyl cyclase w ith  age have been 
shown in other tissues (Smith, 1984), and Kalish et al. (1977) have proposed tha t 
changes in hepatic ce ll membranes during development m ight produce changes in 
the ca ta ly tic  sub-unit o f adenyl cyclase. The hepatic a c tiv ity  o f the enzyme 
phosphodiesterase, which hydrolyses the cyc lic  AMP formed as a resu lt o f adenyl 
cyclase a c tiv ity , has also been observed to  change in the perina ta l ra t
(Christoffersen et al., 1973). As the ce llu la r events which were seen in the curren t 
work to  be influenced by adrenergic ac tiva tion  a ll depend on the a c tiv itie s  o f 
enzymes o f carbohydrate metabolism, changes in such a c tiv itie s  during 
development (Beaudry E3t  al., 1977; Vernon & Walker, 1968; Burch e t al., 1963) may 
also be at least pa rtly  responsible fo r the observed differences in response to  
adrenergic agonists o f hepatocytes prepared from  animals at d iffe re n t perinata l 
ages.
The concentration-response curves fo r the glucose production ra te  in 
hepatocytes isolated from  term  fe ta l rats and incubated in the presence o f each o f 
the catecholamines investigated are shown in Figure 3.5. The para lle l s h ift  o f the 
curve when hepatocytes are exposed to agents w ith  d iffe ring  a ffin it ie s  fo r a - and 
B-adrenoceptors indicates the nature o f the receptor mediating the s tim u la tion  o f 
glucose production by these agents. The sh ift o f the curve showing the response to 
increasing phenylephrine concentrations to  the rig h t o f tha t fo r  isoprenaline, 
together w ith  an almost 400-fold higher EC^g fo r phenylephrine compared w ith  
isoprenaline, demonstrates c learly  th a t the e ffe c t o f catecholam ines on glucose 
production in term  fe ta l ra t hepatocytes is a B -adrenoceptor mediated phenomenon 
(Ahlquist, 1948). S im ila rly , the para lle l s h ift to the rig h t o f the noradrenaline 
response curve compared w ith  the adrenaline response curve, and the 
approxim ately ten -fo ld  higher EC^g fo r  noradrenaline than fo r adrenaline, 
demonstrates tha t the B-adrenoceptor involved is o f the B2-subtype (Lands e t al., 
1967).
As fo r the e ffec ts  on glucose production, comparison o f the concen tra tion - 
response curves (Fig. 3.6) produced by the adrenergic agonists studied, and o f th e ir 
EC^g values (Table 3.7) confirm  catecholam ine e ffec ts  on glycogen breakdown to 
be mediated p rim arily  via B2_adrenoceptors (cf. 3.3.1.).
Response Blocking Experiments
As previously discussed, hepatic carbohydrate metabolism in the adult male 
ra t is believed to  be predom inantly, i f  not exclusively, a ffected  by adrenergic 
agents via a-adrenoceptors, w h ils t in the adult female and im m ature animals, B- 
adrenoceptors have a substantial involvem ent; the work presented in th is  chapter 
supports such a concept. The findings from  both radioligand receptor binding 
studies on hepatic membranes and concentration-response experiments w ith  
isolated hepatocytes suggested a predominance o f B2-adrenoceptors, and response 
blocking experiments were devised in order to confirm  this finding.
The e ffec ts  o f propranolol, a non-subtype selective antagonist a t the B- 
adrenoceptor, and the selective agents atenolol (B2) an^ IC I 118 551 on
stim u la tion  o f glucose production in hepatocytes freshly isolated from  near-te rm  
fe ta l rats by adrenaline provide fu rth e r evidence tha t the predominant 
adrenoceptor activated in producing th is response is o f the subtype.
This e ffe c t o f the a-antagonist phentolamine, in prom oting glucose 
production, was unexpected. This agent e lic ited  a 50% increase in the glucose 
production ra te  compared w ith  the contro l ra te , and when i t  was present in the 
incubation medium together w ith  adrenaline, the very high ra te  o f glucose 
production observed appeared to suggest an additive s tim u la to ry  e ffe c t o f these 
two agents (Table 3.8). Phentolamine, a non-subtype selective a-adrenerg ic 
antagonist (Goodhardt et al., 1982), m ight produce an increase in glucose 
production by blocking the e ffe c t o f adrenergic agonists a t c^-adrenoceptors; 
activa tion  o f th is a-adrenoceptor subtype is associated w ith  a decrease in adenyl 
cyclase a c t iv ity  (see section 1.3.1) and thus a reduction in glucose production. The 
re la tive  size o f the a2"adrenoceptor population o f the perina ta l ra t liv e r  is 
disputed: Butlen et al. (1980) reported tha t hepatic a-adrenoceptors in fe ta l and
neonatal rats are m ostly o f the a^ subtype, w h ils t M cM illian  et al. (1983) showed 
figures in the ir work suggesting tha t -adrenoceptors were at least tw o-fo ld  more 
numerous than c^-adrenoceptors throughout the perinata l period. However, even i f  
substantia l numbers o f o^-adrenoceptors are present in the liv e r o f near-term  fe ta l 
rats, blocking o f these receptors by phentolamine would a ffe c t only glucose 
production influenced by the ir po ten tia l ac tiva tion  due to  the presence o f a - 
adrenergic agonists. In the preparation used, extensive washing was used to 
remove any endogenous agents, so tha t hepatocytes were exposed only to 
compounds included in the incubation m ixture . I t  is therefore d if f ic u lt  to explain 
the s tim u la tory  e ffe c t o f phentolamine alone on glucose production in term s o f a 
decreased occupation o f c^-adrenoceptors by adrenergic agonists.
A lthough no explanation o f the observed e ffe c ts  o f phentolamine on in v itro  
hepatic glucose production is cu rren tly  available, the rep roduc ib ility  o f the e ffe c t, 
and the observations o f the e ffec ts  o f th is compound in an a-adrenoceptor 
radioligand binding assay (see section 2.3.2) suggest tha t th is is a genuine finding. 
O ther workers have found tha t the e ffec ts  o f adrenaline on tyrosine 
aminotransferase induction in fe ta l hepatocytes are potentia ted by phentolamine, 
although the e ffec ts  o f the a-antagonist alone have not been investigated (G. 
Sparmann, In s titu t fu r Biochemie, Leipzig, GDR, personal communication).
Tim e Course Experiments
Having established an optim al concentration o f adrenaline fo r s tim u la tion  o f 
In v itro  glucose production, the tim e course o f th is stim u la to ry  e ffe c t on glycogen 
breakdown and glucose production in te rm  fe ta l hepatocytes was studied over two 
hours (Table 3.10 & Table 3.11; Figure 3.8 & Figure 3.9). The ab ilities  o f adrenaline 
and noradrenaline to increase glucose production during a three hour incubation 
were also compared w ith  the e ffe c t o f an identica l concentration o f glucagon 
(Table 3.12).
A general trend o f decreasing glucose production rates (and decreasing 
glycogen breakdown rates when these were assessed) in successive tim e periods was 
observed. This m ight be expected i f  glucose production is the result o f glycogen 
breakdown, as Abdullah et al. (1963) showed tha t the ra te  o f glycogen breakdown is 
proportional to the m olecular weight o f the glycogen being degraded; thus, as the 
mass o f glycogen remaining decreases, so w ill the rate o f glucose production. The 
proportion o f degraded glycogen which was released as glucose in to  the medium 
also decreased w ith  tim e during the two hour tim e course (Table 3.11).
In the current work, ICT^M glucagon did not produce a s ign ifican t increase in 
the glucose production ra te  a fte r one, two or three hours o f incubation (Table 
3.12). In hepatocytes isolated from  adult rats, glucagon at concentrations as low as 
5 x lC f ^ M  have been shown to s tim ula te  glucose production (Assimacopoulos- 
Jeannet et al., 1982). Huhn et al. (1983) reported stim u la tion  to 124% and 115% o f 
the contro l rate o f glucose production ra te  and glycogenolysis, respective ly, in 
te rm  fe ta l hepatocytes exposed to 2.9 x lC f^M  glucagon over three hours. I t  is 
possible tha t the glucagon concentration chosen in the current work was supra- 
optim al, however other workers have also observed insensitiv ity  o f the fe ta l ra t 
liv e r to the e ffec ts  o f glucagon (Blazquez et al., 1976; Snell & Walker, 1978; 
V in ico r et al., 1976).
Experiments using the O ffspring o f D iabetic Rats
The elevation in the contro l glucose production ra te  in hepatocytes isolated 
from  term  fe ta l rats o f diabetic mothers is the resu lt o f the higher ra te  o f 
glycogen breakdown in these cells compared w ith  those obtained from  the offspring 
o f normal dams (Table 3.13 & Table 3.14; Figure 3.10 & Figure 3.11). Glycogen- 
breakdown rates in hepatocytes from  fetuses o f d iabetic ra ts were 180-240% o f 
those seen in hepatocytes from  normal fetuses. This additional glycogenolysis is
more than su ffic ien t to  account fo r the increase in glucose production seen, and in 
fa c t the d iabetic condition led to a decrease in the proportion o f degraded glycogen 
released as glucose. The high ra te  o f glycogen breakdown in hepatocytes from  the 
young o f d iabetic rats results from  the high hepatic glycogen content o f these 
animals (Cuezva & Patel, 1980a; Snell 1982b), and thus the high in it ia l glycogen 
content observed in the isolated hepatocytes used in th is study. Fe ta l 
hyperinsulinaemia is exaggerated in the offspring o f gestationally d iabetic rats 
(Cuezva & Patel, 1980b; Cuezva e t al., 1982a), and this, together w ith  fe ta l 
hyperglycaemia (both o f which result from  m aternal hyperglycaemia) are 
responsible fo r this increase in hepatic glycogen content in the in fants o f d iabetic 
mothers.
The observations o f the e ffec ts  o f m aternal diabetes on contro l glucose 
metabolism in hepatocytes freshly isolated from  term  fe ta l rats were there fo re  as 
predicted from  known facts. The find ing o f an apparently absent, or a t least 
severely attenuated, response o f glycogenolysis and glucose production to  the 
s tim u la to ry  e ffec ts  o f adrenaline in hepatocytes from  the fetuses o f gestationally 
d iabetic dams has not, however, been previously reported. Dighe e t al. (1984) has 
reported a decrease in [^H ] -prazosin binding sites (presumably representing o ^ - 
adrenoceptors) in the livers o f adult ra ts w ith  streptozotocin-induced diabetes, but 
no reports o f e ffec ts  on 8-adrenoceptors, or on any receptors in the o ffspring o f 
a ffected  animals, have been made.
A prolonged period o f postnatal hypoglycaemia has been observed in neonatal 
ra ts born to diabetic dams (Cuezva et al., 1982b; Snell, 1982b). Snell suggested th a t 
this resulted from  a delay in the in itia tio n  o f glycogen breakdown secondary to  the 
hyperinulinaemic condition o f these animals. A ttenuation  o f the postnatal increase
in plasma glucagon has also been proposed as a cause o f the delay in glycogenolysis 
(Cuezva & Patel, 1983). The findings reported in th is chapter provide another 
possible explanation o f the observation: d im inution o f adrenergic responsiveness 
may reduce adrenergic hormone stim u la tion  o f glycogen breakdown, resulting in a 
delay in recovery o f plasma glucose levels postnatally.
3.4.4 SIGNIFICANCE OF FINDINGS
The work reported in this Chapter c learly  demonstrates th a t glucose 
production and glycogen breakdown in hepatocytes fresh ly isolated from  rats during 
the perinata l period are sensitive to the stim u la to ry  e ffe c t o f adrenergic agents. 
Comparison o f concentration-response curves fo r adrenergic agonists and blocking 
o f adrenergic e ffec ts  w ith  adrenoceptor type and subtype-specific compounds 
confirm  tha t adrenergic e ffec ts  on carbohydrate metabolism in the perina ta l ra t 
live r, in contrast to the adult, are predom inantly f^-nnediated.
CHAPTER 4
ADRENERGIC EFFECTS ON CARBOHYDRATE 
METABOLISM IN  THE PERINATAL RAT IN  VIVO
4.1 INTRODUCTION
4.1.1 ADVANTAGES AND DISADVANTAGES OF IN VIVO EXPERIMENTS
The use o f in tac t animals to  investigate the adrenergic responsiveness o f 
perinata l glucose production pathways overcomes many o f the lim ita tions  o f in 
v itro  techniques. Thus, both in tra -hepa tic  and in ter-organ relationships, lost when 
experiments are carried out in isolated cells, are s t i l l  active when work is 
conducted jn  vivo. Provided tha t suitable contro ls are used, de fin ite  conclusions 
regarding the physiological role o f the adrenergic system in the newly bom ra t may 
be drawn from  in vivo experiments, whereas in v itro  work can show only the 
po tentia l significance o f th is system.
However, findings made from  in v ivo  experiments require very ca re fu l 
in te rpre ta tion . Although a pa rticu la r response may be observed in an animal, the 
organ(s) and biochemical pathway(s) a ffec ted  to  produce such a response cannot be 
easily established. I f  jn  vivo adm in istra tion o f an adrenergic agent is seen to  
produce a change in plasma glucose concentration, there is no evidence tha t th is  is 
due to  adrenergic modulation o f hepatic glucose production pathways. In add ition , 
the dose o f any administered substance is crucia l; i f  plasma levels in excess o f 
those norm ally present jn  vivo are obtained, then changes observed may be due to  
pharmacological ra ther than physiological e ffe c ts .
4.1.2 AGENTS USED AND TIME POINTS STUDIED
In this series o f experiments, the e ffe c ts  of adrenaline, the a-adrenerg ic 
antagonist phentolamine,and the B-adrenergic antagonist propranolol were 
examined by th e ir in traperitoneal adm in istra tion im m ediate ly a fte r  caesarian 
delivery of term  fe ta l rats.
I f  ac tiva tion  o f hepatic adrenoceptors im m ediate ly a fte r b irth  stim ulates 
live r glucose production in v ivo, then adm in istra tion o f adrenaline would be 
expected to produce an elevation o f plasma glucose concentration. I f  increased 
glucose production by adrenaline is the result o f s tim ula tion o f hepatic glycogen 
breakdown, then a re la tive ly  greater loss o f glycogen in adrenaline-treated 
neonates should be seen than in contro l animals. As plasma glucose levels in 
untreated neonates have been reported to reach a nadir a t one to two hours post 
partum (Cake et al., 1971; Cuezva e t al., 1982a; Dawkins, 1963a; G irard e t al., 
1973a; Snell & Walker, 1973b), th is tim e period should be the most sensitive to  the 
e ffec ts  o f agents increasing plasma glucose concentration. Therefore, in 
experiments investigating the e ffec ts  o f jn  vivo adm in istra tion o f adrenaline, 
plasma glucose and lacta te  concentrations and live r glycogen content were 
determ ined two hours a fte r delivery.
I f  activa tion  o f a - or 8 -adrenoceptors is an essential event in the increase in 
hepatic glucose production in the postnatal period, then blocking o f these receptors 
w ith  phentolamine or propranolol, respective ly, would be expected to prevent the 
elevation o f plasma glucose resulting from  increased hepatic glucose production. 
Recovery from  postnatal hypoglycemia in the ra t is usually seen to  be com plete by 
three or four hours post partum (Blazquez et al., 1974; Butcher & P o tte r, 1972; 
Cuezva et al., 1982a; Fernandez e t al., 1983; G irard e t al., 1973a; Kervran e t al., 
1976); therefore the e ffec ts  o f an agent which in te rfe res w ith  the pathways o f 
glucose production responsible fo r the re tu rn  to  normoglycemia should be most 
easily demonstrated at th is tim e. Three hours a fte r delivery was there fo re  chosen 
as the optimum tim e point to investigate the e ffec ts  o f phentolam ine and 
propranolol on plasma glucose and lac ta te  and live r glycogen levels in the neonatal 
ra t in vivo.
Because o f the importance o f the dose o f agent administered in an jn  vivo 
experiment (see section 4.1.1), the po ten tia l elevation o f plasma catecholam ine 
levels by in traperitonea lly  adm inistered adrenaline was care fu lly  considered when 
choosing the dose range to be investigated. The plasma concentration o f 
catecholamines a t the tim e o f caesarian delivery o f term  ra t fetuses has been 
reported to  be around 7 ng/m l, dropping rap id ly to around 1 ng/m l at one hour post 
partum  (Cuezva et al., 1982a). Assuming a volume o f d is tribu tion  o f 4 m l, and i f  
there was complete absorption and no metabolism or excretion o f exogenously 
administered adrenaline, then doses in the range of 4 to 400 ng would produce 
increases in the plasma catecholam ine concentration at one hour post partum  o f 
approxim ately 2 to  100-fold. In it ia l experiments therefore  involved adm in istra tion 
o f doses o f adrenaline in th is range in an a ttem pt to establish a threshold dose 
producing an elevation o f plasma glucose concentration. Doses o f adrenaline used 
in la te r experiments, and the reasons fo r using such doses, w ill be discussed in 
section 4.4.2. The doses o f antagonist used were based on adrenaline doses observed 
to  produce e ffects , and w ill be considered in the discussion of th is  series o f 
experiments (section 4.4.3).
4.1.3 AIMS OF THE EXPERIMENTS
Experim ental findings reported in Chapters 2 and 3 provide evidence fo r  a 
changing population o f 8-adrenoceptors on ra t liv e r membranes during the 
perinatal period, and fo r  the responsiveness o f glucose production in hepatocytes 
freshly isolated from  perinata l rats to  the s tim u la to ry  e ffe c ts  o f adrenergic 
agonists. However, although this establishes tha t 8 -adrenoceptors are present, and 
are coupled to post-receptor events a ffe c ting  carbohydrate metabolism  w ith in  the 
hepatocyte, i t  provides no insight in to the possible physiological s ign ificance o f 
hepatic adrenoceptor ac tiva tion  in the newly born ra t. In vivo experim ents are 
essential to investigate this question.
In these experiments the e ffec ts  o f an adrenergic agonist, adrenaline, and 
two adrenergic antagonists, phentolamine and propranolol, on glucose metabolism 
in vivo in the im m ediate ly postnatal period were investigated. I f  adrenaline can be 
shown to produce changes in glucose m etabolic pathways, then this indicates tha t 
adrenoceptor activa tion  m ight influence postnatal carbohydrate metabolism. More 
s ign ifican tly , i f  an antagonist a t the adrenoceptor is observed to  prevent the 
recovery in the plasma glucose level usually seen in the healthy neonatal ra t from  
around two hours post partum (Cake et al., 1971; Dawkins, 1963a; Fernandez e t al., 
1983; Snell & Walker, 1973b), i t  may be argued tha t activa tion  o f adrenoceptors is 
an essential fa c to r in the physiological re tu rn  to  normoglycemia in the postnatal 
period in the ra t.
4.2 MATERIALS &  METHODS
4.2.1 MATERIALS
(+)Adrenaline, amyloglucosidase (7 iu/m g as a suspension in 3.2M (N H ^ S O ^ ) 
and type II oyster glycogen were obtained from  Sigma Chemical Company L td ., 
Poole, Dorset. G lacia l acetic  acid was from  May & Baker L td ., Dagenham, Essex. 
DL-Propranolo l HC1 was a kind g if t  from  IC I, A lderley Edge, Cheshire; prazosin 
was generously donated by P fize r L td ., Sandwich, Kent. Phentolamine mesylate 
was supplied by Ciba Laboratories, Horsham, West Sussex. A l l other reagents were 
from  BDH Chemicals L td ., Poole, Dorset.
4.2.2 ANIMALS
Rats o f a random-bred W istar albino strain, obtained from  the U n ivers ity  o f 
Surrey An im al U n it, were used. Each male was housed overnight w ith  5-10 females, 
and pregnancy was established by palpation 10 to 20 days a fte r mating. The day 
fo llow ing overnight housing w ith  the male was taken as day 1 post co itum . 
Unanaesthetized m aternal rats were k illed  by cerv ica l dislocation. A l l animals 
were given food and w ater ad lib itu m .
Term fe ta l rats were obtained by caesarian section at a tim e between 9 and 
10.30 a.m. on day 22 post co itum . U m bilica l cords were broken by a sharp tug 
close to the fe ta l trunk. This procedure, which m im ics tha t observed in the natura l 
s ituation, prevented the blood loss seen i f  the cords were cut, and avoided tim e - 
consuming suturing. Follow ing delivery, a ll fetuses o f a l i t t e r  were weighed 
together, and a mean weight per fetus was calculated. Fetuses were then randomly 
assigned to one o f three groups. Anim als in the f ir s t  and second group were given 
an in traperitoneal in jection o f 5 p i o f 20 gg /m l ascorbic acid in 0.9% NaCl 
solution, using a Ham ilton m icrosyringe (H am ilton Bonaduz AG, Bonaduz,
Switzerland) held in a clamp. Anim als o f the f ir s t  group were k ille d  im m ediate ly, 
those o f the second group were placed on tissue dampened w ith  w ater a t 37°C in a 
p lastic box, which was then placed in a w ater bath at 37°C. Anim als o f the th ird  
group were given an in traperitonea l in jection  o f 3 p i o f 0.9% NaC l solution 
containing 20 pg /m l ascorbic acid and e ithe r an adrenergic agonist or antagonist 
and maintained iden tica lly  to the second group described above. A l l in jections were 
completed w ith in  ten minutes o f delivery.
E ffec ts  o f adrenergic stim ula tion
In experiments to investigate the e ffec ts  o f adm in istra tion o f adrenaline to 
new ly-delivered rats, doses in the range 4 ng-10 pg o f adrenaline per fetus were 
in jected. When adrenaline was given to  the animals o f the th ird  group, these 
fetuses and the contro l fetuses o f the second group were k illed  two hours a fte r  the 
i.p. in jection.
E ffec ts  o f adrenergic antagonism
In experiments to assess the e ffec ts  o f adm in istra tion o f adrenergic 
antagonists to  new ly-delivered rats, a dose o f 5 or 10 pg o f the 8 -adrenergic 
antagonist propranolol, or 6.4 or 12.8 pg o f the a-adrenergic antagonist 
phentolamine, was administered per fetus. 6.4 and 12.8 pg o f phentolam ine were 
calculated to be the molar equivalents o f 3 and 10 pg o f propranolol, respective ly. 
When an antagonist compound was given, the animals o f the th ird  group (which 
received this compound) and the contro l animals o f the second group were k ille d  
three hours a fte r the i.p. in jection.
Procedure
Unanaesthetized fe ta l animals were k ille d  by decapitation. Blood was 
collected from  the axia l vessels o f the trunk in to fluoridated cap illa ry  tubes
(M icrove tte  CB 300, Sarstedt, Leicester). The tubes were im m ediate ly centrifuged 
a t 1800 g fo r 10 minutes at 4°C  (Beckman J6B or IEC Centra-3R centrifuge). 
Plasma was aspirated using a pasteur p ipette , and stored in a polypropylene tube 
fo r glucose and lac ta te  assays; i f  the assays were not to be carried out w ith in  24 
hours, samples were kept at -20°C. Im m ediate ly a fte r k illin g  fe ta l animals and 
obtaining blood, livers were rapid ly excised and frozen in liquid I f  the glycogen 
assay could not be carried out im m ediate ly, livers were stored at -20°C.
4.2.3 ASSAYS
Plasma glucose assay
Plasma glucose was measured d ire c tly  using the hexokinase - glucose-6- 
phosphate dehydrogenase method on a Cobas-Bio cen trifuga l autoanalyser (Roche, 
Welwyn Garden C ity , Herts). No deproteinisation was necessary. Reagent k its  
(Glucose 'rapid', Roche Diagnostics, Welwyn Garden C ity , Herts., or 'C en trifichem ' 
glucose assay k it, Baker Instruments, A llentown, P.A., U.S.A.) were usedaccording 
to manufacturers' instructions. Appropria te glucose standards in d is tilled  w a te r (in 
the range 1-10 mM) were included fo r each set o f determ inations.
Plasma lacta te  assay
Plasma lac ta te  was measured using the lac ta te  dehydrogenase - g lu tam ate 
pyruvate-transaminase method on a Cobas-Bio cen trifuga l autoanalyser (Roche, 
Welwyn Garden C ity , Herts). No deproteinisation was needed. A reagent k i t  (U.V. 
lacta te  k it,  Boehringer Mannheim, Lewes, East Sussex) was used according to  the 
m anufacturer's instructions, which did not require the inclusion o f standards.
L ive r glycogen assay
Frozen livers (weighing about 300 mg) were rapid ly weighed, placed in 1 m l o f 
ice-cold 0.6M HCIO^ and im m ediate ly homogenised using a P o tte r-E lveh jem  type
homogeniser. The tube and pestle were rinsed w ith  two x 1 m l o f 0.6M HCIO^. The 
homogenate was dilu ted 1:20 in 0.2M sodium acetate bu ffe r, pH 4.8. Two 0.2 m l 
aliquots o f the d iluted homogenate were placed in 7.3 m l glass tubes and mixed 
w ith  1.0 m l o f 0.2M acetate bu ffe r, pH.4.8; one aliquot was mixed w ith  bu ffe r 
alone and one w ith  bu ffe r containing 74 iu /m l o f amyloglucosidase. The tubes were 
shaken at 30 strokes/m in in a w ater bath a t 37°C fo r 4 hours, and were vortex 
mixed approxim ately ha lf way through this tim e. D is tilled  water blanks and 0.2 m l 
aliquots o f glycogen standards (0.1 - 1.0 m g/m l oyster glycogen in d is tilled  water) 
were treated iden tica lly . A t  the end o f the incubation, a ll tubes were centrifuged 
at 2,000 g fo r 10 minutes a t room tem perature (Beckman J6B or IEC Centra-3R  
centrifuge) to remove any sediment. Glucose in the supernatant was measured 
using the Cobas-Bio autoanalyser (see above). S ign ificant levels o f free  glucose 
were found in the homogenates, and therefo re  glucose values obtained in the 
absence o f amyloglucosidase were subtracted from  those obtained in the presence 
o f the enzyme in order to calculate the glycogen-derived glucose leve l. The 
glycogen content o f the livers was then calculated from  the standard curve; 97- 
100% o f the glycogen present in standards was hydrolysed to glucose by th is 
method.
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4.3 RESULTS
4.3.1 PLASMA GLUCOSE
Contro l levels
The plasma glucose concentrations in con tro l animals im m edia te ly 
postnatally and at two and three hours post partum are shown in Table 4.1. These 
animals were term  fe ta l rats, given an in tra -peritonea l in jection  o f 5 u l o f a 0.9% 
NaCl solution containing 20 pg /m l ascorbic acid im m ediate ly a fte r  de livery by 
.caesarian section and maintained w ithou t feeding a t 37°C. The plasma glucose 
level decreased s ign ifican tly  to  65% o f the in it ia l value by two hours post pa rtum , 
and recovered s ligh tly  by three hours post partum  (Fig. 4.1).
E ffe c t o f adrenaline
A dm in istra tion o f various doses o f adrenaline im m ediate ly a fte r de live ry  
resulted in a dose-related increase in the plasma glucose concentration a t tw o 
hours post partum when doses o f 20 ng or higher were given (Table 4.2). The 
plevation o f plasma glucose was s ta tis tic a lly  s ign ifican t only fo llow ing  
adm in istration o f 2 pg or 5 pg o f adrenaline, bu t i t  would appear th a t an increase 
did occur at other doses, although in te r-an im a l varia tion in plasma glucose levels 
prevented this being o f s ta tis tica l s ignificance. A peak in the s tim u la to ry  e ffe c t o f 
adrenaline on plasma glucose concentration was seen w ith  a dose o f 2 pg, which 
produced a plasma glucose level 166% of the leve l in con tro l animals (Fig. 4.2).
E ffe c t o f adrenergic antagonists
Table 4.3 presents the plasma glucose concentrations three hours a fte r  
surgical delivery o f term  fe ta l rats; the con tro l level is shown together w ith  the 
levels obtained when an adrenergic antagonist had been adm inistered im m edia te ly  
post partum . Both the a-adrenergic antagonist phentolamine, and the 8 -adrenerg ic
TABLE 4.1
C ontro l levels o f carbohydrate m etabolites in vivo during 
the f ir s t  three hours post partum
Plasma3 
glucose (mM)
Plasma3 
la c ta te  (mM)
L iv e r3 
glycogen (mg/g liv e r wt)
Time
post partum 
(h) .........
0 4.49 + 0.12 
(n = 35)
8.03 + 0.50 
(n = 39)
105.6 + 4.2 
(n = 51)
2 *3.03 + 0.19 
(n = 28)
*3.13 + 0.44 
(n = 21)
102.0 + 4.6 
(n = 25)
3 *3.17 + 0.05 
(n = 46)
*2.99 + 0.39 
(n = 12)
b*D 80.6 + 3.7 
(n = 42)
5 p i o f 0.9% NaCl solution containing 0.1 pg ascorbic acid was adm inistered i.p. to 
a ll animals im m ediate ly a fte r delivery.
n = to ta l number o f fetuses from  3-14 lit te rs  (values obtained fo r  ind iv idual 
fetuses, see te x t fo r details).
a Values are shown as mean + SEM
*  S ign ifican tly  lower than a t zero tim e, p < 0.001
b S ign ifican tly  lower than at 2 hours p.p., p < 0.001
FI GU RE 4 . 1 Pl asma g l u c o s e ,  pl asma l a c t a t e  and l i v e r
gl ycogen l e v e l s  in t he p o s t n a t a l  p e r i o d
i n t he r a t .
Liver Glycogen
Plasma Glucose
Plasma Lactate
T im e A fte r D e livery  (h )
Day 2 2 c.. f e t a 1 r a t s  were de l i v e r ed b y c a e s a r i an sec t i  on » and
ma i n t a i ne d a t 37 0 c w i t h o u t feed i ng un t i 1 s a c r i f i c e d . P 1 a s m a
gl ucose  con c e n t r a t i on (O-------—o) , P 1as m a 1a c t a t e c o n c e n t r a t ion
(■---------- ■) a nd 1 i v e r gl ycogen con t e n t (*- -*) we r e d e t e r m i n e d f o r
i n d i v i d u a l a n i m a 1 s ( 8 e e t e x t f o r de t a i  1 8 ) .
TABLE 4.2
E ffe c t o f adrenaline administered in vivo on levels o f carbohydrate 
m etabolites at two hours post partum
Plasma3 Plasma3 L iv e r3
glucose (mM) lac ta te  (mM) glycogen (mg/g live r w t)
Dose o f
adrenaline
(ys)
0 3.03 + 0.19 3.13 + 0.44 102.0 + 4.6
(n = 28) (n = 21) (n = 25)
.004 2.99 + 0.22 3.33 + 0.48 96.7 + 9.6
(n = 5) (n = 3) (n = 5)
.02 3.16 + 0.29 3.28 + 0.57 104.8 + 9.7
(n = 4) (n = 5) (n = 4)
.04 3.04 + 0.18 2.51 + 0.23 112.6 + 5.9
(n = 5) (n = 4) (n = 5)
.4 3.17 + 0.28 3.09 + 0.37 97.9 + 16.4
(n = 5) (n = 5) (n = 5)
1 4.24 + 1.10 
(n = 4)
5.27 + 1.38 
(n = 4) ND
2 3.04 + 0.33 *5.82 + 0.69 91.3 + 8.3
(n = 4) (n = 4) (n = 5)
3 3.76 + 0.31 4.10 + 0.59 94.1 + 7.2
(n = 3) (n = 5) (n = 5)
5 *3.79 + 0.18 11.16 + 0.68 92.7 + 6.0
(n = 5) (n = 4) (n = 4)
10 3.58 + 0.47 
(n = 5)
ND
* *
59.3 + 6.3 
(n = 4)
5 p i o f 0.9% NaCl solution containing 0.1 pg ascorbic acid and adrenaline as 
indicated was administered i.p. im m ediate ly a fte r delivery.
n = to ta l number o f fetuses from  1-7 lit te rs  (values obtained fo r ind iv idual fetuses, 
see te x t fo r details).
a Values are shown as mean + SEM
ND Not determined
*  S ign ifican tly  d iffe re n t from  contro l, p < 0.01 
* *  S ign ifican tly  d iffe re n t from  contro l, p < 0.001
FI GURE A . 2 E f f e c t  of  a d r e n a l i n e  a d m i n i s t e r e d  I n v i v o
on c a r b o h y d r a t e  m e t a b o l i t e s  at  2 hours  
p o 8 t p a r t u i .
200
o
O
■O
160
120
80
40 -
_L I
2  4  6  8
Amount of  a d r e n a l i n e  a d m i n i s t e r e d  ( ug)
10
A d r e n a l i n e wa s adm in i s t er ed i . P . i mme d i a t e l y  a f t e r s u r g i c a 1
d e l i v e r y  o f day 22 c_ f e t a 1 r a t s » whi e h were m a i n t a i n e d a t 37
wi t h o u t  fe e d i n g u n t i l s a c r i f i c ed . P l as ma g 1 u c o 8 e c o n c e n t ra t ion
(O------------ O) , P l as m a l ac t a t e c o nc en t r a t ion (■------------ ■) and 1 i v e r .
gl ycogen c o n t en t (A----- —*) w e r e de t e r m i ned f or  in d i v i d u a 1
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TABLE 4.3
E ffe c t o f adrenergic antagonists administered in vivo on levels o f 
carbohydrate m etabolites at three hours post partum
Plasma3 
glucose (mM)
Plasma3 
la c ta te  (mM)
L iv e r3 
glycogen (mg/g liv e r wt)
Dose and
drug
0 3.17 + 0.05 2.99 + 0.39 80.6 + 3.7
(n = 46) (n=  12) (n = 42)
* * *
5 pg 2.78 + 0.22 8.61 + 1.23 68.5 + 10.8
propranolol (n = 12) (n = 9) (n=  11)
* * * *
10 pg 2.41 + 0.15 7.32 + 0.59 63.6 + 6.7
propranolol (n = 15) (n = 8) (n = 17)
6.4 pg *2.87 + 0.11 ND 62.7 + 6.1
phentolamine (n=  11) (n = 16)
12.8 pg 2.59 + 0.22 ND 83.5 + 5.6
phentolamine (n = 9) (n = 9)
3 p i o f 0.9% NaCl solution containing 0.1 pg ascorbic acid and an adrenergic 
antagonist as indicated was administered i.p. im m ediate ly a fte r delivery.
n = to ta l number o f fetuses from  2-11 l i t te rs  (values obtained fo r ind iv idual 
fetuses, see te x t fo r details).
a Values are shown as mean + SEM
ND Not determined
*  S ign ifican tly  d iffe re n t from  contro l, p < 0.023 
* *  S ign ifican tly  d iffe re n t from  contro l, p < 0.001
F I G U R E  4.3 E f f e c t  of  a d r e n e r g i c  a n t a g o n i s t s
a d m i n i s t e r e d  In v i vo  on c a r b o h y d r a t e  
m e t a b o l i t e s  at  3 hours post  pa r t um.
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antagonist propranolol produced a s ign ifican t decrease in the plasma glucose 
concentration determined at three hours post partum . For both compounds, a more 
marked e ffe c t was seen w ith  the higher dose, and a molar equivalent dose o f 
propranolol had a greater e ffe c t than phentolamine (Table 4.3 and Fig. 4.3).
4.3.2 PLASMA LACTATE
C ontro l levels
Plasma lac ta te  concentrations in term  fetuses given i.p. in jections o f 3 p i o f 
a 0.9% NaCl solution containing 0.1 pg o f ascorbic acid im m ediate ly a fte r  surgical 
de livery decreased s ign ifican tly  from  im m ediate ly postnatally to  two hours post 
partum , and showed a fu rth e r s light decrease in the fo llow ing hour (Table 4.1 & 
Fig. 4.1).
E ffe c t o f adrenaline
Adrenaline administered i.p. im m ediate ly a fte r caesarian de livery produced 
an increase in the plasma lac ta te  concentration a t two hours post partum  when 
doses in the pg range were given (Table 4.2). This elevation o f plasma la c ta te  
levels was o f s ta tis tica l significance only when 2 or 5 pg adrenaline were given, 
although i t  appeared to be only the in te r-an im a l varia tion  which prevented doses o f 
1 and 3 pg achieving s ta tis tica lly  s ign ifican t e ffects . The m axim al e ffe c t o f 
adrenaline on piasma lac ta te  concentration was at 3 pg, when a leve l 360% o f the 
contro l value was obtained.
E ffe c t o f adrenergic antagonists
Due to  a freezer fa ilu re , plasma samples from  a ll animals receiv ing 
phentolamine, and some animals receiving propranolol, were lost before th e ir 
lac ta te  content could be determined. In Table 4.3, therefore, plasma la c ta te  
concentrations a t three hours post partum  are shown only fo r con tro l animals and
those receiving propranolol fo r which lac ta te  levels were found. The (3-adrenergic 
antagonist propranolol, administered i.p. im m ediate ly a fte r surgical de livery o f 
term  ra t fetuses, stim ulated the plasma lac ta te  concentration three hours la te r 
whether 5 pg or 10 pg was given; w ith  both doses the increase in plasma lac ta te  
level was s ta tis tica lly  s ign ifican t. The plasma lac ta te  level obtained was 290% or 
230% o f the contro l level w ith  the lower or higher dose o f propranolol, 
respectively.
4.3.3 LIVER GLYCOGEN
Contro l levels
The amounts o f glycogen per un it weight o f live r im m ediate ly a fte r and at 
two and three hours a fte r delivery o f te rm  fetuses in the contro l group are shown 
in Table 4.1. The liv e r glycogen content in animals receiving no drug trea tm en t did 
not decrease s ign ifican tly  from  the level at delivery u n til three hours post partum , 
when the amount of hepatic glycogen present was reduced to 75% o f the sta rting  
level (Fig. 4.1).
E ffe c t o f adrenaline
In traperitoneal adm in istra tion o f adrenaline a t doses in the pg range to 
new ly-delivered term  fe ta l ra ts produced an increase in postnatal glycogenolysis 
(Table 4.2). The reduction in liv e r glycogen content a t two hours post partum  
achieved s ta tis tica l significance only when 10 pg o f adrenaline was in jected, but 
th is is probably due to  the small number o f fetuses receiving each dose o f 
adrenaline, and the in te r-an im al varia tion  in in it ia l liv e r glycogen content. 10 pg o f 
adrenaline reduced the amount o f hepatic glycogen at two hours post partum  to 
60% o f the amount present in contro l fetuses a t th is tim e point.
Effect of adrenergic antagonists
Table 4.3 shows the liv e r  glycogen content a t three hours post partum  o f 
animals given saline w ith  or w ithou t an adrenergic antagonist. Surprisingly, both 
doses o f the B-adrenergic antagonist propranolol appeared to stim ula te  glycogen 
loss by three hours post partum  (although th is result was not s ta tis tic a lly  
s ign ificant); the lower dose o f the a-adrenergic antagonist phentolamine had a 
s im ila r (non-significant) s tim u la to ry  e ffe c t, w h ils t the higher dose had no apparent 
e ffe c t on liv e r glycogen content.
4.4 DISCUSSION
4.4.1 CONTROL VALUES
In the experiments reported in th is chapter, the mean plasma glucose 
concentration in neonatal ra ts given contro l in jections decreased from  4.3 mM 
im m ediate ly a fte r delivery to  3.0 mM tw o hours la te r, and increased to  3.2 mM by 
the th ird  postnatal hour (Table 4.1). Plasma glucose levels reported in the 
lite ra tu re  range from  2.6 to 9.0 mM im m ediate ly a fte r delivery, from  1.1 to 
2.9 mM at two hours post partum , and from  1.5 to 5.0 mM at three hours post 
partum  (Benito e t al., 1980; Butcher & P o tte r, 1972; Cake et al., 1971; Cuezva et 
al., 1980b, 1982a; Fernandez e t al., 1983; G irard e t al., 1973a; Jansen e t al., 1984; 
P h illipe  & K itz m ille r, 1981; Snell &. Walker, 1973b; Sodoyez-Goffaux e t al., 1979a). 
The plasma glucose levels and the changes in these levels seen in con tro l animals in 
the f ir s t  three hours postnatally were therefo re  o f s im ila r magnitude to those 
reported by other workers.
The mean plasma lac ta te  concentration in contro l ra ts m aintained a t 37°C 
w ithou t feeding fo llow ing surgical delivery dropped from  8.0 mM to  3.1 mM in the 
f ir s t  two hours post partum and remained at a s im ila r level during the fo llow ing  
hour (Table 4.1). Reports o f plasma lac ta te  levels in newly delivered ra ts found in 
the lite ra tu re  range from  7.2 to  13.5 mM, w ith  values o f 2.0 to  3.2 nM and 1.8 to
3.0 mM at two and three hours post partum , respective ly (Cuezva e t al., 1980b; 
Fernandez et al., 1983; G irard et al., 1973a; Haymond et al., 1972; Jansen e t al., 
1984; Snell & Walker, 1973b). The contro l plasma lac ta te  concentrations found in 
the current work at zero tim e and two and three hours post partum  are there fo re  in 
agreement w ith  levels reported fo r this tim e period by other workers.
Mean live r glycogen content im m ediate ly a fte r delivery was 106 mg/g liv e r 
w t; th is showed very l i t t le  change in the f ir s t  two hours post partum  in con tro l
animals, dropping only to 102 mg/g, but decreased s ign ifican tly  to 81 mg/g by three 
hours post partum (Table 4.1). The in it ia l hepatic glycogen content determ ined in 
these experiments was o f a s im ila r order to values reported fo r caesarian-delivered 
animals in the lite ra tu re , which range from  78 to 99 mg/g liv e r w t. (Benito et al., 
1980; Butcher & P o tte r, 1972; Cuezva et al., 1980b, 1982a; Fernandez et al., 1983; 
G irard et al., 1972, 1973a; Jansen et al., 1984; Snell & Walker, 1973b). There was 
no s ign ifican t loss o f live r glycogen u n til the th ird  postnatal hour in contro l 
neonates in these experiments (Table 4.1). A delay before the onset o f postnatal 
glycogenolysis has been observed by a number o f other workers, as discussed in 
Chapter 1, section 1.1.2. The decrease to 76% o f the in it ia l level o f liv e r glycogen 
by three hours post partum in the curren t work is comparable w ith  published 
glycogen breakdown levels over this tim e period, varying from  54 to  76% (Benito et 
al., 1980; Cuezva et al., 1982a; G irard et al., 1972; Fernandez e t al., 1983; Snell & 
Walker, 1973b).
4.4.2 EFFECT OF ADRENALINE
400 ng o f adrenaline adm inistered i.p., although calculated to po ten tia lly  
increase plasma catecholam ine concentration by 100-fo ld  at two hours post partum  
(see section 4.1.2), had no s ign ifican t e ffe c t on the parameters studied a t th is tim e. 
The lack o f e ffe c t may be a re fle c tion  o f incomplete absorption and/or rapid 
clearance o f administered adrenaline. D eterm ination o f plasma catecholam ine 
levels in contro l neonates and those receiving various doses o f adrenaline would 
have been o f great help in in te rp re ting  the observations made, but th is was 
precluded by the com plexity and/or expense o f available assay techniques (Ben- 
Jonathan & Porter, 1976; Cuezva & Patel, 1982; Eriksson & Persson, 1982; Peuler & 
Johnson, 1977).
Doses o f adrenaline o f 1 pg appeared to s tim ula te  net glucose and la c ta te  
production, w h ils t 2 pg produced a detectable increase in glycogenolysis; however,
the e ffe c t o f adrenaline reached s ta tis tica l s ignificance only at 2 pg fo r glucose 
and lac ta te  concentrations and 10 pg fo r  glycogen content. The peak e ffe c t o f 
adrenaline in increasing plasma glucose concentration was seen when 2 pg were 
administered, w h ils t the stim u la tion  o f plasma lac ta te  was maxim al a t 5 pg (the 
highest doese fo r which samples were assayed), and prom otion o f glycogen 
breakdown increased w ith  increasing dose up to  the highest dose given (10 pg).
There have been very few reports o f the e ffe c ts  on carbohydrate metabolism 
o f adrenergic agonists given jn  vivo to  rats during the perinatal period. Infusion o f 
a 0.1% solution o f the $ -adrenergic agonist salbutamol in to the saphenous vein o f a 
gravid ra t on day 21 post coitum  produced a tw o -fo ld  increase in blood glucose 
concentration in the fetuses, w ith  a five  m inute la tency and a peak 15 m inutes 
a fte r commencement o f the infusion (Hauguel e t al., 1982). This finding suggests 
metabolism o f adrenergic compounds in the ra t is rapid, possibly accounting fo r the 
high dose o f adrenaline required to achieve an e ffe c t. In a study by Goldwater and 
S tetten (1974), a dose o f adrenaline o f 40 pg per 100 g body weight was given as 
two subcutaneous in jections to a gravid ra t at day 18.5 post co itum , and fetuses 
were taken 1 or 3 hours la te r. A marked decrease in fe ta l glycogen levels, to only 
10-15% o f contro l levels was seen. Yeung and O live r (1968) adm inistered 5 or 10 pg 
o f adrenaline in tra -pe ritonea lly  to  fe ta l ra ts in u tero. They observed tha t when 
fetuses were k illed  five  hours a fte r this trea tm ent, hepatic phosphoenolpyruvate 
carboxykinase was present a t detectable levels from  as early as day 16 post 
co itum .
The observation tha t doses o f adrenaline having a threshold and a peak e ffe c t
on the three parameters o f carbohydrate metabolism determined d iffe r , is due to
the fa c t tha t plasma levels o f glucose and lac ta te  re fle c t the net resu lt o f th e ir
production and u tilisa tion . Hems (1977 a) noted tha t in adult rats, liv e r
-8glycogenolysis was seen w ith  plasma adrenaline concentrations o f 10 M and above.
However, i t  was also seen tha t the lowest e ffe c tive  concentration o f adrenaline 
produced no increase in the glucose released by the live r, and i t  was proposed tha t 
glycogen breakdown induced by adrenaline leads to the production o f hexose 
phosphates fo r use in catabolic pathways such as glycolysis. Adrenaline trea tm en t 
o f perfused ra t heart has been shown to induce not only glycogenolysis but 
increased uptake o f glucose and fo rm ation  o f lac ta te  (C lark & Patten, 1984); i f  the 
adrenaline administered to newly delivered rats in the current study had s im ila r 
e ffec ts  on the live r, i t  m ight produce apparently anomalous changes in the three 
parameters determined in th is work.
4.4.3 EFFECT OF ANTAGONISTS
The doses o f adrenergic antagonists given were equivalent fo r the two 
compounds, on a molar basis, being 5 or 10 pg of the B-adrenergic antagonist 
propranolol and 6.4 or 12.8 pg o f the a-adrenergic antagonist phentolamine. The 
lower and higher doses o f the antagonists were the m olar equivalents o f 3 and 6 pg 
adrenaline, respectively, and would therefo re  be expected to have some e ffe c t on 
carbohydrate m etabolites i f  adrenergic stim u la tion  is m odifying the pathways o f 
carbohydrate metabolism. As m ight be predicted from  the experim ental findings 
reported in Chapters 2 and 3, the B-adrenergic antagonist propranolol adm inistered 
m vivo a t b irth  produced a decrease in the plasma glucose concentration compared 
w ith  contro l a t three hours post partum  (Table 4.3). However, the a-adrenerg ic 
antagonist phentolamine was also e ffe c tive  in reducing the physiological increase 
in plasma glucose concentration postnatally (Table 4.3). The studies reported in 
Chapter 3 provide evidence tha t the pathway fo r adrenergic m odulation o f hepatic 
carbohydrate metabolism in the perinata l ra t is B-mediated. However, i t  was also 
shown tha t an a-adrenergic agonist, phenylephrine, stim ulated glucose production 
by hepatocytes m v itro , a lbe it at higher concentrations than the B-adrenergic 
agonist isoprenaline (Fig. 3.3 vs. Fig. 3.4). A lthough the amounts o f the two
antagonists adm inistered to neonatal ra ts jn  vivo were identica l on a m olar basis, 
d ifferences in absorption and/or clearance o f the two components may have 
resulted in the liv e r being exposed to very d iffe re n t concentrations o f the agents. 
As subtype se le c tiv ity  o f any adrenergic agent is a re la tive  phenomenon, e ffec ts  o f 
phentolamine m ight be the result o f blocking o f (3-adrenoceptors by th is agent, i f  
present in su ffic ie n tly  high concentration.
As plasma lac ta te  concentration was increased by adrenergic stim u la tion , i t  
m ight be expected tha t adrenergic antagonism would decrease the lac ta te  level. In 
fa c t, as seen in Table 4.3, the B-adrenergic antagonist propranolol produced an 
increase in the mean plasma lac ta te  concentration. As plasma lac ta te  levels 
re fle c t its  production and its  u tilisa tion , an increase in the fo rm er or decrease in 
the la tte r, or a combination o f both o f these, would produce an increase in plasma 
lac ta te  concentration. This w ill be discussed fu rth e r a fte r the e ffec ts  o f adrenergic 
antagonists on live r glycogen content has been considered.
As propranol and phentolamine both produce decreases in plasma glucose 
concentration compared w ith  the contro l level, they m ight be expected to  reduce 
the breakdown o f live r glycogen, which is one source o f plasma glucose. However, 
both doses o f propranolol and the higher dose o f phentolamine produced increased 
glycogenolysis compared w ith  contro l, although this e ffe c t was not s ta tis tic a lly  
s ign ifican t (Table 4.3).
A possible explanation fo r the observed e ffec ts  o f adm in istra tion  o f 
propranolol is that, in addition to glycogen breakdown, glucose may be produced 
postnatally by hepatic gluconeogenesis, the po tentia l fo r which develops rap id ly  
a fte r b irth  (G irard et al., 1975; Snell & Walker, 1973b). Thus, i f  the decrease in 
plasma glucose levels induced by adrenergic antagonists is a result o f inh ib ition  o f
gluconeogenesis, th is m ight explain the apparent discrepancy between changes in 
plasma glucose and live r glycogen levels in Table 4.3. As discussed earlie r, plasma 
lac ta te  levels result from  the balance o f production and u tilisa tio n  o f this 
m etabolite  in m etabolic pathways; la c ta te  levels m ight be expected to  increase 
w ith  increasing glycogenolysis providing the substrate (glucose) fo r its  production 
but to decrease w ith  increasing gluconeogenesis which utilises this molecule as a 
substrate. The finding th a t trea tm en t w ith  an adrenergic antagonist produces a 
much greater proportional increase in plasma lac ta te  concentration than in hepatic 
glycogenolysis is strong support fo r an inh ib ito ry  action o f propranolol on 
gluconeogenesis. A possible mechanism fo r inh ib ition  o f the gluconeogenic pathway 
by an adrenergic antagonist is suggested by Yeung and O live r (1968) who observed 
prem ature induction o f the key gluconeogenic enzyme, hepatic 
phosphoenolpyruvate carboxykinase, in ra t fetuses receiving adrenaline jn  v ivo ; 
in terference w ith  the normal postnatal appearance o f th is enzyme would prevent 
the development o f gluconeogenic capacity in the live r.
G irard et al. (1973b) investigated the e ffe c t o f adm in istra tion o f 10 pg o f 
phentolamine or propranolol subcutaneously to  day 21.5 post coitum  fe ta l ra ts 
im m ediate ly a fte r caesarian delivery on liv e r glycogen and blood glucose levels a t 
six hours post partum . They found tha t the a-adrenergic antagonist caused some 
reduction in glycogen breakdown and in plasma glucose concentration, w h ils t the $ - 
adrenergic antagonist had no detectable e ffe c t. The reason fo r the discrepancies 
between the current findings and those reported by G irard ’s group are unclear.
4.4.4 SIGNIFICANCE OF FINDINGS
In the experiments reported in th is Chapter, i t  was shown th a t adrenaline 
administered m vivo to new ly-delivered rats produced changes in param eters o f 
carbohydrate metabolism two hours la te r. I t  would therefore seem th a t an
adrenergic system is present and functiona l in the neonatal ra t. The observation 
tha t inh ib ition  o f the adrenergic pathway in te rfe res w ith  the mechanisms o f 
recovery from  the postnatal hypoglycaemic phase suggest tha t ac tiva tion  o f 
adrenoceptors is a necessary fa c to r in the re tu rn  to normoglycaemia seen in the 
healthy neonatal ra t.
CHAPTER 5 
GENERAL DISCUSSION
5.1 HORMONAL CONTROL OF CARBOHYDRATE METABOLISM IN  THE
PERINATAL RAT
5.1.1 CURRENT VIEW
I f  the pathological consequences o f prolonged hypoglycemia are to be 
avoided, a newborn ra t must rapid ly acquire the a b ility  to produce glucose 
fo llow ing the cessation o f its  supply via the placenta and um bilica l blood supply. As 
described in Chapter 1 (Section 1.1.2), i t  is w e ll established tha t, even in the 
absence o f exogenous nutrients, normoglycemia is regained w ith in  hours o f b irth  in 
healthy neonates. Glucose production occurs in the live r fo llow ing changes in the 
a c tiv itie s  o f a number o f enzymes o f carbohydrate metabolism, and known 
postnatal changes in some o f these have already been discussed in Chapter 1 
(section 1.1.2). The rap id ity  w ith  which glucose production is in itia ted , together 
w ith  the observation tha t when gestation was experim enta lly prolonged, increases 
in the ac tiv itie s  o f gluconeogenic enzymes and commencement o f glycogen 
breakdown were seen jn  utero despite the absence o f a drop in blood glucose 
concentration (Portha et al., 1976, 1978a), suggest tha t postnatal hypoglycemia per 
se is not a su ffic ien t stimulus fo r induction o f glucose production.
A number o f hormones show w e ll documented changes in the ir plasma levels 
during the perinata l period (see section 1.2 fo r details) and as such may be 
considered candidates fo r regulation o f postnatal carbohydrate metabolism . The 
most prevalent view at present is tha t the pancreatic hormones insulin and 
glucagon are the major hormonal factors con tro lling  onset o f glucose production in 
the neonatal live r G irard e t al. (1973a) described postnatal changes in plasma 
concentrations o f pancreatic hormones which were o f a magnitude and d irection , 
and a t a tim e, such tha t they considered them to be 'prim e regulators' o f m etabolic 
changes in the neonatal ra t. The postnatal increase in plasma glucagon 
concentration, decrease in plasma insulin concentration, or rapid fa ll in the
insulin:glucagon ra tio  have a ll been proposed to be c r it ic a l in triggering  the onset 
o f glucose production. Both glycogenolysis and gluconeogenesis have been 
suggested to be in itia ted  by changes in the levels o f these pancreatic hormones. 
Increased glucagon secretion and tissue responsiveness to the hormone around the 
tim e o f b irth  has been suggested to s tim u la te  hepatic glycogenolysis (Blazquez £ t  
al., 1972). Secretion o f glucagon was proposed to  result in an ac tiva tion  o f hepatic 
glycogen phosphorylase and thereby glycogen breakdown by one laboratory (G irard 
e t al., 1972), w h ils t another (Bourbon, 1981) has suggested tha t insulin has the 
prim ary physiological role in the regulation o f phosphorylase a c tiv ity  in perinata l 
live r. Hanson et al. (1975) suggested tha t the decrease in insulin leve l and increase 
in glucagon level a t b irth  produced increases in hepatic cyc lic  AMP concentrations 
and thus stim ulated synthesis o f phosphoenolpyruvate carboxykinase, a key enzyme 
o f gluconeogenesis. This would support the suggestion tha t glucagon is a m ajor 
fac to r in the postnatal induction o f gluconeogenesis, w ith  insulin having an 
antagonistic role (G irard e t al., 1976). However, i t  is doubtfu l whether the 
increased synthesis o f th is enzyme a fte r b irth  can occur rap id ly enough to  account 
fo r the onset o f glucose production by the liv e r  postnatally. A marked increase in 
the cyc lic  AMP level in ra t live r has been noted a fte r b irth  (Blazquez e t al., 1974; 
Butcher & P o tte r, 1972; Novak e t al., 1972). D iM arco and coworkers suggested th a t 
the re la tive  concentrations o f insulin and glucagon would regulate the leve l o f 
cyc lic  AMP in the neonatal liver, and thereby the induction o f a number o f 
enzymes, including some c r it ic a l fo r glucose production (D iM arco Sc O live r, 1978; 
D iM arco et al., 1978). Glucagon may also stim ula te  flu x  through the gluconeogenic 
pathway by means o f inh ib ition  o f pyruvate kinase, possibly by phosphorylation 
(Riou et al., 1976), and this would be a rapid regulatory mechanism.
Various experim ental observations support the importance o f the pancreatic 
hormones in the regulation o f postnatal carbohydrate metabolism. When glucagon 
was included in the medium fo r fe ta l ra t liv e r cultures, this resulted in induction o f
phosphoenolpyruvate carboxykinase (Mandelli e t al., 1973). A number o f workers 
have investigated the e ffe c t o f adm inistering glucagon jn  vivo to newly delivered 
animals. Exogenous glucagon has been shown to prevent the period o f hypoglycemia 
norm ally seen postnatally (Cake et al., 1971; Snell & Walker, 1973c, 1978). 
Adm in is tra tion  o f glucagon to a fe ta l ra t has been shown to  induce gluconeogenic 
enzymes (Blazquez et al., 1972), and to a neonatal ra t to stim ula te  gluconeogenesis 
(Cake et al., 1971; G irard et al., 1976; Snell & Walker, 1978) and glycogenolysis 
(Snell &  Walker, 1973c). Exogenous insulin has been shown to reduce 
gluconeogenesis in the neonate (G irard e t al., 1976) and anti-insu lin  serum given 
postnatally promoted glycogen breakdown and abolished postnatal hypoglycemia 
(Snell &  Walker, 1978).
However, there are also a number o f findings which throw  some doubt on the 
concept o f changes in the levels o f insulin and glucagon being the only, or indeed 
even the major, fa c to r in the contro l o f postnatal glucose production.
A lthough i t  has been discussed earlie r tha t postnatal decrease in plasma 
glucose concentration per se is probably not a su ffic ien t stimulus fo r in it ia tio n  o f 
glucose production, i t  would seem reasonable tha t any hormonal system responsible 
fo r regulation o f the plasma glucose leve l would be responsive to tha t level. In the 
adult, sens itiv ity  o f the pancreatic A and B cells to acute glucose concentrations 
ensures appropriate secretion o f glucagon and insulin, respective ly, to  m ainta in 
normoglycemia under normal physiological conditions. There are numerous reports, 
however, tha t the pancreas o f the ra t during the perinata l period does not show 
such glucose sensitiv ity . Asplund et al. (1975) have shown a lack o f glucagon 
secretion in response to acute hypoglycemia, w h ils t Ferre et al. (1977) reported 
tha t the pancreatic A cells in the neonate are insensitive to acute changes in the 
plasma glucose concentration. Heinze &  Steinke (1971) found tha t pancreatic islets 
isolated from  neonatal rats released no insulin in response to glucose in the bathing
medium at a concentration invoking release from  adult islets, u n til day 2 or 3 post 
partum . In v ivo, the mechanism fo r insulin release from  the pancreas in response 
to  a raised plasma glucose concentration has been observed to reach fu ll m a tu rity  
only at 3 weeks post partum  (Blazquez e t al., 1975).
A second series o f observations which raises questions on a c r it ic a l ro le fo r . 
glucagon during the postnatal period are those regarding its  binding to hepatic 
receptors, and the responsiveness o f the liv e r to its  presence. Blazquez e t al. (1976) 
suggested a greatly  reduced sensitiv ity  o f the perinata l live r, compared w ith  the 
adult, to the e ffec ts  o f glucagon. This in te rp re ta tion  was based on the 
paradoxically high live r glycogen content o f fe ta l live r in re la tion  to  plasma 
glucagon concentration (although this m ight also be a result o f the very high fe ta l 
plasma insulin concentration), together w ith  the re la tive ly  poor responsiveness o f 
hepatic adenyl cyclase to glucagon in the perinata l period. V in ico r et al. (1976) 
also observed a re la tive  insensitiv ity  o f perinata l hepatic adenyl cyclase to 
glucagon. The most like ly  reason fo r the poor response o f perina ta l liv e r to 
glucagon is the reduced binding o f th is hormone to hepatic receptors in im m ature 
animals; maximal binding capacity o f glucagon in term  fe ta l liv e r has been 
reported to be 20-25% o f tha t in adult liv e r (Blazquez e t al., 1976; Pingoud e t al., 
1982; V in ico r et al., 1976).
Two fu rthe r studies are o f in terest when considering the possible significance 
o f pancreatic hormones in the regulation o f postnatal carbohydrate m etabolism . In 
the f ir s t  study, i t  was observed tha t mannoheptulose, an inh ib ito r o f insulin 
secretion, did not prevent the inh ib ition  o f glycogenolysis resulting from  
adm in istra tion o f glucose to neonatal rats (M artin  et al., 1981). The authors argued 
tha t th is was evidence tha t a postnatal decrease in insulin was not an essential 
fa c to r in the in itia tio n  o f glycogenolysis, and tha t as such the proposal th a t the 
insulin:glucagon ra tio  was the c r it ic a l param eter in postnatal carbohydrate
metabolism could not be valid. The second study involved measurement o f a range 
o f hormones and m etabolites during the perinata l period, in neonates from  both 
normal and gestationally diabetic dams (Cuezva e t al., 1982a). A c r it ic a l finding in 
th is work was tha t although in the offspring o f d iabetic mothers, the normal 
postnatal increase in plasma glucagon was not observed, an increase in hepatic 
cyc lic  AMP was s t i l l  found in these neonates. As i t  is generally considered tha t the 
observed increase in hepatic cyc lic  AMP is the mechanism fo r enzyme activa tion  
and induction which in turn  leads to  the postnatal in itia tio n  o f glucose production, 
and this study showed tha t this increase can occur w ithou t an increase in plasma 
glucagon, th is is strong evidence fo r a fac to r, or factors, other than glucagon being 
o f major regulatory significance fo r postnatal carbohydrate metabolism.
In searching fo r a lte rna tive  or additional factors to the pancreatic hormones 
which m ight be involved in the regulation o f glucose metabolism in the neonatal ra t 
live r, i t  is worthwhile considering the tim ing  o f events during the postnatal period. 
As described in deta il in Chapter 1 (Section 1.2), plasma insulin decreases and 
glucagon increases rapid ly in the newborn ra t, such tha t the insulinrglucagon ra tio  
reaches a minimum just 30 to 60 m inutes a fte r b irth  (D iM arco ejt al., 2978; G irard 
e t al., 1973a). However, as also discussed in Chapter 1 (Section 1.1), postnatal 
glycogenolysis does not appear to be in itia te d  u n til around two hours post partum , 
and recovery from  hypoglycemia is usually seen from  around th is  tim e. Thus, i t  
would seem tha t the events postulated to be triggered by the changes in plasma 
concentrations o f insulin and glucagon take place some tim e a fte r the maximum 
changes in the ir plasma levels. Plasma catecholam ine levels are also known to 
undergo acute postnatal changes, although as discussed in Section 1.2.5 there is a 
re la tive  paucity o f in fo rm ation  regarding the tim ing  and magnitude o f such 
changes. I t  would appear however, tha t catecholamines are very like ly  to  be 
involved in postnatal in itia tio n  o f glucose production; the evidence fo r  th is  is 
discussed in the fo llow ing section.
5.1.2 EVIDENCE FOR ADRENERGIC MODULATION
Evidence from  the lite ra tu re
I f  i t  is to be argued tha t adrenergic ac tiva tion  is a c r it ic a l fa c to r in invoking 
the required m etabolic changes to  allow recovery from  postnatal hypoglycemia, i t  
must be shown tha t the observations c ited to lend doubt to the predominance of 
insulin and/or glucagon levels in regulation o f carbohydrate metabolism do not 
apply to  catecholamines.
I t  was stated in section 5.1.1 th a t i f  a hormone system were to  be an 
e ffic ie n t regulator o f plasma glucose concentration, then glucose levels should 
a ffe c t hormone release. Ph illipe  & K itz m ille r  (1981) showed tha t fe ta l plasma 
adrenaline and noradrenaline levels were both inversely corre lated w ith  plasma 
glucose concentrations, including during a period o f insulin-induced hypoglycemia.
R e la tive ly  l i t t le  work has been published concerning liv e r responsiveness to  
catecholamines during the perinata l period. The observation by D iM arco e t al. 
(1976) tha t the increase in live r catecholam ine levels in la te  gestation and during 
b irth  is paralleled by an increase in hepatic cyc lic  AMP appears to show tha t 
adenyl cyclase is fu lly  responsive to  adrenergic stim u la tion  during the perina ta l 
period. This group has also shown tha t the increase in hepatic cyc lic  AMP in 
response to exogenous adrenaline reaches a peak at day 2 post partum , w h ils t tha t 
to  glucagon does not show maximum responsiveness u n til day 10 post partum . The 
finding o f live r responsiveness to adrenaline during the perinata l period comparable 
w ith  tha t seen in the adult is o f l i t t le  surprise when the binding o f catecholam ines 
to live r membranes is considered. In the only published study o f the B -adrenoceptor 
(generally considered to be o f greater significance fo r carbohydrate metabolism  
than the a-adrenoceptor in the perinata l ra t), the maxim al binding capacity around 
term  was actua lly  higher (by about tw o-fo ld ) than tha t found in the liv e r  o f m ature 
animals in the same study (M cM illian  e t al., 1983).
When the tim ing  o f changes in the plasma concentrations o f catecholamines
in the im m ediate ly postnatal period is considered, i t  is clear tha t such changes
m ight easily be modulating carbohydrate metabolism and producing the w e ll-
documented tem poral changes in the neonate. Both Cuezva et al. (1982a) and
Jansen e t al. (1984) noted a secondary increase in plasma catecholam ine
concentrations in the tim e shortly fo llow ing b irth  (see section 1.2.5 fo r details). In
both studies a to ta l plasma catecholam ine concentration o f around 3 ng/m l was
-8seen at two hours post partum , which is considerably higher than tha t (1CT M) 
which Hems (1977a) found was the threshold fo r s tim ula tion o f glycogenolysis in 
adu lt ra t live r. In Cuezva's study (Cuezva e t al., 1982a) contro l neonates were 
studied together w ith  neonates from  untreated and insulin-treated d iabetic dams. 
Although the absolute tim ing  o f the changes d iffe red  in these three groups o f 
animals, in each group the secondary increase in plasma catecholam ine 
concentration fo llowed the nadir in plasma glucose concentration, and the increase 
in catecholam ine levels was associated w ith  a decrease in liv e r glycogen content 
and an increase in plasma glucose concentration.
Experiments in which adm in istra tion o f adrenergic agonists and antagonists 
to  newborn rats jn  vivo have been shown to in te rfe re  w ith  the normal physiological 
regulation o f carbohydrate metabolism in the neonate have already been discussed 
in Chapter 4 (sections 4.4.2 and 4.4.3). However, the observation by Cake Sc O live r 
(1969) tha t adm in istra tion o f glucose or ergotam ine ta rtra te  both in h ib it the 
postnatal increase in hepatic cyc lic  AMP concentration is worth noting as fu rth e r 
evidence fo r adrenergic modulation o f cyc lic  AMP levels, and thereby carbohydrate 
metabolism, in the perinata l ra t.
Evidence from  this study
Radio ligand-receptor binding studies, described in Chapter 2, provided 
evidence fo r a substantial 8 -adrenoceptor population in the live r o f te rm  fe ta l ra t,
there being approxim ate ly 50% o f the number o f receptors found in adult liv e r (30 
fmoles/m g prote in  c f. 60 fm ols/m g prote in: Guellaen e t al., 1978; Munnich e t al., 
1981). The observation o f a peak in the number o f 8 -adrenoceptors a t term  is 
consistent' w ith  the concept o f adrenergic regulation o f postnatal glucose 
production, as maximum sens itiv ity  to adrenergic agents would be required at term  
i f  the e ffec ts  o f such agents were o f physiological significance. P roo f o f the 
presence o f 8 -adrenoceptors able to bind adrenergic ligands is necessary, but not 
conclusive, evidence fo r involvement o f the 8 -adrenergic system in modulation o f 
perinata l carbohydrate metabolism. Investigation o f the sens itiv ity  o f hepatic 
adenyl cyclase to adrenergic activa tion  during the perinata l period would have 
provided additional in teresting insight in to the functiona l competence o f the 8- 
adrenoceptors (but tim e lim ita tions  precluded such studies).
A series o f experiments investigating the stim ulation o f glycogen breakdown 
and gluconeogenesis in, and glucose release from , freshly isolated hepatocytes was 
carried out to establish the existence o f functiona l adrenergic pathways able to 
influence carbohydrate metabolism in perinata l ra t liv e r (Chapter 3). The findings 
made in these experiments established tha t adrenergic ac tiva tion  stim ulates 
glucose production by both la te  fe ta l and early neonatal hepatocytes. The observed 
potency order o f agonists in prom oting glucose production and antagonists in 
docking the stim ula tion o f glucose production by adrenaline gave very strong 
support to our view tha t the 8 -adrenoceptor is o f greater im portance in adrenergic 
e ffec ts  on glucose metabolism in perinata l liv e r than the a-adrenoceptor. The 
concentration-response experiments reported gave clear evidence fo r maximum 
sens itiv ity  to the e ffec ts  o f adrenergic agonists a t term ; th is is possibly a 
re flec tion  o f the peak in hepatic 8 -adrenoceptor number tha t we also showed at 
this tim e, although post-receptor events m ight also influence responsiveness. The 
work carried out jn  v itro  therefore produced results en tire ly  com patible w ith  the 
hypothesis tha t catecholamines are o f m ajor physiological significance in in it ia tin g  
the known postnatal changes in pathways o f glucose metabolism.
The experiments reported in Chapter 4 provide conclusive evidence tha t the 
adrenergic system not only could, but actua lly  does, play a v ita l ro le in the 
recovery from  hypoglycemia norm ally observed in the f ir s t  hours a fte r b irth  o f the 
laboratory ra t. As these experiments were carried out jn  v ivo, a ll humoral facto rs 
which m ight influence the pathways o f carbohydrate metabolism would be present. 
Under these conditions, exogenous adrenaline was observed to  reduce or even 
prevent the postnatal decrease in plasma glucose concentration seen in contro l 
animals, w h ils t the 3-adrenergic antagonists propranolol (and to a lesser extent the 
a-adrenergic antagonist phentolamine) inhib ited the re tu rn  to normoglycemia 
which s ta rts  from  two hours post partum .
5.1.3 POSSIBLE MECHANISMS OF ADRENERGIC EFFECTS
The enzymes involved in metabolism o f carbohydrates, and th e ir regulation, 
were described in Chapter 1 (section 1.1), as were the known adrenergic e ffe c ts  on 
hepatic carbohydrate metabolism in the perinata l ra t (section 1.3.3).
S tim ulation o f glycogen breakdown by catecholamines in the neonatal ra t is 
generally thought to  result from  conversion o f glycogen phosphorylase b to a as a 
resu lt o f phosphorylation by cyc lic  AMP-dependent prote in kinase; th is  view is 
supported by the observation o f ac tiva tion  o f phosphorylase by adrenaline or 
isoprenaline, but not by re la tive ly  high concentrations o f the a-adrenergic agonist, 
phenylephrine (Sherline et al., 1974). An a lte rna tive  mechanism is suggested 
however, by the demonstration in a number o f studies tha t term  fe ta l liv e r contains 
a high proportion o f lysosomal glycogen (Devos & Hers, 1980; Iwamasa e t al., 1975; 
Kotoulas & Phillips, 1970). Breakdown o f glycogen in lysosomal structures is 
mediated via acid a-glucosidase ra ther than glycogen phosphorylase. No work 
appears to have been reported regarding possible e ffec ts  o f catecholam ines on such 
enzymes, but Kotoulas & Phillips (1971) have shown tha t exogenous adrenaline 
stim ulates breakdown o f lysosomal glycogen in neonatal live r in v ivo.
Stim ulation o f the gluconeogenic path by catecholamines m ight occur at a 
number o f points: inh ib ition  o f the g lyco ly tic  enzymes pyruvate kinase and 
phosphofructokinase; or induction and/or ac tiva tion  o f the gluconeogenic enzyme 
phosphoenolpyruvate carboxykinase, appear to be the most like ly  mechanisms of 
regulation and the f ir s t  two are known to  be o f importance in the adult (see 
Chapter 1, section 1.3.2). The experim ental observations reported in Chapters 2, 3 
and 4 provide strong evidence fo r a functiona l 3 -adrenergic pathway in perinata l 
live r. The plasma levels o f catecholamines during the postnatal period reported in 
the lite ra tu re  are o f a magnitude such tha t 3 -adrenoceptors would be activa ted  jn  
v ivo , and such an activa tion  is w e ll documented to result in ac tiva tion  o f adenyl 
cyclase, production o f cyc lic  AMP and the classical 'cascade' o f prote in 
phosphorylation reactions.
Evidence tha t prote in phosphorylation reactions induced by ac tiva tion  o f the 
3 -adrenergic pathway could produce appropriate changes in the a c t iv ity  o f 
gluconeogenic enzymes comes from  a range o f studies. B la ir ^ t  al. (1979b) observed 
inh ib ition o f pyruvate kinase, w ith  a reduction in lac ta te  production, when 
hepatocytes isolated from  juvenile (100-150g) rats were exposed to  10 uM 
adrenaline or isoprenaline; phenylephrine at a s im ila r concentration had no such 
e ffe c t. These workers also concluded tha t the inh ib ition  o f pyruvate kinase by 
cyc lic  AMP in perfused adult liv e r was a result o f phosphorylation o f the enzyme 
by cyc lic  AMP-dependent prote in kinase (B la ir e t al., 1976). L jungstrom  e t al. 
(1974) confirm ed tha t phosphorylation o f pyruvate kinase by cyc lic  AMP-dependent 
prote in kinase produced a decrease in the enzyme's a c tiv ity ; th is  work was 
perform ed using the isolated, purified  enzyme. Inactiva tion  o f pyruvate kinase and 
an associated increase in gluconeogenesis were produced in isolated adu lt 
hepatocytes by e ithe r adrenaline or cyc lic  AMP (Feliu et al., 1976). Exposure o f 
isolated adult hepatocytes to cyc lic  AMP has also been shown to in h ib it flu x  
through phosphofructokinase, and to  enhance flux  through the opposing
gluconeogenic enzyme fructose 1,6-bisphosphatase (Castano e t al., 1979; C lark et 
al., 1974). The lack o f observations made using tissue from  perinata l animals makes 
f irm  conclusions regarding adrenergic e ffe c ts  on the enzymes pyruvate kinase and 
phosphofructokinase in the im m ediate ly postnatal period impossible, but i t  does 
seem highly like ly  tha t such inh ib ition  o f these enzymes would occur and thus 
resu lt in increased gluconeogenic flux . Presumably because o f the known dram atic 
changes which take place in phosphoenolpyruvate carboxykinase (PEPCK) around 
the tim e o f b irth  (see section 1.1.2), th is enzyme has been studied in ra ther more 
de ta il than other enzymes o f carbohydrate m etabolic pathways during the perinata l 
period. Jost & Picon (1970) described ac tiva tion  o f PEPCK in fe ta l liv e r by 
adrenaline and noradrenaline, and Yeung & O live r (1968) found th a t 5 or 10 pg o f 
adrenaline in jected jn  utero in tra  peritoneally  would induce the appearance o f 
PEPCK w ith in  five  hours from  as early as day 16 post coitum . Adrenaline, the 8 - 
adrenergic agonist isoprenaline, or cyc lic  AMP were each able to s tim u la te  the 
a c tiv ity  o f PEPCK in fe ta l liv e r explants, but these experiments used long organ 
cu lture  periods (Wicks, 1969, 1971) known to change adult liv e r adrenoceptor 
characteristics (see Chapter 1, section 1.3.3).
In addition to any d irec t e ffec ts  which catecholamines m ight have in 
producing the dram atic changes in carbohydrate metabolism occurring around the 
tim e o f b irth , ind irec t e ffec ts  o f the catecholamines mediated via th e ir a b ility  to 
modulate pancreatic secretion o f glucagon and insulin m ight also be o f 
significance. Insulin secretion is s tim ulated via 8-adrenoceptor ac tiva tion , and 
inhib ited via a-adrenoceptor ac tiva tion  (Gray et al., 1980; Hornbrook, 1970; Porte  
& Robertson, 1973; Woods & Porte, 1974). There is some evidence tha t s tim u la tion  
o f glucagon secretion by catecholamines is due to  8-adrenoceptor ac tiva tio n  
(Woods & Porte, 1974). 10 pg o f noradrenaline administered subcutaneously to te rm  
fetuses reduced the plasma level o f insulin and increased the plasma leve l o f 
glucagon (G irard et al., 1974); catecholam ine release around p a rtu ritio n  would
therefore  re in force the observed changes in the plasma levels o f the pancreatic 
hormones.
Figure 5.1 is a schematic representation o f po ten tia l mechanisms by which 
catecholamines m ight modulate carbohydrate metabolism in the pe rin ta l ra t.
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5.2 FINDINGS IN  OTHER SPECIES
Variations are known to exist between d iffe re n t species in the exact 
pathways and contro l o f hepatic carbohydrate metabolism; Pogson et al. (1983) 
demonstrated a number o f species differences using isolated hepatocytes and 
Dawkins (1966) commented on the heterogeneity o f fe ta l and neonatal hepatic 
carbohydrate metabolism when a number o f animal species are studied. This, 
together w ith  the observation tha t there is wide inter-species varia tion  in the 
degree o f adrenal medulla development during the perinatal period o f (Com line & 
Silver, 1966), makes i t  inadvisable to extrapolate findings made in the laboratory 
ra t to other species too free ly .
5.2.1 EXPERIMENTAL ANIMALS
The balance o f evidence from  the lite ra tu re  would appear to support a 
po ten tia l role fo r catecholam ine-stim ulated in itia tio n  o f glucose production via a 
B-adrenergic mechanism in the rabb it at b irth . In the la te fe ta l rabb it the adrenal 
medulla contains adrenaline which is released in response to s tim u li, such as 
anoxia, which would be present a t p a rtu rition  (R o ffi, 1972). Using hepatocytes 
isolated from  adult rabbits, Yorek et al. (1980, 1981) have demonstrated th a t 
adrenaline, isoprenaline, phenylephrine and cyc lic  AMP a ll s tim u la te  
gluconeogenesis by inh ib iting pyruvate kinase; the use o f adrenoceptor-selective 
adrenergic agonists and antagonists lead this group to conclude tha t th is e ffe c t was 
mediated via activa tion  o f B-adrenoceptors. Increased glycogenolysis, resulting 
from  stim ula tion o f glycogen phosphorylase a c tiv ity , is also seen in isolated rabb it 
hepatocytes in response to adrenergic agonists, and has been shown to  be &2~ 
mediated (A rinze & Kawai, 1979, 1983; A rinze et al., 1983). Selective s tim u la tion  
and blockage o f a -  and B -adrenoceptors in a perfused rabb it liv e r system provided 
evidence tha t adrenergic stim ula tion o f glycogenolysis in the rabb it was also B- 
mediated, from  as early as seven weeks o f age (Rufo et al., 1981). Radioligand 
binding studies demonstrated a predominance o f B-adrenoceptors, m ainly o f the
subtype, in adult rabb it liv e r (Kawai & Arinze, 1983). F ina lly , in a detailed study o f 
developmental changes in the hepatic adrenergic system of the rabb it, Kawai et al. 
(1985) demonstrated a reduction in the coupling o f the B-adrenoceptor to adenyl 
cyclase at 4-6 hours post partum  compared w ith  a t b irth , w ith  a subsequent 
increase in coupling up to  24 hours a fte r delivery. Such a change in the B- 
adrenergic pathway in the hours fo llow ing b irth  is suggestive o f a functiona l role 
fo r  th is pathway in the im m ediate ly postnatal period in the rabb it.
Studies o f carbohydrate metabolism in newborn lambs have produced some 
con flic ting  findings. Warnes et al. (1977a) found no gluconeogenesis from  lac ta te  in 
sheep jn  utero, despite the presence o f s ign ifican t phosphoenolpyruvate 
carboxykinase a c tiv ity ; th is group suggested (Warnes e t al., 1977b) th a t the very 
rapid postnatal onset o f gluconeogenesis is the result o f oxygenation, not increase 
in the a c tiv ity  o f any enzyme or enzymes, a view previously put forw ard fo r  the ra t 
(Philippid is & Ballard, 1970). Parameswaren & A rinze  (1981), by contrast, suggested 
tha t the rapid postnatal increase in m itochondria l phosphoenolpyruvate 
carboxykinase seen in sheep live r was v ita l fo r the in itia tio n  o f gluconeogenesis. 
In it ita t io n  o f glycogen breakdown was reported to be induced by catecholam ines 
secreted a t b irth  in the sheep (Sperling et al., 1984); however, while there is strong 
evidence fo r B-adrenergic mediated e ffec ts  in neonatal ra t, the e ffe c t in sheep was 
believed by these authors to  be due to  a-adrenoceptor activa tion .
Work by A rinze ’s group has provided evidence fo r  an involvem ent o f 
ac tiva tion  o f the B-adrenergic pathway in postnatal changes in carbohydrate 
metabolism in the guinea-pig live r. In hepatocytes isolated from  adult guinea pigs, 
s tim ulation o f glycogen phosphorylase and thereby o f glycogen breakdown by 
adrenergic agonists was shown to be due to ac tiva tion  of the adrenergic pathway 
via binding to  B2“ adrenoceptors (A rinze & Kawai, 1979, 1983; A rinze  e t al., 1983). 
Receptor labelling, studied using guinea pig live r membranes, demonstrated an age-
dependent increase in the size o f the B-adrenoceptor population postnatally (Kawai 
& A rinze, 1981).
5.2.2 CLIN IC AL OBSERVATIONS
Studies o f perinata l changes in pathways o f carbohydrate metabolism and o f 
the hormonal contro l o f these pathways have largely been carried out using 
experim ental animals. However, a great number o f relevant observations have been 
made in human subjects, and Adam (1971) has reviewed the contro l o f glucose 
metabolism in the human fetus and neonate. A newborn human baby shows a 
number o f m etabolic characteris tics in common w ith  neonatal rats. In the f ir s t  24 
hours a fte r b irth , cord blood from  human in fants showed increasing concentrations 
o f glucagon and free fa tty  acids, decreasing insulin levels, and catecholam ine 
concentrations decreasing from  very high levels at b irth  w ith  some ind ica tion o f a 
secondary increase soon a fte r delivery (Blazquez e t al., 1974; Lagercrantz & 
B is to lle ti, 1977; Leone tti e t al., 1980; Sperling e t al., 1974). Gluconeogenesis, 
absent from  the human liv e r jn  u tero, is active  a m a tte r o f hours a fte r  b ir th  in 
healthy neonates (Frazer et al., 1981; Kalhan e t al., 1980). As in many animal 
species, there is a period o f postnatal hypoglycemia in the human neonate which is 
corrected even in the absence of suckling; prolongation o f th is hypoglycemic phase 
m ight occur i f  the mechanisms involved in in itia tin g  glucose production postnata lly  
where disturbed in some way, and this could have trag ic  consequences. The 
po ten tia lly  damaging e ffec ts  o f hypoglycemia in an in fan t are w e ll documented 
(Beard et al., 1971; Cryer, 1983). Severe hypoglycemia in newborn babies is known 
to have serious consequences, which may include permanent neurological damage 
(Haworth and McRae, 1965; Pagliara et al., 1973).
I t  is o f great in te rest to establish the possible role o f catecholam ines in 
regulation o f perinata l hepatic carbohydrate metabolism in the human, so th a t 
appropriate steps m ight be taken to co rrec t exceptionally prolonged or pronounced
postnatal hypoglycemia. L i t t le  d irec t evidence is available as to the role, i f  any, 
o f the high catecholam ine levels seen at b irth , although i t  has been suggested tha t 
the adrenergic system does have a ’ functiona l ro le * in the neonate (Lagercrantz & 
B is to lle ti, 1977), and tha t fe ta l catecholam ine secretion during delivery may be an 
'im p o rta n t adaptive m echanism1 (Padbury et al., 1982). Some in teresting 
observations have arisen from  the use o f $ -sym pathom im etic drugs in the contro l 
o f prem ature labour. M etabolic e ffec ts  have been observed to resu lt from  such 
trea tm ent (Lunell e t al., 1977, 1978; Wager e t al., 1981), and po ten tia tion  o f 
postnatal hypoglycemia has been reported in some cases (Epstein e t al., 1979), 
which i t  has been suggested m ight be due to B-adrenergic mediated depletion o f 
fe ta l hepatic glycogen stores (Unbehaun, 1974). However, other case reports have 
shown no such e ffe c t (Andersson et al., 1977) and i t  has been suggested tha t 
tolerance to the drug trea tm ent would develop rapid ly (Wager e t al., 1981) and 
adverse e ffec ts  to the fetus were unlike ly (Lunell et al., 1977). This series o f 
findings would seem to suggest tha t, although adm in istra tion o f B- 
sym pathom im etic drugs to pregnant women is unlike ly to produce any harm fu l 
changes in perinata l hepatic carbohydrate metabolism, an active  adrenergic 
pathway fo r modulation o f glucose production a fte r  b irth  does exist in the human 
fetus and neonate.
5.3 CONCLUSIONS
The present study has included characterisation o f the developmental changes 
o f hepatic 3-adrenoceptors during the days im m ediate ly before and a fte r  b irth . To 
complete this p icture, s im ila r studies o f the a-adrenoceptor population are 
required, as previous studies showed m ajor discrepancies, as discussed in Chapter 2 
(section 2.4.6). Recent work on the interconversion o f adrenoceptor subtypes in 
incubated or cultured hepatocytes (see Chapter 1, section 1.3.1) reveals the 
p la s tic ity  o f receptor organisation in the live r. Since the perinata l ra t liv e r has 
been c learly  shown in th is study to  be characterised by a B -specific  adrenergic 
responsiveness, which is in contrast to the established adrenergic responsiveness o f 
the adult, the tim ing , contro l and physiological role o f th is sw itch to  an oi- 
adrenoceptor mediated adrenergic pathway are in trigu ing  questions. This tem poral 
change in the predominant hepatic adrenergic receptor population m ight involve a 
red is tribu tion  in the proportions o f the adrenoceptor population consisting o f the 
d iffe re n t types, or may be the result o f m aturation o f the in tra ce llu la r post- 
receptor signalling mechanisms.
Evaluation o f the roles o f the adenyl cyclase-cyclic AMP and the 
phosphatidyl inosito l-ca lc ium  signalling mechanisms as possible 'second messengers' 
in the e ffec ts  o f catecholamines on glucose production observed in the present 
work both jn  v itro  (Chapter 3) and jn  vivo (Chapter 4) would be o f great help in 
e lucidating the developmental changes taking place in the perinata l ra t live r. Such 
studies m ight also c la r ify  the unanticipated but in trigu ing observations made w ith  
the a-adrenergic antagonist phentolamine, both in the radioligand binding studies 
(Chapter 2) and the experiments in which glucose production rates in isolated 
hepatocytes were determ ined (Chapter 3). Complex in terre la tionships between 
occupation o f various adrenoceptor subtypes and subsequent e ffec ts  on a lte rna tive  
in trace llu la r signalling systems m ight underlie the apparently paradoxical e ffe c ts  
observed.
In the present study, the e ffec ts  o f catecholamines on glucose production in 
hepatocytes isolated from  rats a t various tim es in the perina ta l period were 
characterised in term s o f m inimum concentration to e lic it  an e ffe c t, maximal 
e ffe c t achieved and sens itiv ity  o f the glucose production pathway to stim u la tion  by 
catecholamines; th is is the f ir s t  tim e such findings have been reported. To gain 
greater insight in to  these observed e ffec ts , i t  would be very in fo rm a tive  to 
determ ine the f lw lc  enzymes o f glucose metabolism in isolated
perinata l hepatocytes in the absence or presence o f concentrations o f 
catecholamines known to stim ulate glucose production.
A physiological role fo r the adrenergic system in postnatal in it ia tio n  o f 
hepatic glucose production in the laboratory ra t has been demonstrated by the 
experiments reported in th is thesis. The paucity o f re levant human data makes 
extrapolation o f the observations in the ra t to the human neonate unreasonable, 
and s im ila r studies to those described here should be carried out using post m ortem  
human fe ta l and neonatal live r tissue before any conclusions may be drawn 
regarding the relevance o f the findings o f th is study to the c lin ica l s ituation.
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